<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1-3.dtd?><?SourceDTD.Version 1.3?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Life (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Life (Basel)</journal-id><journal-id journal-id-type="publisher-id">life</journal-id><journal-title-group><journal-title>Life</journal-title></journal-title-group><issn pub-type="epub">2075-1729</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">10221674</article-id><article-id pub-id-type="doi">10.3390/life13051073</article-id><article-id pub-id-type="publisher-id">life-13-01073</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Modern Trends in Natural Antibiotic Discovery</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Baranova</surname><given-names>Anna A.</given-names></name><xref rid="af1-life-13-01073" ref-type="aff">1</xref><xref rid="af2-life-13-01073" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8961-5890</contrib-id><name><surname>Alferova</surname><given-names>Vera A.</given-names></name><xref rid="af1-life-13-01073" ref-type="aff">1</xref><xref rid="af2-life-13-01073" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9436-6561</contrib-id><name><surname>Korshun</surname><given-names>Vladimir A.</given-names></name><xref rid="af1-life-13-01073" ref-type="aff">1</xref><xref rid="c1-life-13-01073" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5597-6161</contrib-id><name><surname>Tyurin</surname><given-names>Anton P.</given-names></name><xref rid="af1-life-13-01073" ref-type="aff">1</xref><xref rid="c1-life-13-01073" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Chuang</surname><given-names>Duen-Yau</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-life-13-01073"><label>1</label>Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Miklukho-Maklaya 16/10, 117997 Moscow, Russia; <email>anjabaranowa@list.ru</email> (A.A.B.); <email>alferovava@gmail.com</email> (V.A.A.)</aff><aff id="af2-life-13-01073"><label>2</label>Gause Institute of New Antibiotics, Bolshaya Pirogovskaya 11, 119021 Moscow, Russia</aff><author-notes><corresp id="c1-life-13-01073"><label>*</label>Correspondence: <email>v-korshun@yandex.ru</email> (V.A.K.); <email>anton2rin@gmail.com</email> (A.P.T.)</corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>4</month><year>2023</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2023</year></pub-date><volume>13</volume><issue>5</issue><elocation-id>1073</elocation-id><history><date date-type="received"><day>11</day><month>3</month><year>2023</year></date><date date-type="rev-recd"><day>10</day><month>4</month><year>2023</year></date><date date-type="accepted"><day>21</day><month>4</month><year>2023</year></date></history><permissions><copyright-statement>&#x000a9; 2023 by the authors.</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Natural scaffolds remain an important basis for drug development. Therefore, approaches to natural bioactive compound discovery attract significant attention. In this account, we summarize modern and emerging trends in the screening and identification of natural antibiotics. The methods are divided into three large groups: approaches based on microbiology, chemistry, and molecular biology. The scientific potential of the methods is illustrated with the most prominent and recent results.</p></abstract><kwd-group><kwd>antibiotics</kwd><kwd>natural products</kwd><kwd>dereplication</kwd><kwd>BGC activation</kwd><kwd>genome mining</kwd><kwd>in situ cultivation</kwd><kwd>co-cultivation</kwd></kwd-group><funding-group><award-group><funding-source>Russian Science Foundation</funding-source><award-id>22-74-00155</award-id></award-group><funding-statement>The work was supported by the Russian Science Foundation, project no. 22-74-00155, <uri xlink:href="https://rscf.ru/en/project/22-74-00155/">https://rscf.ru/en/project/22-74-00155/</uri> (accessed on 20 April 2023).</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-life-13-01073"><title>1. Introduction</title><p>Prevention and treatment of many infectious diseases is impossible without the use of antibiotics. At the same time, the efficacy of medical antibiotics is steadily declining due to the spread of antimicrobial resistance on the one hand, and the lack of fundamentally new antimicrobial agents on the other. The WHO already lists some infections caused by resistant bacteria as a &#x0201c;critical priority&#x0201d; for the development of new antibiotics [<xref rid="B1-life-13-01073" ref-type="bibr">1</xref>].</p><p>Selman Waksman, one of the pioneers in the development of medical antibiotics, defined antibiotics as &#x0201c;a chemical substance, produced by micro-organisms, which has the capacity to inhibit the growth of and even to destroy bacteria and other micro-organisms&#x0201d; [<xref rid="B2-life-13-01073" ref-type="bibr">2</xref>]. Since then, the definition has undergone many changes [<xref rid="B3-life-13-01073" ref-type="bibr">3</xref>,<xref rid="B4-life-13-01073" ref-type="bibr">4</xref>,<xref rid="B5-life-13-01073" ref-type="bibr">5</xref>], and there is still no consensus. Today, &#x0201c;antibiotics&#x0201d; usually refers to antibacterial therapeutic agents based on small molecules, without insisting on their production by microorganisms. Therefore, &#x0201c;antibiotics&#x0201d; can be natural products, their semisynthetic derivatives, or fully synthetic substances. Each group contributes to the fight against microbial infections. Semisynthetic antibiotics rely on parent natural precursors, and fully synthetic antibacterials are often bioinspired. Therefore, broadly speaking, natural compounds are the main source of new antimicrobial agents [<xref rid="B6-life-13-01073" ref-type="bibr">6</xref>,<xref rid="B7-life-13-01073" ref-type="bibr">7</xref>].</p><p>Together with the definition of antibiotics, Waksman introduced the first platform for systematic screening of new antibiotics [<xref rid="B8-life-13-01073" ref-type="bibr">8</xref>]. The workflow includes the isolation of soil-dwelling microorganisms, largely actinobacteria, and a growth inhibition assay. The subsequent purification of active compounds from selected culture broths gave us many useful natural products (<xref rid="life-13-01073-f001" ref-type="fig">Figure 1</xref>). The main classes of medicinal antibiotics were discovered in this &#x0201c;golden age&#x0201d;&#x02014;1940&#x02013;1960s&#x02014;when the Waksman phenotypic screening approach was exploited by many groups both in academia and in the pharmaceutical industry [<xref rid="B9-life-13-01073" ref-type="bibr">9</xref>]. The stagnation in antibiotic discovery, along with various difficulties in their development, allows one to ask a question: &#x0201c;Is the success story over?&#x0201d; [<xref rid="B10-life-13-01073" ref-type="bibr">10</xref>]. Due to a variety of issues, antibiotic development became very risky and costly for pharmaceutical companies. Since improving antibiotic development requires primarily legislative solutions, there is little that researchers can contribute. However, scientists can and should extract all useful antimicrobial substances from nature to the largest extent possible. Thus, let us take a look at the current trends in this area.</p><p>After decades of success, researchers recognized the limitations of the &#x0201c;Waksman platform&#x0201d;:<list list-type="order"><list-item><p>Most of the soil microbiome is unculturable in standard lab conditions. Even for actinomycetes, classical isolation methods yield a large number of Streptomyces colonies, but other species of the class are underrepresented. As a result, we cannot evaluate the biosynthetic potential of the majority of microorganisms (the microbial dark matter problem).</p></list-item><list-item><p>Screening of cultures with broad antimicrobial activity often yields toxic and/or well-known compounds (the re-isolation problem).</p></list-item><list-item><p>The screening requires prolonged cultivations (to isolate axenic cultures, for test fermentations, etc.) and resource-consuming activity-guided isolation of antibiotics. In general, it cannot be adapted for fast and high-throughput screening.</p></list-item></list></p><p>Although random search sporadically provides some interesting results (e.g., the recent discovery of gausemycins (<xref rid="life-13-01073-f002" ref-type="fig">Figure 2</xref>), a new class of lipoglycopeptide antibiotics possessing an original mechanism of action against Gram-positive bacteria [<xref rid="B11-life-13-01073" ref-type="bibr">11</xref>]), it cannot be considered a modern methodology anymore.</p><p>In this review, we summarize the main advancements that overcome the limitations of traditional phenotypic screening or increase its efficiency. We have critically analyzed both the methodology and the outcome of recent studies (from 2012 to the present). The new approaches emerging in this multidisciplinary area of research can be schematically divided into three main classes, as shown in <xref rid="life-13-01073-f003" ref-type="fig">Figure 3</xref>.</p></sec><sec id="sec2-life-13-01073"><title>2. Microbiology</title><p>Isolating antibiotic producers the traditional way leads to systematic selection of only a small fraction of the existing microbial diversity. New genomic data [<xref rid="B12-life-13-01073" ref-type="bibr">12</xref>] indicate that the production of specific metabolites can occur in uncultured microbial taxa. Obviously, only a small portion of the antibiotics produced by microorganisms has been selected so far, while their biosynthetic potential is much higher [<xref rid="B13-life-13-01073" ref-type="bibr">13</xref>].</p><p>Novel data spurred ecology-driven antibiotic discovery in understudied environments (<xref rid="life-13-01073-f004" ref-type="fig">Figure 4</xref>). Since the adaptation of microorganisms to specific ecological niches is realized by bizarre biochemistry and unusual pathways and metabolism, such microorganisms can be a source of new biosynthetic gene clusters [<xref rid="B14-life-13-01073" ref-type="bibr">14</xref>]. Moreover, even for well-studied habitats, it is possible to increase the seeding capacity of the producers. It is known that 95&#x02013;99% of the total microbiome belongs to microorganisms that are not cultivatable under standard laboratory conditions [<xref rid="B15-life-13-01073" ref-type="bibr">15</xref>,<xref rid="B16-life-13-01073" ref-type="bibr">16</xref>,<xref rid="B17-life-13-01073" ref-type="bibr">17</xref>,<xref rid="B18-life-13-01073" ref-type="bibr">18</xref>]. New cultivation technologies enable access to a part of this cryptic microbiome.</p><p>Another step at which some potentially valuable antibiotic metabolites are lost is primary screening. Most often, producers exhibiting a broad spectrum of activity of cultural broth are selected. Recently, the paradigm has changed, and metabolites with more selective action are attracting more and more attention [<xref rid="B19-life-13-01073" ref-type="bibr">19</xref>].</p><sec id="sec2dot1-life-13-01073"><title>2.1. Exploring New Habitats</title><p>The high frequency of streptomycetes and the rediscovery problem have led to a natural decline in interest in soil microorganisms. Since most antibacterial agents come from well-known terrestrial or aquatic actinomycete isolates [<xref rid="B20-life-13-01073" ref-type="bibr">20</xref>], researchers focused on microorganisms isolated from unusual habitats [<xref rid="B21-life-13-01073" ref-type="bibr">21</xref>]. The search for new bioactive molecules has shifted toward marine ecosystems [<xref rid="B22-life-13-01073" ref-type="bibr">22</xref>,<xref rid="B23-life-13-01073" ref-type="bibr">23</xref>,<xref rid="B24-life-13-01073" ref-type="bibr">24</xref>], taxa living in extreme environments [<xref rid="B25-life-13-01073" ref-type="bibr">25</xref>,<xref rid="B26-life-13-01073" ref-type="bibr">26</xref>,<xref rid="B27-life-13-01073" ref-type="bibr">27</xref>,<xref rid="B28-life-13-01073" ref-type="bibr">28</xref>], plant-associated endophytes [<xref rid="B29-life-13-01073" ref-type="bibr">29</xref>,<xref rid="B30-life-13-01073" ref-type="bibr">30</xref>] and epiphytes [<xref rid="B31-life-13-01073" ref-type="bibr">31</xref>], and hard-to-reach habitats (such as karst caves) [<xref rid="B32-life-13-01073" ref-type="bibr">32</xref>].</p><p>Marine ecosystems are highly diverse in terms of temperature fluctuations, pressure, light, composition and nutrient concentration. Due to the unique features of polyextremophilic adaptation and a wide range of secondary metabolites, producers of marine origin are an interesting subject in terms of expanding the space of pharmacophores [<xref rid="B28-life-13-01073" ref-type="bibr">28</xref>,<xref rid="B33-life-13-01073" ref-type="bibr">33</xref>,<xref rid="B34-life-13-01073" ref-type="bibr">34</xref>]. Microorganisms of marine origin are often associated with various marine invertebrates, algae and plants, contributing to the nutrient cycle and decomposition of organic matter [<xref rid="B35-life-13-01073" ref-type="bibr">35</xref>]. Therefore, they produce a huge number of secondary metabolites with antitumor and antibiotic activity [<xref rid="B28-life-13-01073" ref-type="bibr">28</xref>,<xref rid="B36-life-13-01073" ref-type="bibr">36</xref>]. The main source of the majority of modern antibiotics of natural origin is actinobacteria, which can live in a variety of environmental conditions [<xref rid="B37-life-13-01073" ref-type="bibr">37</xref>,<xref rid="B38-life-13-01073" ref-type="bibr">38</xref>,<xref rid="B39-life-13-01073" ref-type="bibr">39</xref>,<xref rid="B40-life-13-01073" ref-type="bibr">40</xref>].</p><p>Natural products produced in extreme environments are optimized for these niches and might require significant modification to work in humans. Certain symbiont habitats impose requirements on microorganisms that facilitate the selection of metabolites with high therapeutic potential (e.g., nontoxic to mammals and active against Gram-negative bacteria) [<xref rid="B14-life-13-01073" ref-type="bibr">14</xref>]. Bacteria and fungi that participate in symbiosis are an area that still remains underexplored for the discovery and development of new antibiotics. Symbiosis with plants, invertebrates, marine sponges and other organisms has evolved under the influence of the host organism, which makes bacterial symbionts a promising source of unusual metabolites [<xref rid="B41-life-13-01073" ref-type="bibr">41</xref>,<xref rid="B42-life-13-01073" ref-type="bibr">42</xref>,<xref rid="B43-life-13-01073" ref-type="bibr">43</xref>].</p><p>One such microorganism is <italic toggle="yes">Photorhabdus</italic> sp., a nematophilic bacteria, a key member of the nematode gut microbiome. Darobactin (<xref rid="life-13-01073-f005" ref-type="fig">Figure 5</xref>), an antibiotic isolated in 2019 by a group led by Kim Lewis, was derived from the nematode symbiont strain <italic toggle="yes">Photorhabdus khanii</italic> HGB1456 [<xref rid="B44-life-13-01073" ref-type="bibr">44</xref>]. Darobactin acts against Gram-negative bacteria by inhibiting the assembly of outer membrane proteins [<xref rid="B45-life-13-01073" ref-type="bibr">45</xref>]. In 2022, the Lewis group isolated a new potent and selective antibiotic, evybactin (<xref rid="life-13-01073-f005" ref-type="fig">Figure 5</xref>), active against <italic toggle="yes">Mycobacterium tuberculosis</italic>, from another nematode symbiont strain, <italic toggle="yes">Photorhabdus noenieputensis</italic> DSM 25462 [<xref rid="B46-life-13-01073" ref-type="bibr">46</xref>].</p><p>Endophytic microorganisms, especially actinomycetes [<xref rid="B47-life-13-01073" ref-type="bibr">47</xref>,<xref rid="B48-life-13-01073" ref-type="bibr">48</xref>] and fungi [<xref rid="B49-life-13-01073" ref-type="bibr">49</xref>], possess a great variety of biologically active metabolites. Endophytic bacteria are used not only in medicine and veterinary medicine, but also as biofertilizers and biocontrol agents in agriculture [<xref rid="B50-life-13-01073" ref-type="bibr">50</xref>,<xref rid="B51-life-13-01073" ref-type="bibr">51</xref>].</p></sec><sec id="sec2dot2-life-13-01073"><title>2.2. New Cultivation Techniques</title><sec id="sec2dot2dot1-life-13-01073"><title>2.2.1. The Co-Cultivation Approach</title><p>The complete diversity of secondary metabolites produced by microorganisms cannot be harvested by standard monocultivation techniques. Unconventional methods are needed to awaken &#x0201c;silent&#x0201d; biosynthetic pathways and induce the production of secondary metabolites. One of the most promising approaches to in vitro cultivation is simulation of the natural interaction between different species of microorganisms by means of co-culturing [<xref rid="B52-life-13-01073" ref-type="bibr">52</xref>] to obtain a large variety of secondary metabolites [<xref rid="B53-life-13-01073" ref-type="bibr">53</xref>]. In a co-culture, two or more distinct microorganisms are incubated together in order to mimic the natural environment [<xref rid="B52-life-13-01073" ref-type="bibr">52</xref>,<xref rid="B54-life-13-01073" ref-type="bibr">54</xref>,<xref rid="B55-life-13-01073" ref-type="bibr">55</xref>]. It is possible that this method of cultivation will contribute to the disinhibition of the &#x0201c;silent&#x0201d; genes responsible for the production of certain antibiotics. Moreover, co-cultivation may lead to diversification of secondary metabolites by biotransformation by other species.</p><p>The interest in obtaining secondary metabolites by co-culturing a fungus with a fungus is also increasing every year [<xref rid="B56-life-13-01073" ref-type="bibr">56</xref>]. Interestingly, the most common microorganisms that co-ferments with other microbes and produces numerous new chemical structures are fungi of the genus <italic toggle="yes">Aspergillus</italic> [<xref rid="B57-life-13-01073" ref-type="bibr">57</xref>].</p></sec><sec id="sec2dot2dot2-life-13-01073"><title>2.2.2. In Situ Cultivation</title><p>As mentioned above, most species of microorganisms are unculturable and cannot grow under normal laboratory conditions [<xref rid="B58-life-13-01073" ref-type="bibr">58</xref>], and alternative methods of in situ cultivation are being considered for them: diffusion chambers [<xref rid="B59-life-13-01073" ref-type="bibr">59</xref>], iChip [<xref rid="B60-life-13-01073" ref-type="bibr">60</xref>], microbial traps [<xref rid="B61-life-13-01073" ref-type="bibr">61</xref>], the double encapsulation technique [<xref rid="B62-life-13-01073" ref-type="bibr">62</xref>] and others. Each of these methods leads to an increase in microorganism isolation rate [<xref rid="B58-life-13-01073" ref-type="bibr">58</xref>]. For example, three times as many new bacterial species were isolated using a diffusion chamber compared to standard direct plating cultivation [<xref rid="B63-life-13-01073" ref-type="bibr">63</xref>].</p><p>The diffusion chamber consists of a stainless steel or plastic washer and membranes with a pore size of 0.03 &#x000b5;m (<xref rid="life-13-01073-f006" ref-type="fig">Figure 6</xref>). After attaching the membrane on one side, the inoculum is placed inside the chamber, and then the chamber is closed on the reverse side with another membrane. After assembly, the chamber is placed in the initial natural medium, and the inoculated microbes are incubated for several weeks. During in situ cultivation, the membrane ensures the exchange of growth factors and nutrients between the natural environment and the agar inside the chamber. This approach should minimize the differences in the chemical environment on both sides of the membrane, thus mimicking natural conditions inside the chamber [<xref rid="B59-life-13-01073" ref-type="bibr">59</xref>].</p><p>The essence of the isolation chip technology (iChip), a high-throughput cultivation method, is the use of a diffusion chamber-type device with a small cell size, closed on both sides by a fine-pored track membrane. The polycarbonate membrane allows only low-molecular-weight substances to pass [<xref rid="B64-life-13-01073" ref-type="bibr">64</xref>].</p><p>This technology made it possible to isolate the beta-proteobacterium <italic toggle="yes">Eleftheria terrae</italic>, a producer of the antibiotic teixobactin (<xref rid="life-13-01073-f007" ref-type="fig">Figure 7</xref>), a non-ribosomal peptide with an original structure, from soil [<xref rid="B65-life-13-01073" ref-type="bibr">65</xref>]. Teixobactin inhibits both peptidoglycan and teichoic acid synthesis by binding bactoprenol-coupled cell wall precursors [<xref rid="B66-life-13-01073" ref-type="bibr">66</xref>]. The macrolide amicobactin, which showed antituberculosis activity, was obtained this way [<xref rid="B67-life-13-01073" ref-type="bibr">67</xref>]. Hypeptin, an antibiotic produced by <italic toggle="yes">Lysobacter</italic> sp. K5869 and obtained using the iChip technology, has common structural features with teixobactin and exhibits potent activity against a wide range of Gram-positive bacteria [<xref rid="B68-life-13-01073" ref-type="bibr">68</xref>].</p></sec><sec id="sec2dot2dot3-life-13-01073"><title>2.2.3. Microtechnology</title><p>Various microtechnologies can also be used to increase microbial biodiversity. They allow to improve of high-throughput screening, reducing the time and resources needed for experiments. Recently [<xref rid="B69-life-13-01073" ref-type="bibr">69</xref>], three main microtechnology methods have appeared: Microarrays, microencapsulation [<xref rid="B70-life-13-01073" ref-type="bibr">70</xref>] and micromechanical devices and microfluidics [<xref rid="B71-life-13-01073" ref-type="bibr">71</xref>].</p><p>Microfluidics, a technique that has been rapidly developing in recent years, is worth mentioning in more detail [<xref rid="B72-life-13-01073" ref-type="bibr">72</xref>]. This droplet-based technique generates homogeneous microdroplets under precise control at the picoliter or nanoliter scale upon high-frequency vibration (~kHz) [<xref rid="B73-life-13-01073" ref-type="bibr">73</xref>]. The droplets can function as bioreactors for versatile chemical/biological studies. Taking advantage of a discrete compartment with limited volume, single-cell isolation and manipulation, improved effective concentrations in droplets, elimination of heterogeneous population effects and reduced contamination risks, this technique is a powerful tool for rapid, sensitive and high-throughput detection and analysis of bacteria, even for rare or unculturable strains [<xref rid="B74-life-13-01073" ref-type="bibr">74</xref>,<xref rid="B75-life-13-01073" ref-type="bibr">75</xref>,<xref rid="B76-life-13-01073" ref-type="bibr">76</xref>]. For example, a platform for ultra-high-throughput screening in microfluidic double water-in-oil-in-water emulsion droplets was created [<xref rid="B77-life-13-01073" ref-type="bibr">77</xref>]. The method is based on the encapsulation of microorganisms into droplets of a monodisperse microfluidic double water-in-oil-in-water emulsion (MDE) and fluorescence-activated cell sorters (FACS) [<xref rid="B71-life-13-01073" ref-type="bibr">71</xref>,<xref rid="B78-life-13-01073" ref-type="bibr">78</xref>,<xref rid="B79-life-13-01073" ref-type="bibr">79</xref>]. The MDE-FACS platform is applicable to a variety of activity types and in-depth microbial community profiling.</p><p>Despite the success in the technical implementation of microfluidic cultivation into the antibiotic screening process [<xref rid="B80-life-13-01073" ref-type="bibr">80</xref>,<xref rid="B81-life-13-01073" ref-type="bibr">81</xref>,<xref rid="B82-life-13-01073" ref-type="bibr">82</xref>,<xref rid="B83-life-13-01073" ref-type="bibr">83</xref>], no new scaffolds have been discovered using this technology.</p></sec></sec><sec id="sec2dot3-life-13-01073"><title>2.3. New Approaches to Phenotypic Screening (Narrow-Spectrum Activity)</title><p>The use of broad-spectrum antibiotics has many side effects: it affects the stability of the human microbiome and the resistance of unrelated pathogens. This encourages researchers to search for drugs with a more selective effect [<xref rid="B84-life-13-01073" ref-type="bibr">84</xref>] among natural antibiotics [<xref rid="B85-life-13-01073" ref-type="bibr">85</xref>].</p><p>The key idea of the approach to finding new antibiotics with a narrow spectrum of action was proposed back in 2016 by Brown and Wright [<xref rid="B19-life-13-01073" ref-type="bibr">19</xref>]. The idea was that, in high-throughput screening, one should select cultures and substances with a narrow spectrum of action or repurpose already known antibiotics. This idea is largely inspired by the example of the natural antibiotic fidaxomicin, introduced into clinical practice in 2010 as a bactericidal antibiotic of narrow action against Gram-positive anaerobic bacteria, primarily <italic toggle="yes">Clostridium difficile</italic> (the main cause of hospital mortality, affecting the human gut and causing fatal diarrhea) [<xref rid="B86-life-13-01073" ref-type="bibr">86</xref>]. Fidaxomicin (<xref rid="life-13-01073-f008" ref-type="fig">Figure 8</xref>) selectively inhibits the <italic toggle="yes">Clostridium difficile</italic> RNA polymerase with minimal effects on gut commensals, such as Proteobacteria and Bacteroidetes [<xref rid="B87-life-13-01073" ref-type="bibr">87</xref>].</p><p>An example of a successful implementation of this approach is hygromycin A (<xref rid="life-13-01073-f008" ref-type="fig">Figure 8</xref>), produced by the actinomycete <italic toggle="yes">Streptomyces hygroscopicus</italic>. This known substance showed highly selective activity against spirochetes, including <italic toggle="yes">Borrelia burgdorferi</italic>. Unexpectedly, it was found that this compound inhibited the growth of <italic toggle="yes">B. burgdorferi</italic> and did not affect the gut microbiome, unlike clinically relevant antibiotics. The compound was tested in a mouse model of acute Lyme disease and showed efficacy when administered both intraperitoneally and orally. This selective antibiotic could, in the future, provide better therapy for Lyme disease and eradicate it from the environment [<xref rid="B88-life-13-01073" ref-type="bibr">88</xref>].</p><p>This approach opens up prospects for the study of bacteriocins and related strain-specific agents as next-generation medicines. For example, threoglucin A (<xref rid="life-13-01073-f009" ref-type="fig">Figure 9</xref>), a post-translationally modified peptide, had remarkable narrow-spectrum activity: a bacteriostatic effect had been detected only for <italic toggle="yes">Streptococcus suis</italic>. Coupled with low toxicity to human cells in vitro, these properties make threoglucins interesting as drug leads [<xref rid="B89-life-13-01073" ref-type="bibr">89</xref>]. Similarly, tryglysins (<xref rid="life-13-01073-f009" ref-type="fig">Figure 9</xref>) specifically inhibit the growth of several streptococcal strains, but not of other Gram-positive bacteria [<xref rid="B90-life-13-01073" ref-type="bibr">90</xref>].</p><p>Thus, the search for narrow-spectrum antibiotics can both help identify unusual structures in primary screening and find new applications for previously described compounds. Treatment with narrow-spectrum antibiotics reduces the rate of spread of antibiotic resistance and reduces unwanted side effects of antibiotic therapy [<xref rid="B91-life-13-01073" ref-type="bibr">91</xref>]. It should be noted that funding agencies tend to prefer to support the development of broad-spectrum drugs over more selective candidates. Therefore, the introduction of narrow-spectrum antibiotics into clinical practice is hindered.</p></sec></sec><sec id="sec3-life-13-01073"><title>3. Molecular Biology</title><p>Natural antibiotics are products of biosynthesis. This transformation of simple precursors into complex compounds is encoded in the genome, usually as a biosynthetic gene cluster (BGC). In this section, we have grouped together various approaches based on processing genomic data to find and activate of BGCs (<xref rid="life-13-01073-f010" ref-type="fig">Figure 10</xref>): the first part primarily collects methods based on homo/heterologous expression, and the second one contains methods for activating the clusters in a native producer. In the third part, we have included new methods for mechanism-based screening, since they are impossible without appropriate methods for genetic engineering, however, applied not to producers, but to test cultures.</p><sec id="sec3dot1-life-13-01073"><title>3.1. Metagenomic Screening and Genome Mining</title><p>The search for biosynthetic gene clusters in metagenomic data and their subsequent heterologous expression theoretically opens up the entire biosynthetic potential of microorganisms [<xref rid="B92-life-13-01073" ref-type="bibr">92</xref>]. Developments in next-generation sequencing technologies have brought the recognition of microbial genomes as a rich resource for novel natural product discovery. The development of community resources for the integration of genomic and metabolomic data spurs interest in this approach [<xref rid="B93-life-13-01073" ref-type="bibr">93</xref>,<xref rid="B94-life-13-01073" ref-type="bibr">94</xref>,<xref rid="B95-life-13-01073" ref-type="bibr">95</xref>]. Genomic studies show high cryptic biotechnological potential even in actively cultured and studied actinobacteria [<xref rid="B96-life-13-01073" ref-type="bibr">96</xref>]. The study of microorganisms from underexploited ecological niches is of the most interest [<xref rid="B97-life-13-01073" ref-type="bibr">97</xref>]. There is also considerable interest in metagenomic studies of the human microbiota as a source of antibiotic compounds [<xref rid="B95-life-13-01073" ref-type="bibr">95</xref>,<xref rid="B98-life-13-01073" ref-type="bibr">98</xref>,<xref rid="B99-life-13-01073" ref-type="bibr">99</xref>]. Recently, several approaches to the search for new antibiotics of various biosynthetic origins, nonribosomal peptides, ribosomally synthesized and post-translationally modified peptides (RiPPs) and polyketides have been successfully applied.</p><p>Nonribosomal peptides are synthesized by nonribosomal peptide synthases, which are easily distinguishable in genome data. These complex protein complexes provide a great deal of structural information for bioinformatics analysis and draw significant attention as targets for genetic manipulations. Significant success was achieved in the search for nonribosomal peptides with antibiotic activity. The lipopeptide taromycin (<xref rid="life-13-01073-f011" ref-type="fig">Figure 11</xref>) was the first compound obtained via transformation-associated recombination (TAR) cloning from marine actinomycete <italic toggle="yes">Saccharomonospora</italic> sp. CNQ-490 into the model organism <italic toggle="yes">Streptomyces coelicolor</italic> [<xref rid="B100-life-13-01073" ref-type="bibr">100</xref>,<xref rid="B101-life-13-01073" ref-type="bibr">101</xref>,<xref rid="B102-life-13-01073" ref-type="bibr">102</xref>].</p><p>Subsequently, this technique was also applied to other nonribosomal peptides. The group of Prof. S. Brady (Rockefeller University) used the sequence responsible for the inclusion of the Asp-X-Asp-Gly motif as a key idea in the metagenomic search. This fragment is responsible for the binding of calcium ions in various calcium-dependent cyclo(depsi)peptides, such as daptomycin. Successful gene transfer using the TAR platform led to isolation of the original calcium-dependent peptide antibiotic malacidin (<xref rid="life-13-01073-f012" ref-type="fig">Figure 12</xref>) [<xref rid="B103-life-13-01073" ref-type="bibr">103</xref>]. This approach was further developed with cadazides&#x02014;they also show a highly distorted calcium-binding motif [<xref rid="B104-life-13-01073" ref-type="bibr">104</xref>]. A similar method was used to search for menaquinone (MK)-binding antibiotics; the conserved sequence GXLXXXW, which represents the minimal MK-binding motif, was used for the genomic search. This approach led to the identification of six new structurally distinct MK-binding peptides [<xref rid="B105-life-13-01073" ref-type="bibr">105</xref>].</p><p>The study of clusters homologous to known BGC of peptide antibiotics remains a promising approach to finding new compounds. A new glycopeptide antibiotic A50926, close to A40926 known as the precursor of the semi-synthetic glycopeptide dalbavancin [<xref rid="B106-life-13-01073" ref-type="bibr">106</xref>], was discovered this way (<xref rid="life-13-01073-f013" ref-type="fig">Figure 13</xref>).</p><p>The study of homologous clusters was also effective in finding colistin-resistant peptide antibiotics, and genome mining of bacterial genomes for polymyxin-like BGCs revealed macolacin (<xref rid="life-13-01073-f014" ref-type="fig">Figure 14</xref>), a structurally divergent colistin congener active against co-li-stin-resistant strains [<xref rid="B107-life-13-01073" ref-type="bibr">107</xref>]. The structure predicted from genomic data was obtained by chemical synthesis. The lipopeptide cilagicin (<xref rid="life-13-01073-f014" ref-type="fig">Figure 14</xref>), which inhibits cell wall biosynthesis of Gram-positive bacteria by an unusual mechanism, was synthesized the same way [<xref rid="B108-life-13-01073" ref-type="bibr">108</xref>]. Another successful example of a genomic search by cluster homology is the discovery of dynobactin (<xref rid="life-13-01073-f014" ref-type="fig">Figure 14</xref>), which is structurally very different from darobactin, but also acts via BamA [<xref rid="B109-life-13-01073" ref-type="bibr">109</xref>].</p><p>The NRPminer platform was developed to search for clusters of non-ribosomal peptides, which made it possible to identify several new families of non-ribosomal peptides by integrating genomic and metabolomic datasets [<xref rid="B110-life-13-01073" ref-type="bibr">110</xref>].</p><p>The genome mining strategy has proven very promising for finding new RiPPs [<xref rid="B111-life-13-01073" ref-type="bibr">111</xref>]. For example, novel head-to-tail cyclized bacteriocins have been identified using a transporter protein-based genome mining strategy [<xref rid="B112-life-13-01073" ref-type="bibr">112</xref>]. Approaches to identifying bacteriocin clusters continue to evolve, with BADASS recently proposed for searching for bacteriocin clusters in metagenomic data [<xref rid="B113-life-13-01073" ref-type="bibr">113</xref>]. In recent years, a series of bacteriocin clusters have been identified, and new peptides, such as sactipeptide estercticin A, have been isolated [<xref rid="B114-life-13-01073" ref-type="bibr">114</xref>].</p><p>Among polyketides, examples of successful genomic approaches have been rarer in recent years than for peptide antibiotics. The discovery of a series of natural macrolactams [<xref rid="B115-life-13-01073" ref-type="bibr">115</xref>] using genomic signature-based PCR screening of a bacterial DNA library can be noted. PCR-based screening was used to search for glycosylated streptomycete metabolites. Strains associated with leaf-cutting ants were examined for the presence of deoxysugar biosynthesis gene clusters [<xref rid="B116-life-13-01073" ref-type="bibr">116</xref>], and several novel macrolactams and angucyclines were found as a result. For aromatic polyketides synthesized by type II polyketide synthases, new productive approaches for bioinformatic analysis of genomic data were developed [<xref rid="B117-life-13-01073" ref-type="bibr">117</xref>].</p><p>Several mining strategies are independent of the natural product class or biosynthetic enzyme homologies and, therefore, can potentially access cryptic BGCs for &#x02018;true&#x02019; chemical novelty [<xref rid="B118-life-13-01073" ref-type="bibr">118</xref>]. An approach to the problem of gene cluster selection by the group of Prof. G. Wright (McMaster University) proposes focusing on the genetic determinants of resistance&#x02014;in the producer or the test culture [<xref rid="B119-life-13-01073" ref-type="bibr">119</xref>,<xref rid="B120-life-13-01073" ref-type="bibr">120</xref>]. This method was effective in the search for nonribosomal peptides: corbomycin (<xref rid="life-13-01073-f015" ref-type="fig">Figure 15</xref>), a new peptide with an original mechanism of action, was isolated this way [<xref rid="B121-life-13-01073" ref-type="bibr">121</xref>]. The corbomycin product was selected based on the fact that the autoresistance gene located in the biosynthesis cluster is very different from the familiar glycopeptides <italic toggle="yes">vanHA</italic> and <italic toggle="yes">vanY</italic>. As a continuation of this work, five new corbomycin family members of high structural novelty, rimomycin-A/B/C and misaugamycin-A/B peptides, were isolated (<xref rid="life-13-01073-f015" ref-type="fig">Figure 15</xref>) [<xref rid="B122-life-13-01073" ref-type="bibr">122</xref>].</p><p>A review of earlier work using this methodology (self-resistance-directed natural product discovery) is presented by Prof. Yi Tang and colleagues [<xref rid="B123-life-13-01073" ref-type="bibr">123</xref>]. A specialized platform for the search for such resistance determinants (Antibiotic-Resistant Target Seeker (ARTS)) [<xref rid="B124-life-13-01073" ref-type="bibr">124</xref>,<xref rid="B125-life-13-01073" ref-type="bibr">125</xref>] and a database with pre-computed ARTS results for &#x0003e;70,000 genomes were developed by Prof. Ziemert&#x02019;s group [<xref rid="B126-life-13-01073" ref-type="bibr">126</xref>]. This approach, called &#x003a8;-footprinting, was also recently adapted to the search for protein synthesis inhibitors (PSI = &#x003a8;) [<xref rid="B127-life-13-01073" ref-type="bibr">127</xref>].</p><p>However, direct cloning of large BGCs remains challenging. We note several works that expand our capabilities in this direction. An efficient in vitro platform for directly capturing large BGCs, named CAT-FISHING (CRISPR/Cas12a-mediated fast direct biosynthetic gene cluster cloning), was developed recently [<xref rid="B128-life-13-01073" ref-type="bibr">128</xref>]. As a proof-of-concept, several large BGCs from various actinomycetal genomic DNA samples were efficiently captured by CAT-FISHING, the largest of which was 145 kb with 75% GC content. A new macrolactam compound with anticancer activity, marinolactam A (<xref rid="life-13-01073-f016" ref-type="fig">Figure 16</xref>), was isolated using this method. A previous achievement was made using the CAPTURE system [<xref rid="B129-life-13-01073" ref-type="bibr">129</xref>], which enables the induction of the biosynthesis of antimicrobial polyketides bipentaromycins A&#x02013;F (<xref rid="life-13-01073-f016" ref-type="fig">Figure 16</xref>).</p><p>In general, the described successful examples of the use of genomic approaches show the prospects of this direction; however, unfortunately, in practice, the implementation of such an approach at all stages is associated with serious difficulties [<xref rid="B130-life-13-01073" ref-type="bibr">130</xref>]. First, the principles of analysis of genetic information to identify metabolites that are of interest for their biological properties are not completely clear. In addition, difficulties arise in obtaining the metabolites revealed by genomic studies. Linking genes to compounds remains a challenging part of the workflow [<xref rid="B118-life-13-01073" ref-type="bibr">118</xref>]. Recent promising approaches to solving this problem include the development of IsoAnalyst&#x02014;an isotopic labelling approach [<xref rid="B131-life-13-01073" ref-type="bibr">131</xref>]&#x02014;and the development of the hcapca (Automated Hierarchical Clustering and Principal Component Analysis) methods [<xref rid="B132-life-13-01073" ref-type="bibr">132</xref>,<xref rid="B133-life-13-01073" ref-type="bibr">133</xref>]. The gene clusters of interest often have a complex organizaton and are large in size (&#x0003e;50 kb) and integrated into the progenitor development cycle via intricate signaling cascades. Nevertheless, the huge number of publications in recent years and numerous discoveries of natural metabolites with a high degree of chemical novelty and unusual mechanisms of action indicate that genome-driven approaches are among the most promising in the field of natural product discovery.</p></sec><sec id="sec3dot2-life-13-01073"><title>3.2. Biosynthetic Gene Cluster Activation</title><p>Here we grouped together various methods that are based on the addition of a small amount of an &#x0201c;inductor&#x0201d;&#x02014;a small molecule, a biopolymer, or a fragment of an inactivated cell. Interestingly, in some cases, other antibiotics, e.g., produced by another species of actinobacteria, can serve as an effective inducer. This greatly enriches and complicates our understanding of what antibiotics are for microorganisms [<xref rid="B134-life-13-01073" ref-type="bibr">134</xref>,<xref rid="B135-life-13-01073" ref-type="bibr">135</xref>,<xref rid="B136-life-13-01073" ref-type="bibr">136</xref>,<xref rid="B137-life-13-01073" ref-type="bibr">137</xref>,<xref rid="B138-life-13-01073" ref-type="bibr">138</xref>].</p><p>The group of Prof. M. Seyedsayamdost is especially active in this area. They are trying to use high-throughput screening methods to find small-molecule inductors (or &#x0201c;elicitors&#x0201d;). Specialized software was developed to analyze the datasets obtained from a large number of elicitors (Metabolomics Explorer, or MetEx, <uri xlink:href="https://mo.princeton.edu/MetEx/">https://mo.princeton.edu/MetEx/</uri> (accessed on 20 April 2023)) [<xref rid="B139-life-13-01073" ref-type="bibr">139</xref>]. Recent successes include the following works. Cebulantin, an antibiotic exhibiting moderate activity against Gram-negative bacteria, especially of genus <italic toggle="yes">Vibrio</italic>, is produced by the rare actinomycete <italic toggle="yes">Saccharopolyspora cebuensis</italic> when one of the inducers, furosemide or fenofibrate, is added to the medium (<xref rid="life-13-01073-f017" ref-type="fig">Figure 17</xref>) [<xref rid="B140-life-13-01073" ref-type="bibr">140</xref>]. Another cyclopeptide antibiotic, cinnapeptin, was found to result from the action of the plant glycoside amygdalin (<xref rid="life-13-01073-f017" ref-type="fig">Figure 17</xref>) on a <italic toggle="yes">Streptomyces ghanaensis</italic> culture [<xref rid="B141-life-13-01073" ref-type="bibr">141</xref>].</p><p>Interestingly, the new cytotoxic peptide antibiotic momomycin was discovered in a culture of <italic toggle="yes">Streptomyces rimosus</italic> ATCC 10970, a well-known industrial oxytetracycline producer [<xref rid="B142-life-13-01073" ref-type="bibr">142</xref>]. The biosynthesis of momomycin is enabled by plant metabolites phytosphingosine and isoscopoletin (<xref rid="life-13-01073-f018" ref-type="fig">Figure 18</xref>). A targeted search for antiproliferative compounds using elicitation techniques has been described [<xref rid="B143-life-13-01073" ref-type="bibr">143</xref>].</p><p>Despite a large number of interesting results, there is no pattern among the inducers used: Both natural substances of very different origins and synthetic ones turned out to be inducers.</p><p>More selective methods of BGCs activation do not require screening a wide panel of activating factors. Initially, hopes were pinned on genetic engineering manipulations with regulatory (global or pathway-specific) genes and promoters. Early successes in the activation of antibiotic biosynthesis using this strategy are summarized in previous reviews [<xref rid="B144-life-13-01073" ref-type="bibr">144</xref>,<xref rid="B145-life-13-01073" ref-type="bibr">145</xref>,<xref rid="B146-life-13-01073" ref-type="bibr">146</xref>]. Some of the most recent works are CRISPR/Cas-based strategies for unearthing the hidden chemical space [<xref rid="B147-life-13-01073" ref-type="bibr">147</xref>]. Using a CRISPR-Cas9 gene cluster activation strategy, a unique macrolactam glycosylated by two aminosugars, auroramycin (<xref rid="life-13-01073-f019" ref-type="fig">Figure 19</xref>), was isolated [<xref rid="B148-life-13-01073" ref-type="bibr">148</xref>,<xref rid="B149-life-13-01073" ref-type="bibr">149</xref>]. A transcription factor decoy strategy for targeted activation of large BGCs was reported [<xref rid="B150-life-13-01073" ref-type="bibr">150</xref>]. Transcription factor decoys are DNA molecules designed to interfere with gene regulation by mimicking regulatory DNAs that are bound to regulators and thus prevent the latter from binding to their cognate DNA targets. This could result in the de-repression of a target silent BGC as well as the de-activation of a target naturally active BGC. Based on this approach, a new oxazole compound (<xref rid="life-13-01073-f019" ref-type="fig">Figure 19</xref>) was identified.</p><p>Ribosomal engineering as an approach was formulated and actively developed by a group of Japanese researchers under the leadership of Prof. Ochi [<xref rid="B151-life-13-01073" ref-type="bibr">151</xref>,<xref rid="B152-life-13-01073" ref-type="bibr">152</xref>]. Its essence is the selection of mutants of the producing strain on a media with increasing concentrations of the corresponding antibiotic translation inhibitor. The accumulation of mutations changing the structure and normal functioning of the ribosomal machinery leads to a qualitative change in the metabolome. Ribosomal engineering is still often used today as an approach to strain improvement [<xref rid="B153-life-13-01073" ref-type="bibr">153</xref>].</p><p>A new approach to ribosomal engineering&#x02014;so-called &#x0201c;Transcription&#x02013;Translation in One&#x0201d; (TTO)&#x02014;was recently described [<xref rid="B154-life-13-01073" ref-type="bibr">154</xref>]. This approach aims to alter the metabolite profiles of the target strains by directly overexpressing exogenous rpsL (encoding ribosomal protein S12) and rpoB (encoding the RNA polymerase &#x003b2; subunit) genes containing mutations for biosynthesis activation using a plug-and-play plasmid system. TTO was successfully applied to activating cryptic BGCs in three <italic toggle="yes">Streptomyces</italic> strains: New polyketide antibiotics, piloquinone and homopiloquinone (<xref rid="life-13-01073-f019" ref-type="fig">Figure 19</xref>), were discovered.</p><p>Reporter-guided mutant selection (RGMS) was developed as an effective and widely applicable method for targeted activation of silent BGCs. RGMS combines two technologies: genome-scale random mutagenesis to generate genetic diversity and a promoter&#x02013;reporter system to facilitate the selection of mutants in which transcription from the targeted gene cluster was activated [<xref rid="B155-life-13-01073" ref-type="bibr">155</xref>]. The strategy was applied to the <italic toggle="yes">pga</italic> gene cluster in <italic toggle="yes">Streptomyces</italic> sp. PGA64, leading to the identification of two new anthraquinone aminoglycosides, gaudimycin D and E (<xref rid="life-13-01073-f020" ref-type="fig">Figure 20</xref>). Using improved RGMS, several cryptic metabolites from mutant libraries of various <italic toggle="yes">Burkholderia</italic> species were identified. The authors used transposon mutagenesis instead of UV [<xref rid="B156-life-13-01073" ref-type="bibr">156</xref>] and MS-based metabolomics instead of a reporter construct [<xref rid="B157-life-13-01073" ref-type="bibr">157</xref>,<xref rid="B158-life-13-01073" ref-type="bibr">158</xref>].</p></sec><sec id="sec3dot3-life-13-01073"><title>3.3. Reporter Strains and Mechanism-Guided Isolation</title><p>Establishing the molecular target and mechanism of action of an antibiotic is important not only in terms of research but also for further rational modification and evaluation of the potential of the compound. Today, this information is also needed to promote a potential drug to the pharmaceutical market [<xref rid="B159-life-13-01073" ref-type="bibr">159</xref>]. Typically, additional profiling and biochemical tests need to be performed for a new natural product to elucidate its mechanism of action (MoA). Among various assays for target determination, reporter strains are most suitable for mechanism-based screening and antibiotic discovery [<xref rid="B160-life-13-01073" ref-type="bibr">160</xref>]. The effect of reporter strains is based on a selective increase in the expression of a gene under the action of sublethal concentrations of the antibiotic. There are many such systems that allow a bacterial cell to activate genes, whose products neutralize or mitigate the effects of antibacterial compounds. For easy visualization, the activated gene product needs to be replaced with a reporter construct (<xref rid="life-13-01073-f021" ref-type="fig">Figure 21</xref>) [<xref rid="B161-life-13-01073" ref-type="bibr">161</xref>].</p><p>A test culture or a small panel of strains that allows immediate identification of the active substance and its target/mechanism of action is a highly productive approach to screening. The basic approaches to reporter strains and their applications in antibiotic screening have been summarized previously [<xref rid="B161-life-13-01073" ref-type="bibr">161</xref>]. Further developments and successful applications in this field are rather scarce in the past few years.</p><p>Double fluorescent reporter strains for high-throughput screening [<xref rid="B162-life-13-01073" ref-type="bibr">162</xref>] were shown to be effective for mechanism-based sorting of antimicrobial compounds: the reporter strain, based on a susceptible mutant of <italic toggle="yes">E. coli</italic> as the model organism, sorts out antimicrobials that cause ribosome stalling and those that induce the SOS response due to DNA damage. This approach was very fruitful primarily for MoA clarification of known compounds. For example, it was recently found that the aromatic polyketide antibiotic tetracenomycin X is a potent inhibitor of protein synthesis and does not induce DNA damage as previously thought [<xref rid="B163-life-13-01073" ref-type="bibr">163</xref>]. Recently, a pipeline based on the dual reporter system was upgraded for utilization in citizen science projects [<xref rid="B164-life-13-01073" ref-type="bibr">164</xref>] by the introduction of reporter genes visualized by the naked eye.</p><p>The most recent advance in this field is the reporter strain panel based on <italic toggle="yes">Bacillus subtilis</italic> as the model organism [<xref rid="B165-life-13-01073" ref-type="bibr">165</xref>]. The bioreporters demonstrate visible promoter induction under various conditions: cell envelope stress, lipid II cycle stress, DNA stress, RNA stress and translation arrest. Therefore, testing against the bioreporter panel provides valuable insight into the most common types of antimicrobial MoA of the tested compounds. The panel was validated on known antibiotics and applied to the screening of 500 strains, and the signals of the bioreporters matched the described MoA of known and dereplicated antibiotics in all cases.</p><p>Targeted mechanism-guided search and identification of new scaffolds could be based on chemical genetics. This emerging approach was recently validated in anti-tubercular activity screening [<xref rid="B166-life-13-01073" ref-type="bibr">166</xref>]. New chemotypes and new promising targets were established, although for synthetic compounds. In a similar vein, but on a smaller scale, natural products have been screened for their potential effect on bacterial biotin biosynthesis. A known biotin antimetabolite, amiclenomycin, was isolated, and its cellular target&#x02014;the biotin transporter yigM&#x02014;was identified simultaneously [<xref rid="B167-life-13-01073" ref-type="bibr">167</xref>]. Early identification of chemical&#x02013;gene interactions could open a new pathway for antibiotic discovery [<xref rid="B168-life-13-01073" ref-type="bibr">168</xref>].</p><p>To conclude, reporter strains have drawn significantly less attention in the past few years than genome-guided approaches (described in <xref rid="sec3dot1-life-13-01073" ref-type="sec">Section 3.1</xref>). Although MoA-based screening is a rather questionable strategy for the development of novel antibiotics with valuable therapeutic properties, these methods are still very promising for the development of novel targets. As the main result, reporter strain-based approaches lead to a profound understanding of molecular modes of action for known antibiotics (including secondary mechanisms), thus enabling further rational structural design.</p></sec></sec><sec id="sec4-life-13-01073"><title>4. Chemistry</title><p>Although we do not consider advances in the field of synthetic compounds and semi-synthetic modification of natural products in this review, chemistry still remains one of the most important areas of innovation in the search for new natural compounds (<xref rid="life-13-01073-f022" ref-type="fig">Figure 22</xref>). First of all, effective and widely used approaches for identifying and prioritizing natural antibiotics are based on chemical methods&#x02014;the first section is devoted to an overview of this area. However, the experience in highly selective transformations accumulated within the framework of bioorthogonal chemistry makes it possible today to use some reagents for screening and prioritization of certain structural groups directly in extracts and mixtures of natural origin (see <xref rid="sec4dot2-life-13-01073" ref-type="sec">Section 4.2</xref>). The last section is devoted to methods for working with labile compounds.</p><sec id="sec4dot1-life-13-01073"><title>4.1. Dereplication</title><p>The term &#x0201c;dereplication&#x0201d; was used in the first CRC Handbook of Antibiotic Compounds, published in 1980, to denote the recognition and elimination of already-studied active substances at the early stages of the screening process [<xref rid="B169-life-13-01073" ref-type="bibr">169</xref>,<xref rid="B170-life-13-01073" ref-type="bibr">170</xref>]. Now, it can be used in a broader sense as a technology for the detection and/or elimination of repeating samples (cultures, compound mixtures or pure compounds) or samples containing well-known active compounds in natural product screening. In this review, &#x0201c;dereplication&#x0201d; is defined as an analytical technique or a complex approach which enables the detection of known compounds at the first step of antibiotic screening: in culture broths, extracts and crude fractionated mixtures. As a result, dereplication is a solution to the re-discovery problem and allows us to prioritize the objects of study, focusing the resources only on new cultures and compounds.</p><p>From early reviews [<xref rid="B169-life-13-01073" ref-type="bibr">169</xref>,<xref rid="B171-life-13-01073" ref-type="bibr">171</xref>], most works in the area relate to MS-based dereplication. Mass spectrometry is a powerful and informative technique for this use thanks to its high sensitivity, valuable structural information and reproducibility. The current standard in MS dereplication (<xref rid="life-13-01073-f023" ref-type="fig">Figure 23</xref>) is based on public (or partially public, such as DNP) databases, e.g., the Global Natural Products Social molecular network (GNPS, <uri xlink:href="https://gnps.ucsd.edu/">https://gnps.ucsd.edu/</uri> accessed on 20 April 2023) [<xref rid="B172-life-13-01073" ref-type="bibr">172</xref>], the Natural Products Atlas (NPAtlas, <uri xlink:href="https://www.npatlas.org/">https://www.npatlas.org/</uri> accessed on 20 April 2023) [<xref rid="B173-life-13-01073" ref-type="bibr">173</xref>,<xref rid="B174-life-13-01073" ref-type="bibr">174</xref>], and the Dictionary of Natural Products (DNP, <uri xlink:href="http://dnp.chemnetbase.com/">http://dnp.chemnetbase.com/</uri> accessed on 20 April 2023). Other specific databases and the main problems with their use were summarized in recent reviews [<xref rid="B175-life-13-01073" ref-type="bibr">175</xref>,<xref rid="B176-life-13-01073" ref-type="bibr">176</xref>].</p><p>Another option based on MS/MS fragmentation is molecular networking (MN). MN implemented in GNPS could be useful for the study of complex mixtures. The hcapca (hierarchical cluster analysis with principal component analysis) algorithm can identify similar patterns of fragmentation and unique and ubiquitous components and simplify the search for congeners or characteristic compounds [<xref rid="B177-life-13-01073" ref-type="bibr">177</xref>,<xref rid="B178-life-13-01073" ref-type="bibr">178</xref>]. MN is a very promising approach for a more complete and in-depth analysis of LC-MS/MS data routinely used for dereplication.</p><p>With the help of MN, 18 previously unknown cyclosporins (cyclopeptides with immunosuppressive activity) [<xref rid="B179-life-13-01073" ref-type="bibr">179</xref>], four novel valinomycin congeners [<xref rid="B180-life-13-01073" ref-type="bibr">180</xref>] and new ribosome-targeting antibiotics hetiamacins E and F [<xref rid="B181-life-13-01073" ref-type="bibr">181</xref>] were discovered. Now, MN is becoming a key method for visualizing and annotating the chemical space in untargeted metabolomics [<xref rid="B182-life-13-01073" ref-type="bibr">182</xref>,<xref rid="B183-life-13-01073" ref-type="bibr">183</xref>,<xref rid="B184-life-13-01073" ref-type="bibr">184</xref>,<xref rid="B185-life-13-01073" ref-type="bibr">185</xref>].</p><p>Dereplication based on NMR spectral data is under active development. We should mention several works:<list list-type="bullet"><list-item><p>The DEREP-NP (<uri xlink:href="https://github.com/clzani/DEREP-NP">https://github.com/clzani/DEREP-NP</uri> accessed on 20 April 2023) platform has been developed for structural feature search in the UNPD public NMR database [<xref rid="B186-life-13-01073" ref-type="bibr">186</xref>]. Later, diffusion-ordered NMR spectroscopy (DOSY)-related functionality was implemented [<xref rid="B187-life-13-01073" ref-type="bibr">187</xref>].</p></list-item><list-item><p>To decipher complex mixtures using <sup>13</sup>C-NMR data, MixONat (<uri xlink:href="https://sourceforge.net/projects/mixonat/">https://sourceforge.net/projects/mixonat/</uri> accessed on 20 April 2023) open-source software was developed [<xref rid="B188-life-13-01073" ref-type="bibr">188</xref>].</p></list-item><list-item><p>The MADByTE data analysis platform (Metabolomics and Dereplication by Two-Dimensional Experiments, <uri xlink:href="https://github.com/liningtonlab/MADByTE">https://github.com/liningtonlab/MADByTE</uri> accessed on 20 April 2023) for complex mixture analysis was developed. This platform employs a combination of TOCSY and HSQC spectra to identify spin system features within complex mixtures and create a chemical similarity network [<xref rid="B189-life-13-01073" ref-type="bibr">189</xref>].</p></list-item></list></p><p>This methodology has several significant limitations:<list list-type="bullet"><list-item><p>Poor compatibility with the main methods of mixture separation: LC-NMR is an exotic combination, unlike LC-MS.</p></list-item><list-item><p>Limited throughput due to the significant duration of registration of the spectra.</p></list-item><list-item><p>Distinguishing the components of complex mixtures is difficult: the characteristic spectral range for natural compounds (0&#x02013;10 ppm for <sup>1</sup>H signals) is very narrow and it takes time to register reliable signal at a sufficient resolution in mixtures with additional correlations and/or additional computation [<xref rid="B190-life-13-01073" ref-type="bibr">190</xref>,<xref rid="B191-life-13-01073" ref-type="bibr">191</xref>].</p></list-item></list></p><p>The third type of data available for efficient dereplication and prioritization of natural antibiotics is activity fingerprinting. The bioactivity fingerprint consists of data on the activity of a given sample in various cultures. To search for new antibiotics, it is useful to measure inhibitory concentrations against a representative panel of microorganisms. Obviously, for identical substances (or substances with an identical mechanism of action), similar patterns will be observed in their bioactivity fingerprints.</p><p>Historically, the first platform based on this strategy was BioMAP (antibiotic mode of action profile) [<xref rid="B192-life-13-01073" ref-type="bibr">192</xref>]. Using a panel of clinically relevant bacterial strains, the presence of known antibiotics in natural product extracts was accurately predicted, and arromycin (<xref rid="life-13-01073-f024" ref-type="fig">Figure 24</xref>)&#x02014;a naphthoquinone-based antibiotic from the marine natural product library&#x02014;was discovered.</p><p>A similar approach was used with a library of antibiotic-resistant transformants of both wild-type <italic toggle="yes">E. coli</italic> BW25113 and a hyperpermeable, efflux-deficient mutant of <italic toggle="yes">E. coli</italic> BW25113, &#x00394;<italic toggle="yes">bamA</italic>&#x00394;<italic toggle="yes">tolC</italic> [<xref rid="B193-life-13-01073" ref-type="bibr">193</xref>]. Screening using the antibiotic resistance platform (ARP) was carried out, and a new echinoserine congener was isolated.</p><p>A new platform, NPAnalyst (<uri xlink:href="www.npanalyst.org">www.npanalyst.org</uri>, accessed on 20 April 2023), has been developed for direct prediction of metabolite bioactivity profiles from complex mixtures. This platform is compatible with both mzML (mass spectrometry open-data format) and most open-data processing platforms (GNPS and MZmine 2). Validation of the platform was performed by analyzing a &#x0201c;low-resolution&#x0201d; antimicrobial bioassay dataset for 925 natural product prefractions. Two new antibiotics, dracolactam C and amychelin C (<xref rid="life-13-01073-f025" ref-type="fig">Figure 25</xref>), were described [<xref rid="B194-life-13-01073" ref-type="bibr">194</xref>].</p></sec><sec id="sec4dot2-life-13-01073"><title>4.2. Chemical Labeling and Reactivity-Guided Isolation</title><p>Chemical derivatization techniques are well-known and are used extensively for routine analysis. However, only recently they were adopted as a platform for natural product screening. The main idea is based on selective reagents capable of labeling the functional groups or structural features of natural products right in the extracts or pre-fractioned mixtures. Despite the original metabolites becoming modified, the resulting adducts often have enhanced visibility by UV and MS. This emerging topic in natural product chemistry was recently described [<xref rid="B195-life-13-01073" ref-type="bibr">195</xref>].</p><p>As an illustration of the approach, we could note a recent work [<xref rid="B196-life-13-01073" ref-type="bibr">196</xref>] on reactivity-based screening for the detection and isolation of alkaloid and terpene isonitriles in the cyanobacterium <italic toggle="yes">Fischerella ambigua</italic> and a marine sponge of the order Bubarida (<xref rid="life-13-01073-f026" ref-type="fig">Figure 26</xref>).</p><p>The modification of the antibiotic can be reversible. For example, a reversible modification of amines was recently reported [<xref rid="B197-life-13-01073" ref-type="bibr">197</xref>].</p></sec><sec id="sec4dot3-life-13-01073"><title>4.3. Methods for Detection and Isolation of Unstable Metabolites</title><p>The first natural antibiotic, penicillin, was elusive for researchers for many years due to its thermolabile nature. Only the development of freeze drying could solve the problem and enable its research and further medical use. Perhaps the development of new methods for working with labile substances will open up new opportunities and new chemotypes in the field of natural antibiotics.</p><p>The isolation of light-sensitive, highly volatile, chemically active substances from complex mixtures is still challenging, and no specific techniques address this problem. The main advantages and relevant problems in the field are summarized in a review [<xref rid="B198-life-13-01073" ref-type="bibr">198</xref>].</p><p>Some progress was achieved with bacillaenes&#x02014;well-known light- and oxygen-sensitive unsaturated compounds. New bacillaene structures (<xref rid="life-13-01073-f027" ref-type="fig">Figure 27</xref>) were identified in compound mixtures using the DANS-SVI (differential analysis of 2D NMR spectrum&#x02212;single spectrum with variable intensities) method. After identification, compounds of interest were isolated under strictly controlled conditions [<xref rid="B199-life-13-01073" ref-type="bibr">199</xref>].</p></sec></sec><sec sec-type="conclusions" id="sec5-life-13-01073"><title>5. Conclusions and Outlook</title><p>The spread of antibiotic resistant-strains makes the development of novel antimicrobials outstandingly important. Nonetheless, effective and efficient development of new drugs is impossible without the discovery of appropriate drug leads. In this account, we summarized current problems in natural antibiotic discovery and the main approaches to solving them. None of these approaches provide a conclusive answer to the question &#x02018;How do we make antibiotics great again?&#x02019;. Moreover, the basic workflow remains the same and generally resembles traditional phenotypic screening (the &#x0201c;Waksman platform&#x0201d;) (<xref rid="life-13-01073-f028" ref-type="fig">Figure 28</xref>).</p><p>All of the described methods are improvements of some stage in the classic discovery model. The integration of these improvements could lead to a significant increase in the discovery rate of novel antibiotics. Combining various datasets (e.g., genomic and metabolomics) was shown to provide novel types of valuable information. Nonetheless, further integration of the data requires advanced instrumentation, technologies and computational resources.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, V.A.A., V.A.K. and A.P.T.; methodology, A.A.B., V.A.A. and A.P.T.; writing&#x02014;original draft preparation, A.A.B., V.A.A. and A.P.T.; writing&#x02014;review and editing, V.A.A., V.A.K. and A.P.T.; visualization, A.A.B., V.A.K. and A.P.T.; supervision, A.P.T.; project administration, V.A.A.; funding acquisition, A.P.T. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Not applicable.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><glossary><title>Abbreviations</title><p>BGC, biosynthetic gene cluster; CRISPR, clustered regularly interspaced short palindromic repeats; DNA, deoxyribonucleic acid; iChip, isolation chip technology; FACS, fluorescence-activated cell sorting; GNPS, Global Natural Products Social molecular network; HSQC, heteronuclear single quantum coherence spectroscopy; LC, liquid chromatography; MDE, microfluidic double water-in-oil-in-water emulsion; MoA, mechanism of action; MN, molecular networking; MS, mass-spectra(l); NMR, nuclear magnetic resonance; NRP, nonribosomal peptide; PCR, polymerase chain reaction; RGMS, reporter-guided mutant selection; RiPP, ribosomally synthesized and post-translationally modified peptide; RNA, ribonucleic acid; TAR, transformation-associated recombination; TOCSY, total correlation spectroscopy; UV, ultraviolet; WHO, World Health Organisation.</p></glossary><ref-list><title>References</title><ref id="B1-life-13-01073"><label>1.</label><element-citation publication-type="webpage"><article-title>World Health Organization Prioritization of Pathogenes to Guide Discovery, Research and Development of New Antibiotics for Drug-Resistant Bacterial Infections, including Tuberculosis</article-title><year>2017</year><comment>Available online: <ext-link xlink:href="https://www.who.int/publications/i/item/WHO-EMP-IAU-2017.12" ext-link-type="uri">https://www.who.int/publications/i/item/WHO-EMP-IAU-2017.12</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2023-04-20">(accessed on 20 April 2023)</date-in-citation></element-citation></ref><ref id="B2-life-13-01073"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Waksman</surname><given-names>S.A.</given-names></name>
</person-group><article-title>What is an antibiotic or an antibiotic substance?</article-title><source>Mycologia</source><year>1947</year><volume>39</volume><fpage>565</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.1080/00275514.1947.12017635</pub-id><?supplied-pmid 20264541?><pub-id pub-id-type="pmid">20264541</pub-id></element-citation></ref><ref id="B3-life-13-01073"><label>3.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Bentley</surname><given-names>R.</given-names></name>
<name><surname>Bennett</surname><given-names>J.W.</given-names></name>
</person-group><article-title>What is an antibiotic? Revisited</article-title><source>Advances in Applied Microbiology</source><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2003</year><volume>Volume 52</volume><fpage>303</fpage><lpage>331</lpage><isbn>978-0-12-002654-8</isbn></element-citation></ref><ref id="B4-life-13-01073"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Davies</surname><given-names>J.</given-names></name>
</person-group><article-title>Are antibiotics naturally antibiotics?</article-title><source>J. Ind. Microbiol. Biotechnol.</source><year>2006</year><volume>33</volume><fpage>496</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1007/s10295-006-0112-5</pub-id><?supplied-pmid 16552582?><pub-id pub-id-type="pmid">16552582</pub-id></element-citation></ref><ref id="B5-life-13-01073"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cook</surname><given-names>M.A.</given-names></name>
<name><surname>Wright</surname><given-names>G.D.</given-names></name>
</person-group><article-title>The past, present, and future of antibiotics</article-title><source>Sci. Transl. Med.</source><year>2022</year><volume>14</volume><fpage>eabo7793</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.abo7793</pub-id><?supplied-pmid 35947678?><pub-id pub-id-type="pmid">35947678</pub-id></element-citation></ref><ref id="B6-life-13-01073"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Newman</surname><given-names>D.J.</given-names></name>
<name><surname>Cragg</surname><given-names>G.M.</given-names></name>
</person-group><article-title>Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019</article-title><source>J. Nat. Prod.</source><year>2020</year><volume>83</volume><fpage>770</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.9b01285</pub-id><?supplied-pmid 32162523?><pub-id pub-id-type="pmid">32162523</pub-id></element-citation></ref><ref id="B7-life-13-01073"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Harvey</surname><given-names>A.L.</given-names></name>
<name><surname>Edrada-Ebel</surname><given-names>R.</given-names></name>
<name><surname>Quinn</surname><given-names>R.J.</given-names></name>
</person-group><article-title>The re-emergence of natural products for drug discovery in the genomics era</article-title><source>Nat. Rev. Drug. Discov.</source><year>2015</year><volume>14</volume><fpage>111</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1038/nrd4510</pub-id><pub-id pub-id-type="pmid">25614221</pub-id></element-citation></ref><ref id="B8-life-13-01073"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schatz</surname><given-names>A.</given-names></name>
<name><surname>Bugie</surname><given-names>E.</given-names></name>
<name><surname>Waksman</surname><given-names>S.A.</given-names></name>
<name><surname>Hanssen</surname><given-names>A.D.</given-names></name>
<name><surname>Patel</surname><given-names>R.</given-names></name>
<name><surname>Osmon</surname><given-names>D.R.</given-names></name>
</person-group><article-title>The classic: Streptomycin, a substance exhibiting antibiotic activity against Gram-positive and Gram-negative bacteria</article-title><source>Clin. Orthopaed. Rel. Res.</source><year>2005</year><volume>437</volume><fpage>3</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1097/01.blo.0000175887.98112.fe</pub-id></element-citation></ref><ref id="B9-life-13-01073"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lewis</surname><given-names>K.</given-names></name>
</person-group><article-title>Platforms for antibiotic discovery</article-title><source>Nat. Rev. Drug. Discov.</source><year>2013</year><volume>12</volume><fpage>371</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1038/nrd3975</pub-id><pub-id pub-id-type="pmid">23629505</pub-id></element-citation></ref><ref id="B10-life-13-01073"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bernal</surname><given-names>F.A.</given-names></name>
<name><surname>Hammann</surname><given-names>P.</given-names></name>
<name><surname>Kloss</surname><given-names>F.</given-names></name>
</person-group><article-title>Natural products in antibiotic development: Is the success story over?</article-title><source>Curr. Opin. Biotechnol.</source><year>2022</year><volume>78</volume><fpage>102783</fpage><pub-id pub-id-type="doi">10.1016/j.copbio.2022.102783</pub-id><pub-id pub-id-type="pmid">36088735</pub-id></element-citation></ref><ref id="B11-life-13-01073"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tyurin</surname><given-names>A.P.</given-names></name>
<name><surname>Alferova</surname><given-names>V.A.</given-names></name>
<name><surname>Paramonov</surname><given-names>A.S.</given-names></name>
<name><surname>Shuvalov</surname><given-names>M.V.</given-names></name>
<name><surname>Kudryakova</surname><given-names>G.K.</given-names></name>
<name><surname>Rogozhin</surname><given-names>E.A.</given-names></name>
<name><surname>Zherebker</surname><given-names>A.Y.</given-names></name>
<name><surname>Brylev</surname><given-names>V.A.</given-names></name>
<name><surname>Chistov</surname><given-names>A.A.</given-names></name>
<name><surname>Baranova</surname><given-names>A.A.</given-names></name>
<etal/>
</person-group><article-title>Gausemycins A,B: Cyclic lipoglycopeptides from <italic toggle="yes">Streptomyces</italic> sp.</article-title><source>Angew. Chem. Int. Ed.</source><year>2021</year><volume>60</volume><fpage>18694</fpage><lpage>18703</lpage><pub-id pub-id-type="doi">10.1002/anie.202104528</pub-id></element-citation></ref><ref id="B12-life-13-01073"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Crits-Christoph</surname><given-names>A.</given-names></name>
<name><surname>Diamond</surname><given-names>S.</given-names></name>
<name><surname>Butterfield</surname><given-names>C.N.</given-names></name>
<name><surname>Thomas</surname><given-names>B.C.</given-names></name>
<name><surname>Banfield</surname><given-names>J.F.</given-names></name>
</person-group><article-title>Novel soil bacteria possess diverse genes for secondary metabolite biosynthesis</article-title><source>Nature</source><year>2018</year><volume>558</volume><fpage>440</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0207-y</pub-id><pub-id pub-id-type="pmid">29899444</pub-id></element-citation></ref><ref id="B13-life-13-01073"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Monciardini</surname><given-names>P.</given-names></name>
<name><surname>Iorio</surname><given-names>M.</given-names></name>
<name><surname>Maffioli</surname><given-names>S.</given-names></name>
<name><surname>Sosio</surname><given-names>M.</given-names></name>
<name><surname>Donadio</surname><given-names>S.</given-names></name>
</person-group><article-title>Discovering new bioactive molecules from microbial sources</article-title><source>Microb. Biotechnol.</source><year>2014</year><volume>7</volume><fpage>209</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1111/1751-7915.12123</pub-id><pub-id pub-id-type="pmid">24661414</pub-id></element-citation></ref><ref id="B14-life-13-01073"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lewis</surname><given-names>K.</given-names></name>
</person-group><article-title>The science of antibiotic discovery</article-title><source>Cell</source><year>2020</year><volume>181</volume><fpage>29</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.02.056</pub-id><pub-id pub-id-type="pmid">32197064</pub-id></element-citation></ref><ref id="B15-life-13-01073"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>X.-H.</given-names></name>
<name><surname>Ahmad</surname><given-names>W.</given-names></name>
<name><surname>Zhu</surname><given-names>X.-Y.</given-names></name>
<name><surname>Chen</surname><given-names>J.</given-names></name>
<name><surname>Austin</surname><given-names>B.</given-names></name>
</person-group><article-title>Viable but nonculturable bacteria and their resuscitation: Implications for cultivating uncultured marine microorganisms</article-title><source>Mar. Life Sci. Technol.</source><year>2021</year><volume>3</volume><fpage>189</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1007/s42995-020-00041-3</pub-id><pub-id pub-id-type="pmid">37073345</pub-id></element-citation></ref><ref id="B16-life-13-01073"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Salam</surname><given-names>N.</given-names></name>
<name><surname>Xian</surname><given-names>W.-D.</given-names></name>
<name><surname>Asem</surname><given-names>M.D.</given-names></name>
<name><surname>Xiao</surname><given-names>M.</given-names></name>
<name><surname>Li</surname><given-names>W.-J.</given-names></name>
</person-group><article-title>From ecophysiology to cultivation methodology: Filling the knowledge gap between uncultured and cultured microbes</article-title><source>Mar. Life Sci. Technol.</source><year>2021</year><volume>3</volume><fpage>132</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1007/s42995-020-00064-w</pub-id><pub-id pub-id-type="pmid">37073336</pub-id></element-citation></ref><ref id="B17-life-13-01073"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mu</surname><given-names>D.-S.</given-names></name>
<name><surname>Ouyang</surname><given-names>Y.</given-names></name>
<name><surname>Chen</surname><given-names>G.-J.</given-names></name>
<name><surname>Du</surname><given-names>Z.-J.</given-names></name>
</person-group><article-title>Strategies for culturing active/dormant marine microbes</article-title><source>Mar. Life Sci. Technol.</source><year>2021</year><volume>3</volume><fpage>121</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1007/s42995-020-00053-z</pub-id><pub-id pub-id-type="pmid">37073338</pub-id></element-citation></ref><ref id="B18-life-13-01073"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bodor</surname><given-names>A.</given-names></name>
<name><surname>Bounedjoum</surname><given-names>N.</given-names></name>
<name><surname>Vincze</surname><given-names>G.E.</given-names></name>
<name><surname>Erdein&#x000e9; Kis</surname><given-names>&#x000c1;.</given-names></name>
<name><surname>Laczi</surname><given-names>K.</given-names></name>
<name><surname>Bende</surname><given-names>G.</given-names></name>
<name><surname>Szil&#x000e1;gyi</surname><given-names>&#x000c1;.</given-names></name>
<name><surname>Kov&#x000e1;cs</surname><given-names>T.</given-names></name>
<name><surname>Perei</surname><given-names>K.</given-names></name>
<name><surname>R&#x000e1;khely</surname><given-names>G.</given-names></name>
</person-group><article-title>Challenges of unculturable bacteria: Environmental perspectives</article-title><source>Rev. Environ. Sci. Biotechnol.</source><year>2020</year><volume>19</volume><fpage>1</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1007/s11157-020-09522-4</pub-id></element-citation></ref><ref id="B19-life-13-01073"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brown</surname><given-names>E.D.</given-names></name>
<name><surname>Wright</surname><given-names>G.D.</given-names></name>
</person-group><article-title>Antibacterial drug discovery in the resistance era</article-title><source>Nature</source><year>2016</year><volume>529</volume><fpage>336</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1038/nature17042</pub-id><pub-id pub-id-type="pmid">26791724</pub-id></element-citation></ref><ref id="B20-life-13-01073"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>De Simeis</surname><given-names>D.</given-names></name>
<name><surname>Serra</surname><given-names>S.</given-names></name>
</person-group><article-title>Actinomycetes: A never-ending source of bioactive compounds&#x02014;An overview on antibiotics production</article-title><source>Antibiotics</source><year>2021</year><volume>10</volume><elocation-id>483</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics10050483</pub-id><pub-id pub-id-type="pmid">33922100</pub-id></element-citation></ref><ref id="B21-life-13-01073"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ezeobiora</surname><given-names>C.E.</given-names></name>
<name><surname>Igbokwe</surname><given-names>N.H.</given-names></name>
<name><surname>Amin</surname><given-names>D.H.</given-names></name>
<name><surname>Enwuru</surname><given-names>N.V.</given-names></name>
<name><surname>Okpalanwa</surname><given-names>C.F.</given-names></name>
<name><surname>Mendie</surname><given-names>U.E.</given-names></name>
</person-group><article-title>Uncovering the biodiversity and biosynthetic potentials of rare actinomycetes</article-title><source>Fut. J. Pharm. Sci.</source><year>2022</year><volume>8</volume><fpage>23</fpage><pub-id pub-id-type="doi">10.1186/s43094-022-00410-y</pub-id></element-citation></ref><ref id="B22-life-13-01073"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Subramani</surname><given-names>R.</given-names></name>
<name><surname>Sipkema</surname><given-names>D.</given-names></name>
</person-group><article-title>Marine rare actinomycetes: A promising source of structurally diverse and unique novel natural products</article-title><source>Mar. Drugs</source><year>2019</year><volume>17</volume><elocation-id>249</elocation-id><pub-id pub-id-type="doi">10.3390/md17050249</pub-id><pub-id pub-id-type="pmid">31035452</pub-id></element-citation></ref><ref id="B23-life-13-01073"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Srinivasan</surname><given-names>R.</given-names></name>
<name><surname>Kannappan</surname><given-names>A.</given-names></name>
<name><surname>Shi</surname><given-names>C.</given-names></name>
<name><surname>Lin</surname><given-names>X.</given-names></name>
</person-group><article-title>Marine bacterial secondary metabolites: A treasure house for structurally unique and effective antimicrobial compounds</article-title><source>Mar. Drugs</source><year>2021</year><volume>19</volume><elocation-id>530</elocation-id><pub-id pub-id-type="doi">10.3390/md19100530</pub-id><?supplied-pmid 34677431?><pub-id pub-id-type="pmid">34677431</pub-id></element-citation></ref><ref id="B24-life-13-01073"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sedeek</surname><given-names>A.M.</given-names></name>
<name><surname>Ismail</surname><given-names>M.M.</given-names></name>
<name><surname>Elsayed</surname><given-names>T.R.</given-names></name>
<name><surname>Ramadan</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Recent methods for discovering novel bioactive metabolites, specifically antimicrobial agents, from marine-associated micro-organisms</article-title><source>Lett. Appl. Microbiol.</source><year>2022</year><volume>75</volume><fpage>511</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1111/lam.13728</pub-id><?supplied-pmid 35485872?><pub-id pub-id-type="pmid">35485872</pub-id></element-citation></ref><ref id="B25-life-13-01073"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mahajan</surname><given-names>G.B.</given-names></name>
<name><surname>Balachandran</surname><given-names>L.</given-names></name>
</person-group><article-title>Sources of antibiotics: Hot springs</article-title><source>Biochem. Pharmacol.</source><year>2017</year><volume>134</volume><fpage>35</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2016.11.021</pub-id><?supplied-pmid 27890726?><pub-id pub-id-type="pmid">27890726</pub-id></element-citation></ref><ref id="B26-life-13-01073"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Uma</surname><given-names>G.</given-names></name>
<name><surname>Babu</surname><given-names>M.M.</given-names></name>
<name><surname>Prakash</surname><given-names>V.S.G.</given-names></name>
<name><surname>Nisha</surname><given-names>S.J.</given-names></name>
<name><surname>Citarasu</surname><given-names>T.</given-names></name>
</person-group><article-title>Nature and bioprospecting of haloalkaliphilics: A review</article-title><source>World J. Microbiol. Biotechnol.</source><year>2020</year><volume>36</volume><fpage>66</fpage><pub-id pub-id-type="doi">10.1007/s11274-020-02841-2</pub-id><?supplied-pmid 32323057?><pub-id pub-id-type="pmid">32323057</pub-id></element-citation></ref><ref id="B27-life-13-01073"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tendulkar</surname><given-names>S.</given-names></name>
<name><surname>Hattiholi</surname><given-names>A.</given-names></name>
<name><surname>Chavadar</surname><given-names>M.</given-names></name>
<name><surname>Dodamani</surname><given-names>S.</given-names></name>
</person-group><article-title>Psychrophiles: A journey of hope</article-title><source>J. Biosci.</source><year>2021</year><volume>46</volume><fpage>64</fpage><pub-id pub-id-type="doi">10.1007/s12038-021-00180-4</pub-id><pub-id pub-id-type="pmid">34219740</pub-id></element-citation></ref><ref id="B28-life-13-01073"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Baranova</surname><given-names>A.A.</given-names></name>
<name><surname>Alferova</surname><given-names>V.A.</given-names></name>
<name><surname>Korshun</surname><given-names>V.A.</given-names></name>
<name><surname>Tyurin</surname><given-names>A.P.</given-names></name>
</person-group><article-title>Antibiotics from extremophilic micromycetes</article-title><source>Russ. J. Bioorg. Chem.</source><year>2020</year><volume>46</volume><fpage>903</fpage><lpage>971</lpage><pub-id pub-id-type="doi">10.1134/S1068162020060023</pub-id><pub-id pub-id-type="pmid">33390684</pub-id></element-citation></ref><ref id="B29-life-13-01073"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>El-Bondkly</surname><given-names>E.A.M.</given-names></name>
<name><surname>El-Bondkly</surname><given-names>A.A.M.</given-names></name>
<name><surname>El-Bondkly</surname><given-names>A.A.M.</given-names></name>
</person-group><article-title>Marine endophytic fungal metabolites: A whole new world of pharmaceutical therapy exploration</article-title><source>Heliyon</source><year>2021</year><volume>7</volume><fpage>e06362</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2021.e06362</pub-id><pub-id pub-id-type="pmid">33869822</pub-id></element-citation></ref><ref id="B30-life-13-01073"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aghdam</surname><given-names>S.A.</given-names></name>
<name><surname>Brown</surname><given-names>A.M.V.</given-names></name>
</person-group><article-title>Deep learning approaches for natural product discovery from plant endophytic microbiomes</article-title><source>Environ. Microbiome</source><year>2021</year><volume>16</volume><fpage>6</fpage><pub-id pub-id-type="doi">10.1186/s40793-021-00375-0</pub-id><pub-id pub-id-type="pmid">33758794</pub-id></element-citation></ref><ref id="B31-life-13-01073"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jiang</surname><given-names>Z.</given-names></name>
<name><surname>Tuo</surname><given-names>L.</given-names></name>
<name><surname>Huang</surname><given-names>D.</given-names></name>
<name><surname>Osterman</surname><given-names>I.A.</given-names></name>
<name><surname>Tyurin</surname><given-names>A.P.</given-names></name>
<name><surname>Liu</surname><given-names>S.</given-names></name>
<name><surname>Lukyanov</surname><given-names>D.A.</given-names></name>
<name><surname>Sergiev</surname><given-names>P.V.</given-names></name>
<name><surname>Dontsova</surname><given-names>O.A.</given-names></name>
<name><surname>Korshun</surname><given-names>V.A.</given-names></name>
<etal/>
</person-group><article-title>Diversity, novelty, and antimicrobial activity of endophytic actinobacteria from mangrove plants in Beilun Estuary National Nature Reserve of Guangxi, China</article-title><source>Front. Microbiol.</source><year>2018</year><volume>9</volume><fpage>868</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.00868</pub-id><pub-id pub-id-type="pmid">29780376</pub-id></element-citation></ref><ref id="B32-life-13-01073"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Axenov-Gibanov</surname><given-names>D.V.</given-names></name>
<name><surname>Voytsekhovskaya</surname><given-names>I.V.</given-names></name>
<name><surname>Tokovenko</surname><given-names>B.T.</given-names></name>
<name><surname>Protasov</surname><given-names>E.S.</given-names></name>
<name><surname>Gamaiunov</surname><given-names>S.V.</given-names></name>
<name><surname>Rebets</surname><given-names>Y.V.</given-names></name>
<name><surname>Luzhetskyy</surname><given-names>A.N.</given-names></name>
<name><surname>Timofeyev</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Actinobacteria isolated from an underground lake and moonmilk speleothem from the biggest conglomeratic karstic cave in siberia as sources of novel biologically active compounds</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><elocation-id>e0149216</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0149216</pub-id><pub-id pub-id-type="pmid">26901168</pub-id></element-citation></ref><ref id="B33-life-13-01073"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Carroll</surname><given-names>A.R.</given-names></name>
<name><surname>Copp</surname><given-names>B.R.</given-names></name>
<name><surname>Davis</surname><given-names>R.A.</given-names></name>
<name><surname>Keyzers</surname><given-names>R.A.</given-names></name>
<name><surname>Prinsep</surname><given-names>M.R.</given-names></name>
</person-group><article-title>Marine natural products</article-title><source>Nat. Prod. Rep.</source><year>2023</year><volume>40</volume><fpage>275</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1039/D2NP00083K</pub-id><pub-id pub-id-type="pmid">36786022</pub-id></element-citation></ref><ref id="B34-life-13-01073"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thawabteh</surname><given-names>A.M.</given-names></name>
<name><surname>Swaileh</surname><given-names>Z.</given-names></name>
<name><surname>Ammar</surname><given-names>M.</given-names></name>
<name><surname>Jaghama</surname><given-names>W.</given-names></name>
<name><surname>Yousef</surname><given-names>M.</given-names></name>
<name><surname>Karaman</surname><given-names>R.</given-names></name>
<name><surname>Bufo</surname><given-names>S.A.</given-names></name>
<name><surname>Scrano</surname><given-names>L.</given-names></name>
</person-group><article-title>Antifungal and antibacterial activities of isolated marine compounds</article-title><source>Toxins</source><year>2023</year><volume>15</volume><elocation-id>93</elocation-id><pub-id pub-id-type="doi">10.3390/toxins15020093</pub-id><pub-id pub-id-type="pmid">36828408</pub-id></element-citation></ref><ref id="B35-life-13-01073"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gon&#x000e7;alves</surname><given-names>M.F.M.</given-names></name>
<name><surname>Esteves</surname><given-names>A.C.</given-names></name>
<name><surname>Alves</surname><given-names>A.</given-names></name>
</person-group><article-title>Marine fungi: Opportunities and challenges</article-title><source>Encyclopedia</source><year>2022</year><volume>2</volume><fpage>559</fpage><lpage>577</lpage><pub-id pub-id-type="doi">10.3390/encyclopedia2010037</pub-id></element-citation></ref><ref id="B36-life-13-01073"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Giddings</surname><given-names>L.-A.</given-names></name>
<name><surname>Newman</surname><given-names>D.J.</given-names></name>
</person-group><article-title>Extremophilic fungi from marine environments: Underexplored sources of antitumor, anti-infective and other biologically active agents</article-title><source>Mar. Drugs</source><year>2022</year><volume>20</volume><elocation-id>62</elocation-id><pub-id pub-id-type="doi">10.3390/md20010062</pub-id><pub-id pub-id-type="pmid">35049917</pub-id></element-citation></ref><ref id="B37-life-13-01073"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Siro</surname><given-names>G.</given-names></name>
<name><surname>Pipite</surname><given-names>A.</given-names></name>
<name><surname>Christi</surname><given-names>K.</given-names></name>
<name><surname>Srinivasan</surname><given-names>S.</given-names></name>
<name><surname>Subramani</surname><given-names>R.</given-names></name>
</person-group><article-title>Marine actinomycetes associated with stony corals: A potential hotspot for specialized metabolites</article-title><source>Microorganisms</source><year>2022</year><volume>10</volume><elocation-id>1349</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms10071349</pub-id><pub-id pub-id-type="pmid">35889068</pub-id></element-citation></ref><ref id="B38-life-13-01073"><label>38.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Ruwandeepika</surname><given-names>H.A.D.</given-names></name>
<name><surname>Fernando</surname><given-names>G.C.P.</given-names></name>
<name><surname>Jayaweera</surname><given-names>T.S.P.</given-names></name>
</person-group><article-title>An overview of biomedical, biotechnological, and industrial applications of actinomycetes</article-title><source>Natural Products from Actinomycetes</source><person-group person-group-type="editor">
<name><surname>Rai</surname><given-names>R.V.</given-names></name>
<name><surname>Bai</surname><given-names>J.A.</given-names></name>
</person-group><publisher-name>Springer</publisher-name><publisher-loc>Singapore</publisher-loc><year>2022</year><fpage>475</fpage><lpage>508</lpage><isbn>9789811661310</isbn></element-citation></ref><ref id="B39-life-13-01073"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lu</surname><given-names>Q.-P.</given-names></name>
<name><surname>Huang</surname><given-names>Y.-M.</given-names></name>
<name><surname>Liu</surname><given-names>S.-W.</given-names></name>
<name><surname>Wu</surname><given-names>G.</given-names></name>
<name><surname>Yang</surname><given-names>Q.</given-names></name>
<name><surname>Liu</surname><given-names>L.-F.</given-names></name>
<name><surname>Zhang</surname><given-names>H.-T.</given-names></name>
<name><surname>Qi</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>T.</given-names></name>
<name><surname>Jiang</surname><given-names>Z.-K.</given-names></name>
<etal/>
</person-group><article-title>Metabolomics tools assisting classic screening methods in discovering new antibiotics from mangrove actinomycetia in Leizhou Peninsula</article-title><source>Mar. Drugs</source><year>2021</year><volume>19</volume><elocation-id>688</elocation-id><pub-id pub-id-type="doi">10.3390/md19120688</pub-id><pub-id pub-id-type="pmid">34940687</pub-id></element-citation></ref><ref id="B40-life-13-01073"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shi</surname><given-names>T.</given-names></name>
<name><surname>Wang</surname><given-names>Y.-F.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Wang</surname><given-names>B.</given-names></name>
</person-group><article-title>Genus nocardiopsis: A prolific producer of natural products</article-title><source>Mar. Drugs</source><year>2022</year><volume>20</volume><elocation-id>374</elocation-id><pub-id pub-id-type="doi">10.3390/md20060374</pub-id><pub-id pub-id-type="pmid">35736177</pub-id></element-citation></ref><ref id="B41-life-13-01073"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gogineni</surname><given-names>V.</given-names></name>
<name><surname>Chen</surname><given-names>X.</given-names></name>
<name><surname>Hanna</surname><given-names>G.</given-names></name>
<name><surname>Mayasari</surname><given-names>D.</given-names></name>
<name><surname>Hamann</surname><given-names>M.T.</given-names></name>
</person-group><article-title>Role of symbiosis in the discovery of novel antibiotics</article-title><source>J. Antibiot.</source><year>2020</year><volume>73</volume><fpage>490</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1038/s41429-020-0321-6</pub-id></element-citation></ref><ref id="B42-life-13-01073"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Baranova</surname><given-names>A.A.</given-names></name>
<name><surname>Zakalyukina</surname><given-names>Y.V.</given-names></name>
<name><surname>Ovcharenko</surname><given-names>A.A.</given-names></name>
<name><surname>Korshun</surname><given-names>V.A.</given-names></name>
<name><surname>Tyurin</surname><given-names>A.P.</given-names></name>
</person-group><article-title>Antibiotics from insect-associated actinobacteria</article-title><source>Biology</source><year>2022</year><volume>11</volume><elocation-id>1676</elocation-id><pub-id pub-id-type="doi">10.3390/biology11111676</pub-id><pub-id pub-id-type="pmid">36421390</pub-id></element-citation></ref><ref id="B43-life-13-01073"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Masson</surname><given-names>F.</given-names></name>
<name><surname>Lemaitre</surname><given-names>B.</given-names></name>
</person-group><article-title>Growing ungrowable bacteria: Overview and perspectives on insect symbiont culturability</article-title><source>Microbiol. Mol. Biol. Rev.</source><year>2020</year><volume>84</volume><fpage>e00089-20</fpage><pub-id pub-id-type="doi">10.1128/MMBR.00089-20</pub-id><pub-id pub-id-type="pmid">33177190</pub-id></element-citation></ref><ref id="B44-life-13-01073"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Imai</surname><given-names>Y.</given-names></name>
<name><surname>Meyer</surname><given-names>K.J.</given-names></name>
<name><surname>Iinishi</surname><given-names>A.</given-names></name>
<name><surname>Favre-Godal</surname><given-names>Q.</given-names></name>
<name><surname>Green</surname><given-names>R.</given-names></name>
<name><surname>Manuse</surname><given-names>S.</given-names></name>
<name><surname>Caboni</surname><given-names>M.</given-names></name>
<name><surname>Mori</surname><given-names>M.</given-names></name>
<name><surname>Niles</surname><given-names>S.</given-names></name>
<name><surname>Ghiglieri</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>A new antibiotic selectively kills Gram-negative pathogens</article-title><source>Nature</source><year>2019</year><volume>576</volume><fpage>459</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1791-1</pub-id><?supplied-pmid 31747680?><pub-id pub-id-type="pmid">31747680</pub-id></element-citation></ref><ref id="B45-life-13-01073"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Peterson</surname><given-names>J.H.</given-names></name>
<name><surname>Doyle</surname><given-names>M.T.</given-names></name>
<name><surname>Bernstein</surname><given-names>H.D.</given-names></name>
</person-group><article-title>Small molecule antibiotics inhibit distinct stages of bacterial outer membrane protein assembly</article-title><source>mBio</source><year>2022</year><volume>13</volume><fpage>e02286-22</fpage><pub-id pub-id-type="doi">10.1128/mbio.02286-22</pub-id><?supplied-pmid 36165532?><pub-id pub-id-type="pmid">36165532</pub-id></element-citation></ref><ref id="B46-life-13-01073"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Imai</surname><given-names>Y.</given-names></name>
<name><surname>Hauk</surname><given-names>G.</given-names></name>
<name><surname>Quigley</surname><given-names>J.</given-names></name>
<name><surname>Liang</surname><given-names>L.</given-names></name>
<name><surname>Son</surname><given-names>S.</given-names></name>
<name><surname>Ghiglieri</surname><given-names>M.</given-names></name>
<name><surname>Gates</surname><given-names>M.F.</given-names></name>
<name><surname>Morrissette</surname><given-names>M.</given-names></name>
<name><surname>Shahsavari</surname><given-names>N.</given-names></name>
<name><surname>Niles</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Evybactin is a DNA gyrase inhibitor that selectively kills <italic toggle="yes">Mycobacterium tuberculosis</italic></article-title><source>Nat. Chem. Biol.</source><year>2022</year><volume>18</volume><fpage>1236</fpage><lpage>1244</lpage><pub-id pub-id-type="doi">10.1038/s41589-022-01102-7</pub-id><?supplied-pmid 35996001?><pub-id pub-id-type="pmid">35996001</pub-id></element-citation></ref><ref id="B47-life-13-01073"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ossai</surname><given-names>J.</given-names></name>
<name><surname>Khatabi</surname><given-names>B.</given-names></name>
<name><surname>Nybo</surname><given-names>S.E.</given-names></name>
<name><surname>Kharel</surname><given-names>M.K.</given-names></name>
</person-group><article-title>Renewed interests in the discovery of bioactive actinomycete metabolites driven by emerging technologies</article-title><source>J. Appl. Microbiol.</source><year>2022</year><volume>132</volume><fpage>59</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1111/jam.15225</pub-id><?supplied-pmid 34265147?><pub-id pub-id-type="pmid">34265147</pub-id></element-citation></ref><ref id="B48-life-13-01073"><label>48.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Rajivgandhi</surname><given-names>G.N.</given-names></name>
<name><surname>Vimala</surname><given-names>R.T.V.</given-names></name>
<name><surname>Ramachandran</surname><given-names>G.</given-names></name>
<name><surname>Kanisha</surname><given-names>C.C.</given-names></name>
<name><surname>Manoharan</surname><given-names>N.</given-names></name>
<name><surname>Li</surname><given-names>W.-J.</given-names></name>
</person-group><article-title>An overview on natural product from endophytic actinomycetes</article-title><source>Natural Products from Actinomycetes</source><person-group person-group-type="editor">
<name><surname>Rai</surname><given-names>R.V.</given-names></name>
<name><surname>Bai</surname><given-names>J.A.</given-names></name>
</person-group><publisher-name>Springer</publisher-name><publisher-loc>Singapore</publisher-loc><year>2022</year><fpage>151</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1007/978-981-16-6132-7_6</pub-id><isbn>9789811661310</isbn></element-citation></ref><ref id="B49-life-13-01073"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gakuubi</surname><given-names>M.M.</given-names></name>
<name><surname>Munusamy</surname><given-names>M.</given-names></name>
<name><surname>Liang</surname><given-names>Z.-X.</given-names></name>
<name><surname>Ng</surname><given-names>S.B.</given-names></name>
</person-group><article-title>Fungal endophytes: A promising frontier for discovery of novel bioactive compounds</article-title><source>J. Fungi</source><year>2021</year><volume>7</volume><elocation-id>786</elocation-id><pub-id pub-id-type="doi">10.3390/jof7100786</pub-id></element-citation></ref><ref id="B50-life-13-01073"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Khan</surname><given-names>S.</given-names></name>
<name><surname>Verma</surname><given-names>V.</given-names></name>
<name><surname>Rasool</surname><given-names>S.</given-names></name>
</person-group><article-title>Diversity and the role of endophytic bacteria: A review</article-title><source>Bot. Serb.</source><year>2020</year><volume>44</volume><fpage>103</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.2298/BOTSERB2002103K</pub-id></element-citation></ref><ref id="B51-life-13-01073"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>dos Santos</surname><given-names>R.M.</given-names></name>
<name><surname>Desoignies</surname><given-names>N.</given-names></name>
<name><surname>Rigobelo</surname><given-names>E.C.</given-names></name>
</person-group><article-title>The bacterial world inside the plant</article-title><source>Front. Sustain. Food Syst.</source><year>2022</year><volume>6</volume><fpage>830198</fpage><pub-id pub-id-type="doi">10.3389/fsufs.2022.830198</pub-id></element-citation></ref><ref id="B52-life-13-01073"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Boruta</surname><given-names>T.</given-names></name>
</person-group><article-title>A Bioprocess perspective on the production of secondary metabolites by <italic toggle="yes">Streptomyces</italic> in submerged co-cultures</article-title><source>World J. Microbiol. Biotechnol.</source><year>2021</year><volume>37</volume><fpage>171</fpage><pub-id pub-id-type="doi">10.1007/s11274-021-03141-z</pub-id><pub-id pub-id-type="pmid">34490503</pub-id></element-citation></ref><ref id="B53-life-13-01073"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arora</surname><given-names>D.</given-names></name>
<name><surname>Gupta</surname><given-names>P.</given-names></name>
<name><surname>Jaglan</surname><given-names>S.</given-names></name>
<name><surname>Roullier</surname><given-names>C.</given-names></name>
<name><surname>Grovel</surname><given-names>O.</given-names></name>
<name><surname>Bertrand</surname><given-names>S.</given-names></name>
</person-group><article-title>Expanding the chemical diversity through microorganisms co-culture: Current status and outlook</article-title><source>Biotechnol. Adv.</source><year>2020</year><volume>40</volume><fpage>107521</fpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2020.107521</pub-id><pub-id pub-id-type="pmid">31953204</pub-id></element-citation></ref><ref id="B54-life-13-01073"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Caudal</surname><given-names>F.</given-names></name>
<name><surname>Tapissier-Bontemps</surname><given-names>N.</given-names></name>
<name><surname>Edrada-Ebel</surname><given-names>R.A.</given-names></name>
</person-group><article-title>Impact of co-culture on the metabolism of marine microorganisms</article-title><source>Mar. Drugs</source><year>2022</year><volume>20</volume><elocation-id>153</elocation-id><pub-id pub-id-type="doi">10.3390/md20020153</pub-id><pub-id pub-id-type="pmid">35200682</pub-id></element-citation></ref><ref id="B55-life-13-01073"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Peng</surname><given-names>X.-Y.</given-names></name>
<name><surname>Wu</surname><given-names>J.-T.</given-names></name>
<name><surname>Shao</surname><given-names>C.-L.</given-names></name>
<name><surname>Li</surname><given-names>Z.-Y.</given-names></name>
<name><surname>Chen</surname><given-names>M.</given-names></name>
<name><surname>Wang</surname><given-names>C.-Y.</given-names></name>
</person-group><article-title>Co-culture: Stimulate the metabolic potential and explore the molecular diversity of natural products from microorganisms</article-title><source>Mar. Life Sci. Technol.</source><year>2021</year><volume>3</volume><fpage>363</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1007/s42995-020-00077-5</pub-id><pub-id pub-id-type="pmid">37073292</pub-id></element-citation></ref><ref id="B56-life-13-01073"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Knowles</surname><given-names>S.L.</given-names></name>
<name><surname>Raja</surname><given-names>H.A.</given-names></name>
<name><surname>Roberts</surname><given-names>C.D.</given-names></name>
<name><surname>Oberlies</surname><given-names>N.H.</given-names></name>
</person-group><article-title>Fungal&#x02013;fungal co-culture: A primer for generating chemical diversity</article-title><source>Nat. Prod. Rep.</source><year>2022</year><volume>39</volume><fpage>1557</fpage><lpage>1573</lpage><pub-id pub-id-type="doi">10.1039/D1NP00070E</pub-id><pub-id pub-id-type="pmid">35137758</pub-id></element-citation></ref><ref id="B57-life-13-01073"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>P.</given-names></name>
<name><surname>Ye</surname><given-names>X.</given-names></name>
<name><surname>Wei</surname><given-names>B.</given-names></name>
<name><surname>Emam</surname><given-names>M.</given-names></name>
<name><surname>Zhang</surname><given-names>H.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
</person-group><article-title>The structural diversity of marine microbial secondary metabolites based on co-culture strategy: 2009&#x02013;2019</article-title><source>Mar. Drugs</source><year>2020</year><volume>18</volume><elocation-id>449</elocation-id><pub-id pub-id-type="doi">10.3390/md18090449</pub-id><pub-id pub-id-type="pmid">32867339</pub-id></element-citation></ref><ref id="B58-life-13-01073"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jung</surname><given-names>D.</given-names></name>
<name><surname>Liu</surname><given-names>L.</given-names></name>
<name><surname>He</surname><given-names>S.</given-names></name>
</person-group><article-title>Application of in situ cultivation in marine microbial resource mining</article-title><source>Mar. Life Sci. Technol.</source><year>2021</year><volume>3</volume><fpage>148</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1007/s42995-020-00063-x</pub-id><pub-id pub-id-type="pmid">37073342</pub-id></element-citation></ref><ref id="B59-life-13-01073"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kaeberlein</surname><given-names>T.</given-names></name>
<name><surname>Lewis</surname><given-names>K.</given-names></name>
<name><surname>Epstein</surname><given-names>S.S.</given-names></name>
</person-group><article-title>Isolating &#x0201c;uncultivable&#x0201d; microorganisms in pure culture in a simulated natural environment</article-title><source>Science</source><year>2002</year><volume>296</volume><fpage>1127</fpage><lpage>1129</lpage><pub-id pub-id-type="doi">10.1126/science.1070633</pub-id><pub-id pub-id-type="pmid">12004133</pub-id></element-citation></ref><ref id="B60-life-13-01073"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nichols</surname><given-names>D.</given-names></name>
<name><surname>Cahoon</surname><given-names>N.</given-names></name>
<name><surname>Trakhtenberg</surname><given-names>E.M.</given-names></name>
<name><surname>Pham</surname><given-names>L.</given-names></name>
<name><surname>Mehta</surname><given-names>A.</given-names></name>
<name><surname>Belanger</surname><given-names>A.</given-names></name>
<name><surname>Kanigan</surname><given-names>T.</given-names></name>
<name><surname>Lewis</surname><given-names>K.</given-names></name>
<name><surname>Epstein</surname><given-names>S.S.</given-names></name>
</person-group><article-title>Use of ichip for high-throughput in situ cultivation of &#x0201c;uncultivable&#x0201d; microbial species</article-title><source>Appl. Environ. Microbiol.</source><year>2010</year><volume>76</volume><fpage>2445</fpage><lpage>2450</lpage><pub-id pub-id-type="doi">10.1128/AEM.01754-09</pub-id><pub-id pub-id-type="pmid">20173072</pub-id></element-citation></ref><ref id="B61-life-13-01073"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gavrish</surname><given-names>E.</given-names></name>
<name><surname>Bollmann</surname><given-names>A.</given-names></name>
<name><surname>Epstein</surname><given-names>S.</given-names></name>
<name><surname>Lewis</surname><given-names>K.</given-names></name>
</person-group><article-title>A Trap for in situ cultivation of filamentous actinobacteria</article-title><source>J. Microbiol. Meth.</source><year>2008</year><volume>72</volume><fpage>257</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1016/j.mimet.2007.12.009</pub-id></element-citation></ref><ref id="B62-life-13-01073"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ben-Dov</surname><given-names>E.</given-names></name>
<name><surname>Kramarsky-Winter</surname><given-names>E.</given-names></name>
<name><surname>Kushmaro</surname><given-names>A.</given-names></name>
</person-group><article-title>An in situ method for cultivating microorganisms using a double encapsulation technique: In situ method for cultivating microorganisms</article-title><source>FEMS Microbiol. Ecol.</source><year>2009</year><volume>68</volume><fpage>363</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6941.2009.00682.x</pub-id><pub-id pub-id-type="pmid">19453493</pub-id></element-citation></ref><ref id="B63-life-13-01073"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jung</surname><given-names>D.</given-names></name>
<name><surname>Liu</surname><given-names>B.</given-names></name>
<name><surname>He</surname><given-names>X.</given-names></name>
<name><surname>Owen</surname><given-names>J.S.</given-names></name>
<name><surname>Liu</surname><given-names>L.</given-names></name>
<name><surname>Yuan</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>He</surname><given-names>S.</given-names></name>
</person-group><article-title>Accessing previously uncultured marine microbial resources by a combination of alternative cultivation methods</article-title><source>Microb. Biotechnol.</source><year>2021</year><volume>14</volume><fpage>1148</fpage><lpage>1158</lpage><pub-id pub-id-type="doi">10.1111/1751-7915.13782</pub-id><pub-id pub-id-type="pmid">33638935</pub-id></element-citation></ref><ref id="B64-life-13-01073"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Berdy</surname><given-names>B.</given-names></name>
<name><surname>Spoering</surname><given-names>A.L.</given-names></name>
<name><surname>Ling</surname><given-names>L.L.</given-names></name>
<name><surname>Epstein</surname><given-names>S.S.</given-names></name>
</person-group><article-title>In situ cultivation of previously uncultivable microorganisms using the ichip</article-title><source>Nat. Protoc.</source><year>2017</year><volume>12</volume><fpage>2232</fpage><lpage>2242</lpage><pub-id pub-id-type="doi">10.1038/nprot.2017.074</pub-id><pub-id pub-id-type="pmid">29532802</pub-id></element-citation></ref><ref id="B65-life-13-01073"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ling</surname><given-names>L.L.</given-names></name>
<name><surname>Schneider</surname><given-names>T.</given-names></name>
<name><surname>Peoples</surname><given-names>A.J.</given-names></name>
<name><surname>Spoering</surname><given-names>A.L.</given-names></name>
<name><surname>Engels</surname><given-names>I.</given-names></name>
<name><surname>Conlon</surname><given-names>B.P.</given-names></name>
<name><surname>Mueller</surname><given-names>A.</given-names></name>
<name><surname>Sch&#x000e4;berle</surname><given-names>T.F.</given-names></name>
<name><surname>Hughes</surname><given-names>D.E.</given-names></name>
<name><surname>Epstein</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>A new antibiotic kills pathogens without detectable resistance</article-title><source>Nature</source><year>2015</year><volume>517</volume><fpage>455</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1038/nature14098</pub-id><?supplied-pmid 25561178?><pub-id pub-id-type="pmid">25561178</pub-id></element-citation></ref><ref id="B66-life-13-01073"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Homma</surname><given-names>T.</given-names></name>
<name><surname>Nuxoll</surname><given-names>A.</given-names></name>
<name><surname>Gandt</surname><given-names>A.B.</given-names></name>
<name><surname>Ebner</surname><given-names>P.</given-names></name>
<name><surname>Engels</surname><given-names>I.</given-names></name>
<name><surname>Schneider</surname><given-names>T.</given-names></name>
<name><surname>G&#x000f6;tz</surname><given-names>F.</given-names></name>
<name><surname>Lewis</surname><given-names>K.</given-names></name>
<name><surname>Conlon</surname><given-names>B.P.</given-names></name>
</person-group><article-title>Dual targeting of cell wall precursors by teixobactin leads to cell lysis</article-title><source>Antimicrob. Agents Chemother.</source><year>2016</year><volume>60</volume><fpage>6510</fpage><lpage>6517</lpage><pub-id pub-id-type="doi">10.1128/AAC.01050-16</pub-id><?supplied-pmid 27550357?><pub-id pub-id-type="pmid">27550357</pub-id></element-citation></ref><ref id="B67-life-13-01073"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Quigley</surname><given-names>J.</given-names></name>
<name><surname>Peoples</surname><given-names>A.</given-names></name>
<name><surname>Sarybaeva</surname><given-names>A.</given-names></name>
<name><surname>Hughes</surname><given-names>D.</given-names></name>
<name><surname>Ghiglieri</surname><given-names>M.</given-names></name>
<name><surname>Achorn</surname><given-names>C.</given-names></name>
<name><surname>Desrosiers</surname><given-names>A.</given-names></name>
<name><surname>Felix</surname><given-names>C.</given-names></name>
<name><surname>Liang</surname><given-names>L.</given-names></name>
<name><surname>Malveira</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Novel antimicrobials from uncultured bacteria acting against <italic toggle="yes">Mycobacterium tuberculosis</italic></article-title><source>mBio</source><year>2020</year><volume>11</volume><fpage>e01516-20</fpage><pub-id pub-id-type="doi">10.1128/mBio.01516-20</pub-id><?supplied-pmid 32753498?><pub-id pub-id-type="pmid">32753498</pub-id></element-citation></ref><ref id="B68-life-13-01073"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wirtz</surname><given-names>D.A.</given-names></name>
<name><surname>Ludwig</surname><given-names>K.C.</given-names></name>
<name><surname>Arts</surname><given-names>M.</given-names></name>
<name><surname>Marx</surname><given-names>C.E.</given-names></name>
<name><surname>Krannich</surname><given-names>S.</given-names></name>
<name><surname>Barac</surname><given-names>P.</given-names></name>
<name><surname>Kehraus</surname><given-names>S.</given-names></name>
<name><surname>Josten</surname><given-names>M.</given-names></name>
<name><surname>Henrichfreise</surname><given-names>B.</given-names></name>
<name><surname>M&#x000fc;ller</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Biosynthesis and mechanism of action of the cell wall targeting antibiotic hypeptin</article-title><source>Angew. Chem. Int. Ed.</source><year>2021</year><volume>60</volume><fpage>13579</fpage><lpage>13586</lpage><pub-id pub-id-type="doi">10.1002/anie.202102224</pub-id></element-citation></ref><ref id="B69-life-13-01073"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Davidson</surname><given-names>S.-L.</given-names></name>
<name><surname>Niepa</surname><given-names>T.H.R.</given-names></name>
</person-group><article-title>Micro-technologies for assessing microbial dynamics in controlled environments</article-title><source>Front. Microbiol.</source><year>2022</year><volume>12</volume><fpage>745835</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2021.745835</pub-id><pub-id pub-id-type="pmid">35154021</pub-id></element-citation></ref><ref id="B70-life-13-01073"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pope</surname><given-names>E.</given-names></name>
<name><surname>Cartmell</surname><given-names>C.</given-names></name>
<name><surname>Haltli</surname><given-names>B.</given-names></name>
<name><surname>Ahmadi</surname><given-names>A.</given-names></name>
<name><surname>Kerr</surname><given-names>R.G.</given-names></name>
</person-group><article-title>Microencapsulation and in situ incubation methodology for the cultivation of marine bacteria</article-title><source>Front. Microbiol.</source><year>2022</year><volume>13</volume><fpage>958660</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2022.958660</pub-id><pub-id pub-id-type="pmid">36071955</pub-id></element-citation></ref><ref id="B71-life-13-01073"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Terekhov</surname><given-names>S.S.</given-names></name>
<name><surname>Eliseev</surname><given-names>I.E.</given-names></name>
<name><surname>Ovchinnikova</surname><given-names>L.A.</given-names></name>
<name><surname>Kabilov</surname><given-names>M.R.</given-names></name>
<name><surname>Prjibelski</surname><given-names>A.D.</given-names></name>
<name><surname>Tupikin</surname><given-names>A.E.</given-names></name>
<name><surname>Smirnov</surname><given-names>I.V.</given-names></name>
<name><surname>Belogurov</surname><given-names>A.A.</given-names></name>
<name><surname>Severinov</surname><given-names>K.V.</given-names></name>
<name><surname>Lomakin</surname><given-names>Y.A.</given-names></name>
<etal/>
</person-group><article-title>Liquid drop of DNA libraries reveals total genome information</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2020</year><volume>117</volume><fpage>27300</fpage><lpage>27306</lpage><pub-id pub-id-type="doi">10.1073/pnas.2017138117</pub-id><pub-id pub-id-type="pmid">33087570</pub-id></element-citation></ref><ref id="B72-life-13-01073"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Payne</surname><given-names>E.M.</given-names></name>
<name><surname>Holland-Moritz</surname><given-names>D.A.</given-names></name>
<name><surname>Sun</surname><given-names>S.</given-names></name>
<name><surname>Kennedy</surname><given-names>R.T.</given-names></name>
</person-group><article-title>High-throughput screening by droplet microfluidics: Perspective into key challenges and future prospects</article-title><source>Lab Chip</source><year>2020</year><volume>20</volume><fpage>2247</fpage><lpage>2262</lpage><pub-id pub-id-type="doi">10.1039/D0LC00347F</pub-id><pub-id pub-id-type="pmid">32500896</pub-id></element-citation></ref><ref id="B73-life-13-01073"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hu</surname><given-names>B.</given-names></name>
<name><surname>Xu</surname><given-names>P.</given-names></name>
<name><surname>Ma</surname><given-names>L.</given-names></name>
<name><surname>Chen</surname><given-names>D.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Dai</surname><given-names>X.</given-names></name>
<name><surname>Huang</surname><given-names>L.</given-names></name>
<name><surname>Du</surname><given-names>W.</given-names></name>
</person-group><article-title>One cell at a time: Droplet-based microbial cultivation, screening and sequencing</article-title><source>Mar. Life Sci. Technol.</source><year>2021</year><volume>3</volume><fpage>169</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1007/s42995-020-00082-8</pub-id><pub-id pub-id-type="pmid">37073344</pub-id></element-citation></ref><ref id="B74-life-13-01073"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ning</surname><given-names>R.</given-names></name>
<name><surname>Fan</surname><given-names>J.</given-names></name>
<name><surname>Kong</surname><given-names>L.</given-names></name>
<name><surname>Jiang</surname><given-names>X.</given-names></name>
<name><surname>Qian</surname><given-names>Y.</given-names></name>
<name><surname>Du</surname><given-names>T.</given-names></name>
<name><surname>Zhang</surname><given-names>G.</given-names></name>
<name><surname>Wu</surname><given-names>W.</given-names></name>
</person-group><article-title>Recent developments of droplets-based microfluidics for bacterial analysis</article-title><source>Chin. Chem. Lett.</source><year>2022</year><volume>33</volume><fpage>2243</fpage><lpage>2252</lpage><pub-id pub-id-type="doi">10.1016/j.cclet.2021.08.096</pub-id></element-citation></ref><ref id="B75-life-13-01073"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yu</surname><given-names>Y.</given-names></name>
<name><surname>Wen</surname><given-names>H.</given-names></name>
<name><surname>Li</surname><given-names>S.</given-names></name>
<name><surname>Cao</surname><given-names>H.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Ma</surname><given-names>Z.</given-names></name>
<name><surname>She</surname><given-names>X.</given-names></name>
<name><surname>Zhou</surname><given-names>L.</given-names></name>
<name><surname>Huang</surname><given-names>S.</given-names></name>
</person-group><article-title>Emerging microfluidic technologies for microbiome research</article-title><source>Front. Microbiol.</source><year>2022</year><volume>13</volume><fpage>906979</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2022.906979</pub-id><pub-id pub-id-type="pmid">36051769</pub-id></element-citation></ref><ref id="B76-life-13-01073"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Burmeister</surname><given-names>A.</given-names></name>
<name><surname>Gr&#x000fc;nberger</surname><given-names>A.</given-names></name>
</person-group><article-title>Microfluidic cultivation and analysis tools for interaction studies of microbial co-cultures</article-title><source>Curr. Opin. Biotechnol.</source><year>2020</year><volume>62</volume><fpage>106</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1016/j.copbio.2019.09.001</pub-id><pub-id pub-id-type="pmid">31715386</pub-id></element-citation></ref><ref id="B77-life-13-01073"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Terekhov</surname><given-names>S.S.</given-names></name>
<name><surname>Smirnov</surname><given-names>I.V.</given-names></name>
<name><surname>Stepanova</surname><given-names>A.V.</given-names></name>
<name><surname>Bobik</surname><given-names>T.V.</given-names></name>
<name><surname>Mokrushina</surname><given-names>Y.A.</given-names></name>
<name><surname>Ponomarenko</surname><given-names>N.A.</given-names></name>
<name><surname>Belogurov</surname><given-names>A.A.</given-names></name>
<name><surname>Rubtsova</surname><given-names>M.P.</given-names></name>
<name><surname>Kartseva</surname><given-names>O.V.</given-names></name>
<name><surname>Gomzikova</surname><given-names>M.O.</given-names></name>
<etal/>
</person-group><article-title>Microfluidic droplet platform for ultrahigh-throughput single-cell screening of biodiversity</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2017</year><volume>114</volume><fpage>2550</fpage><lpage>2555</lpage><pub-id pub-id-type="doi">10.1073/pnas.1621226114</pub-id><pub-id pub-id-type="pmid">28202731</pub-id></element-citation></ref><ref id="B78-life-13-01073"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Terekhov</surname><given-names>S.S.</given-names></name>
<name><surname>Nazarov</surname><given-names>A.S.</given-names></name>
<name><surname>Mokrushina</surname><given-names>Y.A.</given-names></name>
<name><surname>Baranova</surname><given-names>M.N.</given-names></name>
<name><surname>Potapova</surname><given-names>N.A.</given-names></name>
<name><surname>Malakhova</surname><given-names>M.V.</given-names></name>
<name><surname>Ilina</surname><given-names>E.N.</given-names></name>
<name><surname>Smirnov</surname><given-names>I.V.</given-names></name>
<name><surname>Gabibov</surname><given-names>A.G.</given-names></name>
</person-group><article-title>Deep functional profiling facilitates the evaluation of the antibacterial potential of the antibiotic amicoumacin</article-title><source>Antibiotics</source><year>2020</year><volume>9</volume><elocation-id>157</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics9040157</pub-id><pub-id pub-id-type="pmid">32252356</pub-id></element-citation></ref><ref id="B79-life-13-01073"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shim</surname><given-names>J.</given-names></name>
<name><surname>Ranasinghe</surname><given-names>R.T.</given-names></name>
<name><surname>Smith</surname><given-names>C.A.</given-names></name>
<name><surname>Ibrahim</surname><given-names>S.M.</given-names></name>
<name><surname>Hollfelder</surname><given-names>F.</given-names></name>
<name><surname>Huck</surname><given-names>W.T.S.</given-names></name>
<name><surname>Klenerman</surname><given-names>D.</given-names></name>
<name><surname>Abell</surname><given-names>C.</given-names></name>
</person-group><article-title>Ultrarapid generation of femtoliter microfluidic droplets for single-molecule-counting immunoassays</article-title><source>ACS Nano</source><year>2013</year><volume>7</volume><fpage>5955</fpage><lpage>5964</lpage><pub-id pub-id-type="doi">10.1021/nn401661d</pub-id><pub-id pub-id-type="pmid">23805985</pub-id></element-citation></ref><ref id="B80-life-13-01073"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mahler</surname><given-names>L.</given-names></name>
<name><surname>Niehs</surname><given-names>S.P.</given-names></name>
<name><surname>Martin</surname><given-names>K.</given-names></name>
<name><surname>Weber</surname><given-names>T.</given-names></name>
<name><surname>Scherlach</surname><given-names>K.</given-names></name>
<name><surname>Hertweck</surname><given-names>C.</given-names></name>
<name><surname>Roth</surname><given-names>M.</given-names></name>
<name><surname>Rosenbaum</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Highly parallelized droplet cultivation and prioritization of antibiotic producers from natural microbial communities</article-title><source>eLife</source><year>2021</year><volume>10</volume><fpage>e64774</fpage><pub-id pub-id-type="doi">10.7554/eLife.64774</pub-id><pub-id pub-id-type="pmid">33764297</pub-id></element-citation></ref><ref id="B81-life-13-01073"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mahler</surname><given-names>L.</given-names></name>
<name><surname>Wink</surname><given-names>K.</given-names></name>
<name><surname>Beulig</surname><given-names>R.J.</given-names></name>
<name><surname>Scherlach</surname><given-names>K.</given-names></name>
<name><surname>Tovar</surname><given-names>M.</given-names></name>
<name><surname>Zang</surname><given-names>E.</given-names></name>
<name><surname>Martin</surname><given-names>K.</given-names></name>
<name><surname>Hertweck</surname><given-names>C.</given-names></name>
<name><surname>Belder</surname><given-names>D.</given-names></name>
<name><surname>Roth</surname><given-names>M.</given-names></name>
</person-group><article-title>Detection of antibiotics synthetized in microfluidic picolitre-droplets by various Actinobacteria</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>13087</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-31263-2</pub-id><pub-id pub-id-type="pmid">30166560</pub-id></element-citation></ref><ref id="B82-life-13-01073"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oberpaul</surname><given-names>M.</given-names></name>
<name><surname>Brinkmann</surname><given-names>S.</given-names></name>
<name><surname>Marner</surname><given-names>M.</given-names></name>
<name><surname>Mihajlovic</surname><given-names>S.</given-names></name>
<name><surname>Leis</surname><given-names>B.</given-names></name>
<name><surname>Patras</surname><given-names>M.A.</given-names></name>
<name><surname>Hartwig</surname><given-names>C.</given-names></name>
<name><surname>Vilcinskas</surname><given-names>A.</given-names></name>
<name><surname>Hammann</surname><given-names>P.E.</given-names></name>
<name><surname>Sch&#x000e4;berle</surname><given-names>T.F.</given-names></name>
<etal/>
</person-group><article-title>Combination of high-throughput microfluidics and FACS technologies to leverage the numbers game in natural product discovery</article-title><source>Microb. Biotechnol.</source><year>2022</year><volume>15</volume><fpage>415</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1111/1751-7915.13872</pub-id><pub-id pub-id-type="pmid">34165868</pub-id></element-citation></ref><ref id="B83-life-13-01073"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Baranova</surname><given-names>M.N.</given-names></name>
<name><surname>Babikova</surname><given-names>P.A.</given-names></name>
<name><surname>Kudzhaev</surname><given-names>A.M.</given-names></name>
<name><surname>Mokrushina</surname><given-names>Y.A.</given-names></name>
<name><surname>Belozerova</surname><given-names>O.A.</given-names></name>
<name><surname>Yunin</surname><given-names>M.A.</given-names></name>
<name><surname>Kovalchuk</surname><given-names>S.</given-names></name>
<name><surname>Gabibov</surname><given-names>A.G.</given-names></name>
<name><surname>Smirnov</surname><given-names>I.V.</given-names></name>
<name><surname>Terekhov</surname><given-names>S.S.</given-names></name>
</person-group><article-title>Live biosensors for ultrahigh-throughput screening of antimicrobial activity against Gram-negative bacteria</article-title><source>Antibiotics</source><year>2021</year><volume>10</volume><elocation-id>1161</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics10101161</pub-id><pub-id pub-id-type="pmid">34680742</pub-id></element-citation></ref><ref id="B84-life-13-01073"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wollein Waldetoft</surname><given-names>K.</given-names></name>
<name><surname>Brown</surname><given-names>S.P.</given-names></name>
</person-group><article-title>Evolving antibiotic spectrum</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2022</year><volume>119</volume><fpage>e2214267119</fpage><pub-id pub-id-type="doi">10.1073/pnas.2214267119</pub-id><pub-id pub-id-type="pmid">36191212</pub-id></element-citation></ref><ref id="B85-life-13-01073"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Johnston</surname><given-names>C.W.</given-names></name>
<name><surname>Badran</surname><given-names>A.H.</given-names></name>
</person-group><article-title>Natural and engineered precision antibiotics in the context of resistance</article-title><source>Curr. Opin. Chem. Biol.</source><year>2022</year><volume>69</volume><fpage>102160</fpage><pub-id pub-id-type="doi">10.1016/j.cbpa.2022.102160</pub-id><?supplied-pmid 35660248?><pub-id pub-id-type="pmid">35660248</pub-id></element-citation></ref><ref id="B86-life-13-01073"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sears</surname><given-names>P.</given-names></name>
<name><surname>Ichikawa</surname><given-names>Y.</given-names></name>
<name><surname>Ruiz</surname><given-names>N.</given-names></name>
<name><surname>Gorbach</surname><given-names>S.</given-names></name>
</person-group><article-title>Advances in the treatment of <italic toggle="yes">Clostridium difficile</italic> with fidaxomicin: A narrow spectrum antibiotic</article-title><source>Ann. N. Y. Acad. Sci.</source><year>2013</year><volume>1291</volume><fpage>33</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1111/nyas.12135</pub-id><?supplied-pmid 23672600?><pub-id pub-id-type="pmid">23672600</pub-id></element-citation></ref><ref id="B87-life-13-01073"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cao</surname><given-names>X.</given-names></name>
<name><surname>Boyaci</surname><given-names>H.</given-names></name>
<name><surname>Chen</surname><given-names>J.</given-names></name>
<name><surname>Bao</surname><given-names>Y.</given-names></name>
<name><surname>Landick</surname><given-names>R.</given-names></name>
<name><surname>Campbell</surname><given-names>E.A.</given-names></name>
</person-group><article-title>Basis of narrow-spectrum activity of fidaxomicin on <italic toggle="yes">Clostridioides difficile</italic></article-title><source>Nature</source><year>2022</year><volume>604</volume><fpage>541</fpage><lpage>545</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-04545-z</pub-id><?supplied-pmid 35388215?><pub-id pub-id-type="pmid">35388215</pub-id></element-citation></ref><ref id="B88-life-13-01073"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Leimer</surname><given-names>N.</given-names></name>
<name><surname>Wu</surname><given-names>X.</given-names></name>
<name><surname>Imai</surname><given-names>Y.</given-names></name>
<name><surname>Morrissette</surname><given-names>M.</given-names></name>
<name><surname>Pitt</surname><given-names>N.</given-names></name>
<name><surname>Favre-Godal</surname><given-names>Q.</given-names></name>
<name><surname>Iinishi</surname><given-names>A.</given-names></name>
<name><surname>Jain</surname><given-names>S.</given-names></name>
<name><surname>Caboni</surname><given-names>M.</given-names></name>
<name><surname>Leus</surname><given-names>I.V.</given-names></name>
<etal/>
</person-group><article-title>A selective antibiotic for Lyme disease</article-title><source>Cell</source><year>2021</year><volume>184</volume><fpage>5405</fpage><lpage>5418.e16</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.09.011</pub-id><pub-id pub-id-type="pmid">34619078</pub-id></element-citation></ref><ref id="B89-life-13-01073"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Covington</surname><given-names>B.C.</given-names></name>
<name><surname>Seyedsayamdost</surname><given-names>M.R.</given-names></name>
</person-group><article-title>Vitamin B3 triggers biosynthesis of secondary metabolite dormancy signals in <italic toggle="yes">Streptococcus suis</italic></article-title><source>J. Am. Chem. Soc.</source><year>2022</year><volume>144</volume><fpage>14997</fpage><lpage>15001</lpage><pub-id pub-id-type="doi">10.1021/jacs.2c05790</pub-id><pub-id pub-id-type="pmid">35969232</pub-id></element-citation></ref><ref id="B90-life-13-01073"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rued</surname><given-names>B.E.</given-names></name>
<name><surname>Covington</surname><given-names>B.C.</given-names></name>
<name><surname>Bushin</surname><given-names>L.B.</given-names></name>
<name><surname>Szewczyk</surname><given-names>G.</given-names></name>
<name><surname>Laczkovich</surname><given-names>I.</given-names></name>
<name><surname>Seyedsayamdost</surname><given-names>M.R.</given-names></name>
<name><surname>Federle</surname><given-names>M.J.</given-names></name>
</person-group><article-title>Quorum sensing in <italic toggle="yes">Streptococcus mutans</italic> regulates production of tryglysin, a novel RaS-RiPP antimicrobial compound</article-title><source>mBio</source><year>2021</year><volume>12</volume><fpage>e02688-20</fpage><pub-id pub-id-type="doi">10.1128/mBio.02688-20</pub-id><pub-id pub-id-type="pmid">33727351</pub-id></element-citation></ref><ref id="B91-life-13-01073"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Avis</surname><given-names>T.</given-names></name>
<name><surname>Wilson</surname><given-names>F.X.</given-names></name>
<name><surname>Khan</surname><given-names>N.</given-names></name>
<name><surname>Mason</surname><given-names>C.S.</given-names></name>
<name><surname>Powell</surname><given-names>D.J.</given-names></name>
</person-group><article-title>Targeted microbiome-sparing antibiotics</article-title><source>Drug Discov. Today</source><year>2021</year><volume>26</volume><fpage>2198</fpage><lpage>2203</lpage><pub-id pub-id-type="doi">10.1016/j.drudis.2021.07.016</pub-id><pub-id pub-id-type="pmid">34329771</pub-id></element-citation></ref><ref id="B92-life-13-01073"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bauman</surname><given-names>K.D.</given-names></name>
<name><surname>Butler</surname><given-names>K.S.</given-names></name>
<name><surname>Moore</surname><given-names>B.S.</given-names></name>
<name><surname>Chekan</surname><given-names>J.R.</given-names></name>
</person-group><article-title>Genome mining methods to discover bioactive natural products</article-title><source>Nat. Prod. Rep.</source><year>2021</year><volume>38</volume><fpage>2100</fpage><lpage>2129</lpage><pub-id pub-id-type="doi">10.1039/D1NP00032B</pub-id><pub-id pub-id-type="pmid">34734626</pub-id></element-citation></ref><ref id="B93-life-13-01073"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schorn</surname><given-names>M.A.</given-names></name>
<name><surname>Verhoeven</surname><given-names>S.</given-names></name>
<name><surname>Ridder</surname><given-names>L.</given-names></name>
<name><surname>Huber</surname><given-names>F.</given-names></name>
<name><surname>Acharya</surname><given-names>D.D.</given-names></name>
<name><surname>Aksenov</surname><given-names>A.A.</given-names></name>
<name><surname>Aleti</surname><given-names>G.</given-names></name>
<name><surname>Moghaddam</surname><given-names>J.A.</given-names></name>
<name><surname>Aron</surname><given-names>A.T.</given-names></name>
<name><surname>Aziz</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>A community resource for paired genomic and metabolomic data mining</article-title><source>Nat. Chem. Biol.</source><year>2021</year><volume>17</volume><fpage>363</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1038/s41589-020-00724-z</pub-id><pub-id pub-id-type="pmid">33589842</pub-id></element-citation></ref><ref id="B94-life-13-01073"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Louwen</surname><given-names>J.J.R.</given-names></name>
<name><surname>Medema</surname><given-names>M.H.</given-names></name>
<name><surname>van der Hooft</surname><given-names>J.J.J.</given-names></name>
</person-group><article-title>Enhanced correlation-based linking of biosynthetic gene clusters to their metabolic products through chemical cass matching</article-title><source>Microbiome</source><year>2023</year><volume>11</volume><fpage>13</fpage><pub-id pub-id-type="doi">10.1186/s40168-022-01444-3</pub-id><pub-id pub-id-type="pmid">36691088</pub-id></element-citation></ref><ref id="B95-life-13-01073"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Muller</surname><given-names>E.</given-names></name>
<name><surname>Algavi</surname><given-names>Y.M.</given-names></name>
<name><surname>Borenstein</surname><given-names>E.</given-names></name>
</person-group><article-title>The gut microbiome-metabolome dataset collection: A curated resource for integrative meta-analysis</article-title><source>npj Biofilms Microbiom.</source><year>2022</year><volume>8</volume><fpage>79</fpage><pub-id pub-id-type="doi">10.1038/s41522-022-00345-5</pub-id></element-citation></ref><ref id="B96-life-13-01073"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hou</surname><given-names>P.</given-names></name>
<name><surname>Nowak</surname><given-names>V.V.</given-names></name>
<name><surname>Taylor</surname><given-names>C.J.</given-names></name>
<name><surname>Calcott</surname><given-names>M.J.</given-names></name>
<name><surname>Knight</surname><given-names>A.</given-names></name>
<name><surname>Owen</surname><given-names>J.G.</given-names></name>
</person-group><article-title>A genomic survey of the natural product biosynthetic potential of actinomycetes isolated from New Zealand lichens</article-title><source>mSystems</source><year>2023</year><volume>8</volume><fpage>e01030-22</fpage><pub-id pub-id-type="doi">10.1128/msystems.01030-22</pub-id><pub-id pub-id-type="pmid">36749048</pub-id></element-citation></ref><ref id="B97-life-13-01073"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tenebro</surname><given-names>C.P.</given-names></name>
<name><surname>Trono</surname><given-names>D.J.V.L.</given-names></name>
<name><surname>Balida</surname><given-names>L.A.P.</given-names></name>
<name><surname>Bayog</surname><given-names>L.K.A.</given-names></name>
<name><surname>Bruna</surname><given-names>J.R.</given-names></name>
<name><surname>Sabido</surname><given-names>E.M.</given-names></name>
<name><surname>Caspe</surname><given-names>D.P.C.</given-names></name>
<name><surname>de Los Santos</surname><given-names>E.L.C.</given-names></name>
<name><surname>Saludes</surname><given-names>J.P.</given-names></name>
<name><surname>Dalisay</surname><given-names>D.S.</given-names></name>
</person-group><article-title>Synergy between genome mining, metabolomics, and bioinformatics uncovers antibacterial chlorinated carbazole alkaloids and their biosynthetic gene cluster from <italic toggle="yes">Streptomyces tubbatahanensis</italic> sp. Nov., a novel actinomycete isolated from Sulu Sea, Philippines</article-title><source>Microbiol. Spectr.</source><year>2023</year><volume>11</volume><fpage>e03661-22</fpage><pub-id pub-id-type="doi">10.1128/spectrum.03661-22</pub-id><pub-id pub-id-type="pmid">36809153</pub-id></element-citation></ref><ref id="B98-life-13-01073"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Milshteyn</surname><given-names>A.</given-names></name>
<name><surname>Colosimo</surname><given-names>D.A.</given-names></name>
<name><surname>Brady</surname><given-names>S.F.</given-names></name>
</person-group><article-title>Accessing bioactive natural products from the human microbiome</article-title><source>Cell Host Microbe</source><year>2018</year><volume>23</volume><fpage>725</fpage><lpage>736</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2018.05.013</pub-id><pub-id pub-id-type="pmid">29902438</pub-id></element-citation></ref><ref id="B99-life-13-01073"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chiumento</surname><given-names>S.</given-names></name>
<name><surname>Roblin</surname><given-names>C.</given-names></name>
<name><surname>Kieffer-Jaquinod</surname><given-names>S.</given-names></name>
<name><surname>Tachon</surname><given-names>S.</given-names></name>
<name><surname>Lepr&#x000e8;tre</surname><given-names>C.</given-names></name>
<name><surname>Basset</surname><given-names>C.</given-names></name>
<name><surname>Aditiyarini</surname><given-names>D.</given-names></name>
<name><surname>Olleik</surname><given-names>H.</given-names></name>
<name><surname>Nicoletti</surname><given-names>C.</given-names></name>
<name><surname>Bornet</surname><given-names>O.</given-names></name>
<etal/>
</person-group><article-title>Ruminococcin C, a promising antibiotic produced by a human gut symbiont</article-title><source>Sci. Adv.</source><year>2019</year><volume>5</volume><fpage>eaaw9969</fpage><pub-id pub-id-type="doi">10.1126/sciadv.aaw9969</pub-id><pub-id pub-id-type="pmid">31579822</pub-id></element-citation></ref><ref id="B100-life-13-01073"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yamanaka</surname><given-names>K.</given-names></name>
<name><surname>Reynolds</surname><given-names>K.A.</given-names></name>
<name><surname>Kersten</surname><given-names>R.D.</given-names></name>
<name><surname>Ryan</surname><given-names>K.S.</given-names></name>
<name><surname>Gonzalez</surname><given-names>D.J.</given-names></name>
<name><surname>Nizet</surname><given-names>V.</given-names></name>
<name><surname>Dorrestein</surname><given-names>P.C.</given-names></name>
<name><surname>Moore</surname><given-names>B.S.</given-names></name>
</person-group><article-title>Direct cloning and refactoring of a silent lipopeptide biosynthetic gene cluster yields the antibiotic taromycin A</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2014</year><volume>111</volume><fpage>1957</fpage><lpage>1962</lpage><pub-id pub-id-type="doi">10.1073/pnas.1319584111</pub-id><pub-id pub-id-type="pmid">24449899</pub-id></element-citation></ref><ref id="B101-life-13-01073"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reynolds</surname><given-names>K.A.</given-names></name>
<name><surname>Luhavaya</surname><given-names>H.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Dahesh</surname><given-names>S.</given-names></name>
<name><surname>Nizet</surname><given-names>V.</given-names></name>
<name><surname>Yamanaka</surname><given-names>K.</given-names></name>
<name><surname>Moore</surname><given-names>B.S.</given-names></name>
</person-group><article-title>Isolation and structure elucidation of lipopeptide antibiotic taromycin B from the activated taromycin biosynthetic gene cluster</article-title><source>J. Antibiot.</source><year>2018</year><volume>71</volume><fpage>333</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1038/ja.2017.146</pub-id></element-citation></ref><ref id="B102-life-13-01073"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Luhavaya</surname><given-names>H.</given-names></name>
<name><surname>Sigrist</surname><given-names>R.</given-names></name>
<name><surname>Chekan</surname><given-names>J.R.</given-names></name>
<name><surname>McKinnie</surname><given-names>S.M.K.</given-names></name>
<name><surname>Moore</surname><given-names>B.S.</given-names></name>
</person-group><article-title>Biosynthesis of <sc>l</sc>-4-chlorokynurenine, an antidepressant prodrug and a non-proteinogenic amino acid found in lipopeptide antibiotics</article-title><source>Angew. Chem. Int. Ed.</source><year>2019</year><volume>58</volume><fpage>8394</fpage><lpage>8399</lpage><pub-id pub-id-type="doi">10.1002/anie.201901571</pub-id></element-citation></ref><ref id="B103-life-13-01073"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hover</surname><given-names>B.M.</given-names></name>
<name><surname>Kim</surname><given-names>S.-H.</given-names></name>
<name><surname>Katz</surname><given-names>M.</given-names></name>
<name><surname>Charlop-Powers</surname><given-names>Z.</given-names></name>
<name><surname>Owen</surname><given-names>J.G.</given-names></name>
<name><surname>Ternei</surname><given-names>M.A.</given-names></name>
<name><surname>Maniko</surname><given-names>J.</given-names></name>
<name><surname>Estrela</surname><given-names>A.B.</given-names></name>
<name><surname>Molina</surname><given-names>H.</given-names></name>
<name><surname>Park</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Culture-independent discovery of the malacidins as calcium-dependent antibiotics with activity against multidrug-resistant Gram-positive pathogens</article-title><source>Nat. Microbiol.</source><year>2018</year><volume>3</volume><fpage>415</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1038/s41564-018-0110-1</pub-id><pub-id pub-id-type="pmid">29434326</pub-id></element-citation></ref><ref id="B104-life-13-01073"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wu</surname><given-names>C.</given-names></name>
<name><surname>Shang</surname><given-names>Z.</given-names></name>
<name><surname>Lemetre</surname><given-names>C.</given-names></name>
<name><surname>Ternei</surname><given-names>M.A.</given-names></name>
<name><surname>Brady</surname><given-names>S.F.</given-names></name>
</person-group><article-title>Cadasides, calcium-dependent acidic lipopeptides from the soil metagenome that are active against multidrug-resistant bacteria</article-title><source>J. Am. Chem. Soc.</source><year>2019</year><volume>141</volume><fpage>3910</fpage><lpage>3919</lpage><pub-id pub-id-type="doi">10.1021/jacs.8b12087</pub-id><pub-id pub-id-type="pmid">30735616</pub-id></element-citation></ref><ref id="B105-life-13-01073"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>L.</given-names></name>
<name><surname>Koirala</surname><given-names>B.</given-names></name>
<name><surname>Hernandez</surname><given-names>Y.</given-names></name>
<name><surname>MacIntyre</surname><given-names>L.W.</given-names></name>
<name><surname>Ternei</surname><given-names>M.A.</given-names></name>
<name><surname>Russo</surname><given-names>R.</given-names></name>
<name><surname>Brady</surname><given-names>S.F.</given-names></name>
</person-group><article-title>Identification of structurally diverse menaquinone-binding antibiotics with in vivo activity against multidrug-resistant pathogens</article-title><source>Nat. Microbiol.</source><year>2021</year><volume>7</volume><fpage>120</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1038/s41564-021-01013-8</pub-id><?supplied-pmid 34949828?><pub-id pub-id-type="pmid">34949828</pub-id></element-citation></ref><ref id="B106-life-13-01073"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yushchuk</surname><given-names>O.</given-names></name>
<name><surname>Vior</surname><given-names>N.M.</given-names></name>
<name><surname>Andreo-Vidal</surname><given-names>A.</given-names></name>
<name><surname>Berini</surname><given-names>F.</given-names></name>
<name><surname>R&#x000fc;ckert</surname><given-names>C.</given-names></name>
<name><surname>Busche</surname><given-names>T.</given-names></name>
<name><surname>Binda</surname><given-names>E.</given-names></name>
<name><surname>Kalinowski</surname><given-names>J.</given-names></name>
<name><surname>Truman</surname><given-names>A.W.</given-names></name>
<name><surname>Marinelli</surname><given-names>F.</given-names></name>
</person-group><article-title>Genomic-led discovery of a novel glycopeptide antibiotic by <italic toggle="yes">Nonomuraea coxensis</italic> DSM 45129</article-title><source>ACS Chem. Biol.</source><year>2021</year><volume>16</volume><fpage>915</fpage><lpage>928</lpage><pub-id pub-id-type="doi">10.1021/acschembio.1c00170</pub-id><?supplied-pmid 33913701?><pub-id pub-id-type="pmid">33913701</pub-id></element-citation></ref><ref id="B107-life-13-01073"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Z.</given-names></name>
<name><surname>Koirala</surname><given-names>B.</given-names></name>
<name><surname>Hernandez</surname><given-names>Y.</given-names></name>
<name><surname>Zimmerman</surname><given-names>M.</given-names></name>
<name><surname>Park</surname><given-names>S.</given-names></name>
<name><surname>Perlin</surname><given-names>D.S.</given-names></name>
<name><surname>Brady</surname><given-names>S.F.</given-names></name>
</person-group><article-title>A naturally inspired antibiotic to target multidrug-resistant pathogens</article-title><source>Nature</source><year>2022</year><volume>601</volume><fpage>606</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-04264-x</pub-id><?supplied-pmid 34987225?><pub-id pub-id-type="pmid">34987225</pub-id></element-citation></ref><ref id="B108-life-13-01073"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Z.</given-names></name>
<name><surname>Koirala</surname><given-names>B.</given-names></name>
<name><surname>Hernandez</surname><given-names>Y.</given-names></name>
<name><surname>Zimmerman</surname><given-names>M.</given-names></name>
<name><surname>Brady</surname><given-names>S.F.</given-names></name>
</person-group><article-title>Bioinformatic prospecting and synthesis of a bifunctional lipopeptide antibiotic that evades resistance</article-title><source>Science</source><year>2022</year><volume>376</volume><fpage>991</fpage><lpage>996</lpage><pub-id pub-id-type="doi">10.1126/science.abn4213</pub-id><pub-id pub-id-type="pmid">35617397</pub-id></element-citation></ref><ref id="B109-life-13-01073"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miller</surname><given-names>R.D.</given-names></name>
<name><surname>Iinishi</surname><given-names>A.</given-names></name>
<name><surname>Modaresi</surname><given-names>S.M.</given-names></name>
<name><surname>Yoo</surname><given-names>B.-K.</given-names></name>
<name><surname>Curtis</surname><given-names>T.D.</given-names></name>
<name><surname>Lariviere</surname><given-names>P.J.</given-names></name>
<name><surname>Liang</surname><given-names>L.</given-names></name>
<name><surname>Son</surname><given-names>S.</given-names></name>
<name><surname>Nicolau</surname><given-names>S.</given-names></name>
<name><surname>Bargabos</surname><given-names>R.</given-names></name>
<etal/>
</person-group><article-title>Computational identification of a systemic antibiotic for Gram-negative bacteria</article-title><source>Nat. Microbiol.</source><year>2022</year><volume>7</volume><fpage>1661</fpage><lpage>1672</lpage><pub-id pub-id-type="doi">10.1038/s41564-022-01227-4</pub-id><pub-id pub-id-type="pmid">36163500</pub-id></element-citation></ref><ref id="B110-life-13-01073"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Behsaz</surname><given-names>B.</given-names></name>
<name><surname>Bode</surname><given-names>E.</given-names></name>
<name><surname>Gurevich</surname><given-names>A.</given-names></name>
<name><surname>Shi</surname><given-names>Y.-N.</given-names></name>
<name><surname>Grundmann</surname><given-names>F.</given-names></name>
<name><surname>Acharya</surname><given-names>D.</given-names></name>
<name><surname>Caraballo-Rodr&#x000ed;guez</surname><given-names>A.M.</given-names></name>
<name><surname>Bouslimani</surname><given-names>A.</given-names></name>
<name><surname>Panitchpakdi</surname><given-names>M.</given-names></name>
<name><surname>Linck</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Integrating genomics and metabolomics for scalable non-ribosomal peptide discovery</article-title><source>Nat. Commun.</source><year>2021</year><volume>12</volume><fpage>3225</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-23502-4</pub-id><pub-id pub-id-type="pmid">34050176</pub-id></element-citation></ref><ref id="B111-life-13-01073"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Russell</surname><given-names>A.H.</given-names></name>
<name><surname>Truman</surname><given-names>A.W.</given-names></name>
</person-group><article-title>Genome mining strategies for ribosomally synthesised and post-translationally modified peptides</article-title><source>Comput. Struct. Biotechnol. J.</source><year>2020</year><volume>18</volume><fpage>1838</fpage><lpage>1851</lpage><pub-id pub-id-type="doi">10.1016/j.csbj.2020.06.032</pub-id><pub-id pub-id-type="pmid">32728407</pub-id></element-citation></ref><ref id="B112-life-13-01073"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Major</surname><given-names>D.</given-names></name>
<name><surname>Flanzbaum</surname><given-names>L.</given-names></name>
<name><surname>Lussier</surname><given-names>L.</given-names></name>
<name><surname>Davies</surname><given-names>C.</given-names></name>
<name><surname>Caldo</surname><given-names>K.M.P.</given-names></name>
<name><surname>Acedo</surname><given-names>J.Z.</given-names></name>
</person-group><article-title>Transporter protein-guided genome mining for head-to-tail cyclized bacteriocins</article-title><source>Molecules</source><year>2021</year><volume>26</volume><elocation-id>7218</elocation-id><pub-id pub-id-type="doi">10.3390/molecules26237218</pub-id><pub-id pub-id-type="pmid">34885800</pub-id></element-citation></ref><ref id="B113-life-13-01073"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Costa</surname><given-names>S.S.</given-names></name>
<name><surname>da Silva Moia</surname><given-names>G.</given-names></name>
<name><surname>Silva</surname><given-names>A.</given-names></name>
<name><surname>Bara&#x000fa;na</surname><given-names>R.A.</given-names></name>
<name><surname>de Oliveira Veras</surname><given-names>A.A.</given-names></name>
</person-group><article-title>BADASS: BActeriocin-Diversity ASsessment software</article-title><source>BMC Bioinform.</source><year>2023</year><volume>24</volume><elocation-id>24</elocation-id><pub-id pub-id-type="doi">10.1186/s12859-022-05106-x</pub-id></element-citation></ref><ref id="B114-life-13-01073"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wambui</surname><given-names>J.</given-names></name>
<name><surname>Stevens</surname><given-names>M.J.A.</given-names></name>
<name><surname>Sieber</surname><given-names>S.</given-names></name>
<name><surname>Cernela</surname><given-names>N.</given-names></name>
<name><surname>Perreten</surname><given-names>V.</given-names></name>
<name><surname>Stephan</surname><given-names>R.</given-names></name>
</person-group><article-title>Targeted genome mining reveals the psychrophilic clostridium estertheticum complex as a potential source for novel bacteriocins, including cesin A and estercticin A</article-title><source>Front. Microbiol.</source><year>2022</year><volume>12</volume><fpage>801467</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2021.801467</pub-id><pub-id pub-id-type="pmid">35095812</pub-id></element-citation></ref><ref id="B115-life-13-01073"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shin</surname><given-names>Y.-H.</given-names></name>
<name><surname>Im</surname><given-names>J.H.</given-names></name>
<name><surname>Kang</surname><given-names>I.</given-names></name>
<name><surname>Kim</surname><given-names>E.</given-names></name>
<name><surname>Jang</surname><given-names>S.C.</given-names></name>
<name><surname>Cho</surname><given-names>E.</given-names></name>
<name><surname>Shin</surname><given-names>D.</given-names></name>
<name><surname>Hwang</surname><given-names>S.</given-names></name>
<name><surname>Du</surname><given-names>Y.E.</given-names></name>
<name><surname>Huynh</surname><given-names>T.-H.</given-names></name>
<etal/>
</person-group><article-title>Genomic and spectroscopic signature-based discovery of natural macrolactams</article-title><source>J. Am. Chem. Soc.</source><year>2023</year><volume>145</volume><fpage>1886</fpage><lpage>1896</lpage><pub-id pub-id-type="doi">10.1021/jacs.2c11527</pub-id><pub-id pub-id-type="pmid">36634356</pub-id></element-citation></ref><ref id="B116-life-13-01073"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Malmierca</surname><given-names>M.G.</given-names></name>
<name><surname>Gonz&#x000e1;lez-Montes</surname><given-names>L.</given-names></name>
<name><surname>P&#x000e9;rez-Victoria</surname><given-names>I.</given-names></name>
<name><surname>Sialer</surname><given-names>C.</given-names></name>
<name><surname>Bra&#x000f1;a</surname><given-names>A.F.</given-names></name>
<name><surname>Garc&#x000ed;a Salcedo</surname><given-names>R.</given-names></name>
<name><surname>Mart&#x000ed;n</surname><given-names>J.</given-names></name>
<name><surname>Reyes</surname><given-names>F.</given-names></name>
<name><surname>M&#x000e9;ndez</surname><given-names>C.</given-names></name>
<name><surname>Olano</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>Searching for glycosylated natural products in actinomycetes and identification of novel macrolactams and angucyclines</article-title><source>Front. Microbiol.</source><year>2018</year><volume>9</volume><fpage>39</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.00039</pub-id><pub-id pub-id-type="pmid">29441046</pub-id></element-citation></ref><ref id="B117-life-13-01073"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>S.</given-names></name>
<name><surname>Zhang</surname><given-names>C.</given-names></name>
<name><surname>Zhang</surname><given-names>L.</given-names></name>
</person-group><article-title>Investigation of the molecular landscape of bacterial aromatic polyketides by global analysis of type II polyketide synthases</article-title><source>Angew. Chem. Int. Ed.</source><year>2022</year><volume>61</volume><fpage>e202202286</fpage><pub-id pub-id-type="doi">10.1002/anie.202202286</pub-id></element-citation></ref><ref id="B118-life-13-01073"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hemmerling</surname><given-names>F.</given-names></name>
<name><surname>Piel</surname><given-names>J.</given-names></name>
</person-group><article-title>Strategies to access biosynthetic novelty in bacterial genomes for drug discovery</article-title><source>Nat. Rev. Drug Discov.</source><year>2022</year><volume>21</volume><fpage>359</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1038/s41573-022-00414-6</pub-id><pub-id pub-id-type="pmid">35296832</pub-id></element-citation></ref><ref id="B119-life-13-01073"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thaker</surname><given-names>M.N.</given-names></name>
<name><surname>Wang</surname><given-names>W.</given-names></name>
<name><surname>Spanogiannopoulos</surname><given-names>P.</given-names></name>
<name><surname>Waglechner</surname><given-names>N.</given-names></name>
<name><surname>King</surname><given-names>A.M.</given-names></name>
<name><surname>Medina</surname><given-names>R.</given-names></name>
<name><surname>Wright</surname><given-names>G.D.</given-names></name>
</person-group><article-title>Identifying producers of antibacterial compounds by screening for antibiotic resistance</article-title><source>Nat. Biotechnol.</source><year>2013</year><volume>31</volume><fpage>922</fpage><lpage>927</lpage><pub-id pub-id-type="doi">10.1038/nbt.2685</pub-id><pub-id pub-id-type="pmid">24056948</pub-id></element-citation></ref><ref id="B120-life-13-01073"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hobson</surname><given-names>C.</given-names></name>
<name><surname>Chan</surname><given-names>A.N.</given-names></name>
<name><surname>Wright</surname><given-names>G.D.</given-names></name>
</person-group><article-title>The antibiotic resistome: A guide for the discovery of natural products as antimicrobial agents</article-title><source>Chem. Rev.</source><year>2021</year><volume>121</volume><fpage>3464</fpage><lpage>3494</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrev.0c01214</pub-id><pub-id pub-id-type="pmid">33606500</pub-id></element-citation></ref><ref id="B121-life-13-01073"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Culp</surname><given-names>E.J.</given-names></name>
<name><surname>Waglechner</surname><given-names>N.</given-names></name>
<name><surname>Wang</surname><given-names>W.</given-names></name>
<name><surname>Fiebig-Comyn</surname><given-names>A.A.</given-names></name>
<name><surname>Hsu</surname><given-names>Y.-P.</given-names></name>
<name><surname>Koteva</surname><given-names>K.</given-names></name>
<name><surname>Sychantha</surname><given-names>D.</given-names></name>
<name><surname>Coombes</surname><given-names>B.K.</given-names></name>
<name><surname>Van Nieuwenhze</surname><given-names>M.S.</given-names></name>
<name><surname>Brun</surname><given-names>Y.V.</given-names></name>
<etal/>
</person-group><article-title>Evolution-guided discovery of antibiotics that inhibit peptidoglycan remodelling</article-title><source>Nature</source><year>2020</year><volume>578</volume><fpage>582</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-1990-9</pub-id><pub-id pub-id-type="pmid">32051588</pub-id></element-citation></ref><ref id="B122-life-13-01073"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>M.</given-names></name>
<name><surname>Wang</surname><given-names>W.</given-names></name>
<name><surname>Waglechner</surname><given-names>N.</given-names></name>
<name><surname>Culp</surname><given-names>E.J.</given-names></name>
<name><surname>Guitor</surname><given-names>A.K.</given-names></name>
<name><surname>Wright</surname><given-names>G.D.</given-names></name>
</person-group><article-title>Phylogeny-informed synthetic biology reveals unprecedented structural novelty in type V glycopeptide antibiotics</article-title><source>ACS Cent. Sci.</source><year>2022</year><volume>8</volume><fpage>615</fpage><lpage>626</lpage><pub-id pub-id-type="doi">10.1021/acscentsci.1c01389</pub-id><pub-id pub-id-type="pmid">35647273</pub-id></element-citation></ref><ref id="B123-life-13-01073"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yan</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>N.</given-names></name>
<name><surname>Tang</surname><given-names>Y.</given-names></name>
</person-group><article-title>Recent developments in self-resistance gene directed natural product discovery</article-title><source>Nat. Prod. Rep.</source><year>2020</year><volume>37</volume><fpage>879</fpage><lpage>892</lpage><pub-id pub-id-type="doi">10.1039/C9NP00050J</pub-id><pub-id pub-id-type="pmid">31912842</pub-id></element-citation></ref><ref id="B124-life-13-01073"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alanjary</surname><given-names>M.</given-names></name>
<name><surname>Kronmiller</surname><given-names>B.</given-names></name>
<name><surname>Adamek</surname><given-names>M.</given-names></name>
<name><surname>Blin</surname><given-names>K.</given-names></name>
<name><surname>Weber</surname><given-names>T.</given-names></name>
<name><surname>Huson</surname><given-names>D.</given-names></name>
<name><surname>Philmus</surname><given-names>B.</given-names></name>
<name><surname>Ziemert</surname><given-names>N.</given-names></name>
</person-group><article-title>The Antibiotic Resistant Target Seeker (ARTS), an exploration engine for antibiotic cluster prioritization and novel drug target discovery</article-title><source>Nucl. Acids Res.</source><year>2017</year><volume>45</volume><fpage>W42</fpage><lpage>W48</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx360</pub-id><pub-id pub-id-type="pmid">28472505</pub-id></element-citation></ref><ref id="B125-life-13-01073"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mungan</surname><given-names>M.D.</given-names></name>
<name><surname>Alanjary</surname><given-names>M.</given-names></name>
<name><surname>Blin</surname><given-names>K.</given-names></name>
<name><surname>Weber</surname><given-names>T.</given-names></name>
<name><surname>Medema</surname><given-names>M.H.</given-names></name>
<name><surname>Ziemert</surname><given-names>N.</given-names></name>
</person-group><article-title>ARTS 2.0: Feature updates and expansion of the antibiotic resistant target seeker for comparative genome mining</article-title><source>Nucl. Acids Res.</source><year>2020</year><volume>48</volume><fpage>W546</fpage><lpage>W552</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa374</pub-id><?supplied-pmid 32427317?><pub-id pub-id-type="pmid">32427317</pub-id></element-citation></ref><ref id="B126-life-13-01073"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mungan</surname><given-names>M.D.</given-names></name>
<name><surname>Blin</surname><given-names>K.</given-names></name>
<name><surname>Ziemert</surname><given-names>N.</given-names></name>
</person-group><article-title>ARTS-DB: A database for antibiotic resistant targets</article-title><source>Nucl. Acids Res.</source><year>2022</year><volume>50</volume><fpage>D736</fpage><lpage>D740</lpage><pub-id pub-id-type="doi">10.1093/nar/gkab940</pub-id><?supplied-pmid 34718689?><pub-id pub-id-type="pmid">34718689</pub-id></element-citation></ref><ref id="B127-life-13-01073"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Handel</surname><given-names>F.</given-names></name>
<name><surname>Kulik</surname><given-names>A.</given-names></name>
<name><surname>Wex</surname><given-names>K.W.</given-names></name>
<name><surname>Berscheid</surname><given-names>A.</given-names></name>
<name><surname>Saur</surname><given-names>J.S.</given-names></name>
<name><surname>Winkler</surname><given-names>A.</given-names></name>
<name><surname>Wibberg</surname><given-names>D.</given-names></name>
<name><surname>Kalinowski</surname><given-names>J.</given-names></name>
<name><surname>Br&#x000f6;tz-Oesterhelt</surname><given-names>H.</given-names></name>
<name><surname>Mast</surname><given-names>Y.</given-names></name>
</person-group><article-title>&#x003a8;-Footprinting approach for the identification of protein synthesis inhibitor producers</article-title><source>NAR Genom. Bioinformat.</source><year>2022</year><volume>4</volume><fpage>lqac055</fpage><pub-id pub-id-type="doi">10.1093/nargab/lqac055</pub-id><?supplied-pmid 35855324?><pub-id pub-id-type="pmid">35855324</pub-id></element-citation></ref><ref id="B128-life-13-01073"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liang</surname><given-names>M.</given-names></name>
<name><surname>Liu</surname><given-names>L.</given-names></name>
<name><surname>Xu</surname><given-names>F.</given-names></name>
<name><surname>Zeng</surname><given-names>X.</given-names></name>
<name><surname>Wang</surname><given-names>R.</given-names></name>
<name><surname>Yang</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>W.</given-names></name>
<name><surname>Karthik</surname><given-names>L.</given-names></name>
<name><surname>Liu</surname><given-names>J.</given-names></name>
<name><surname>Yang</surname><given-names>Z.</given-names></name>
<etal/>
</person-group><article-title>Activating cryptic biosynthetic gene cluster through a CRISPR&#x02013;Cas12a-mediated direct cloning approach</article-title><source>Nucl. Acids Res.</source><year>2022</year><volume>50</volume><fpage>3581</fpage><lpage>3592</lpage><pub-id pub-id-type="doi">10.1093/nar/gkac181</pub-id><?supplied-pmid 35323947?><pub-id pub-id-type="pmid">35323947</pub-id></element-citation></ref><ref id="B129-life-13-01073"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Enghiad</surname><given-names>B.</given-names></name>
<name><surname>Huang</surname><given-names>C.</given-names></name>
<name><surname>Guo</surname><given-names>F.</given-names></name>
<name><surname>Jiang</surname><given-names>G.</given-names></name>
<name><surname>Wang</surname><given-names>B.</given-names></name>
<name><surname>Tabatabaei</surname><given-names>S.K.</given-names></name>
<name><surname>Martin</surname><given-names>T.A.</given-names></name>
<name><surname>Zhao</surname><given-names>H.</given-names></name>
</person-group><article-title>Cas12a-assisted precise targeted cloning using in vivo Cre-<italic toggle="yes">lox</italic> recombination</article-title><source>Nat. Commun.</source><year>2021</year><volume>12</volume><fpage>1171</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-21275-4</pub-id><pub-id pub-id-type="pmid">33608525</pub-id></element-citation></ref><ref id="B130-life-13-01073"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Caesar</surname><given-names>L.K.</given-names></name>
<name><surname>Montaser</surname><given-names>R.</given-names></name>
<name><surname>Keller</surname><given-names>N.P.</given-names></name>
<name><surname>Kelleher</surname><given-names>N.L.</given-names></name>
</person-group><article-title>Metabolomics and genomics in natural products research: Complementary tools for targeting new chemical entities</article-title><source>Nat. Prod. Rep.</source><year>2021</year><volume>38</volume><fpage>2041</fpage><lpage>2065</lpage><pub-id pub-id-type="doi">10.1039/D1NP00036E</pub-id><pub-id pub-id-type="pmid">34787623</pub-id></element-citation></ref><ref id="B131-life-13-01073"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McCaughey</surname><given-names>C.S.</given-names></name>
<name><surname>van Santen</surname><given-names>J.A.</given-names></name>
<name><surname>van der Hooft</surname><given-names>J.J.J.</given-names></name>
<name><surname>Medema</surname><given-names>M.H.</given-names></name>
<name><surname>Linington</surname><given-names>R.G.</given-names></name>
</person-group><article-title>An isotopic labeling approach linking natural products with biosynthetic gene clusters</article-title><source>Nat. Chem. Biol.</source><year>2022</year><volume>18</volume><fpage>295</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1038/s41589-021-00949-6</pub-id><pub-id pub-id-type="pmid">34969972</pub-id></element-citation></ref><ref id="B132-life-13-01073"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chanana</surname><given-names>S.</given-names></name>
<name><surname>Thomas</surname><given-names>C.S.</given-names></name>
<name><surname>Zhang</surname><given-names>F.</given-names></name>
<name><surname>Rajski</surname><given-names>S.R.</given-names></name>
<name><surname>Bugni</surname><given-names>T.S.</given-names></name>
</person-group><article-title><italic toggle="yes">hcapca</italic>: Automated hierarchical clustering and principal component analysis of large metabolomic datasets in R</article-title><source>Metabolites</source><year>2020</year><volume>10</volume><elocation-id>297</elocation-id><pub-id pub-id-type="doi">10.3390/metabo10070297</pub-id><pub-id pub-id-type="pmid">32708222</pub-id></element-citation></ref><ref id="B133-life-13-01073"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wu</surname><given-names>Q.</given-names></name>
<name><surname>Bell</surname><given-names>B.A.</given-names></name>
<name><surname>Yan</surname><given-names>J.-X.</given-names></name>
<name><surname>Chevrette</surname><given-names>M.G.</given-names></name>
<name><surname>Brittin</surname><given-names>N.J.</given-names></name>
<name><surname>Zhu</surname><given-names>Y.</given-names></name>
<name><surname>Chanana</surname><given-names>S.</given-names></name>
<name><surname>Maity</surname><given-names>M.</given-names></name>
<name><surname>Braun</surname><given-names>D.R.</given-names></name>
<name><surname>Wheaton</surname><given-names>A.M.</given-names></name>
<etal/>
</person-group><article-title>Metabolomics and genomics enable the discovery of a new class of nonribosomal peptidic metallophores from a marine <italic toggle="yes">Micromonospora</italic></article-title><source>J. Am. Chem. Soc.</source><year>2023</year><volume>145</volume><fpage>58</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1021/jacs.2c06410</pub-id><pub-id pub-id-type="pmid">36535031</pub-id></element-citation></ref><ref id="B134-life-13-01073"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Okada</surname><given-names>B.K.</given-names></name>
<name><surname>Seyedsayamdost</surname><given-names>M.R.</given-names></name>
</person-group><article-title>Antibiotic dialogues: Induction of silent biosynthetic gene clusters by exogenous small molecules</article-title><source>FEMS Microbiol. Rev.</source><year>2017</year><volume>41</volume><fpage>19</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1093/femsre/fuw035</pub-id><pub-id pub-id-type="pmid">27576366</pub-id></element-citation></ref><ref id="B135-life-13-01073"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zarins-Tutt</surname><given-names>J.S.</given-names></name>
<name><surname>Barberi</surname><given-names>T.T.</given-names></name>
<name><surname>Gao</surname><given-names>H.</given-names></name>
<name><surname>Mearns-Spragg</surname><given-names>A.</given-names></name>
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<name><surname>Newman</surname><given-names>D.J.</given-names></name>
<name><surname>Goss</surname><given-names>R.J.M.</given-names></name>
</person-group><article-title>Prospecting for new bacterial metabolites: A glossary of approaches for inducing, activating and upregulating the biosynthesis of bacterial cryptic or silent natural products</article-title><source>Nat. Prod. Rep.</source><year>2016</year><volume>33</volume><fpage>54</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1039/C5NP00111K</pub-id><pub-id pub-id-type="pmid">26538321</pub-id></element-citation></ref><ref id="B136-life-13-01073"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abdelmohsen</surname><given-names>U.R.</given-names></name>
<name><surname>Grkovic</surname><given-names>T.</given-names></name>
<name><surname>Balasubramanian</surname><given-names>S.</given-names></name>
<name><surname>Kamel</surname><given-names>M.S.</given-names></name>
<name><surname>Quinn</surname><given-names>R.J.</given-names></name>
<name><surname>Hentschel</surname><given-names>U.</given-names></name>
</person-group><article-title>Elicitation of secondary metabolism in actinomycetes</article-title><source>Biotechnol. Adv.</source><year>2015</year><volume>33</volume><fpage>798</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2015.06.003</pub-id><pub-id pub-id-type="pmid">26087412</pub-id></element-citation></ref><ref id="B137-life-13-01073"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zong</surname><given-names>G.</given-names></name>
<name><surname>Fu</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>P.</given-names></name>
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>Xu</surname><given-names>Y.</given-names></name>
<name><surname>Cao</surname><given-names>G.</given-names></name>
<name><surname>Zhang</surname><given-names>R.</given-names></name>
</person-group><article-title>Use of elicitors to enhance or activate the antibiotic production in <italic toggle="yes">Streptomyces</italic></article-title><source>Crit. Rev. Biotechnol.</source><year>2022</year><volume>42</volume><fpage>1260</fpage><lpage>1283</lpage><pub-id pub-id-type="doi">10.1080/07388551.2021.1987856</pub-id><pub-id pub-id-type="pmid">34706600</pub-id></element-citation></ref><ref id="B138-life-13-01073"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tyurin</surname><given-names>A.</given-names></name>
<name><surname>Alferova</surname><given-names>V.</given-names></name>
<name><surname>Korshun</surname><given-names>V.</given-names></name>
</person-group><article-title>Chemical elicitors of antibiotic biosynthesis in actinomycetes</article-title><source>Microorganisms</source><year>2018</year><volume>6</volume><elocation-id>52</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms6020052</pub-id><pub-id pub-id-type="pmid">29890642</pub-id></element-citation></ref><ref id="B139-life-13-01073"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Covington</surname><given-names>B.C.</given-names></name>
<name><surname>Seyedsayamdost</surname><given-names>M.R.</given-names></name>
</person-group><article-title>MetEx, a metabolomics explorer application for natural product discovery</article-title><source>ACS Chem. Biol.</source><year>2021</year><volume>16</volume><fpage>2825</fpage><lpage>2833</lpage><pub-id pub-id-type="doi">10.1021/acschembio.1c00737</pub-id><pub-id pub-id-type="pmid">34859662</pub-id></element-citation></ref><ref id="B140-life-13-01073"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moon</surname><given-names>K.</given-names></name>
<name><surname>Xu</surname><given-names>F.</given-names></name>
<name><surname>Seyedsayamdost</surname><given-names>M.R.</given-names></name>
</person-group><article-title>Cebulantin, a cryptic lanthipeptide antibiotic uncovered using bioactivity-coupled HiTES</article-title><source>Angew. Chem. Int. Ed.</source><year>2019</year><volume>58</volume><fpage>5973</fpage><lpage>5977</lpage><pub-id pub-id-type="doi">10.1002/anie.201901342</pub-id></element-citation></ref><ref id="B141-life-13-01073"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>C.</given-names></name>
<name><surname>Seyedsayamdost</surname><given-names>M.R.</given-names></name>
</person-group><article-title>Discovery of a cryptic depsipeptide from <italic toggle="yes">Streptomyces ghanaensis</italic> via MALDI-MS-guided high-throughput elicitor screening</article-title><source>Angew. Chem. Int. Ed.</source><year>2020</year><volume>59</volume><fpage>23005</fpage><lpage>23009</lpage><pub-id pub-id-type="doi">10.1002/anie.202009611</pub-id></element-citation></ref><ref id="B142-life-13-01073"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Lee</surname><given-names>S.R.</given-names></name>
<name><surname>Han</surname><given-names>E.J.</given-names></name>
<name><surname>Seyedsayamdost</surname><given-names>M.R.</given-names></name>
</person-group><article-title>Momomycin, an antiproliferative cryptic metabolite from the oxytetracycline producer <italic toggle="yes">Streptomyces rimosus</italic></article-title><source>Angew. Chem. Int. Ed.</source><year>2022</year><volume>61</volume><fpage>e202208573</fpage><pub-id pub-id-type="doi">10.1002/anie.202208573</pub-id></element-citation></ref><ref id="B143-life-13-01073"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Han</surname><given-names>E.J.</given-names></name>
<name><surname>Lee</surname><given-names>S.R.</given-names></name>
<name><surname>Hoshino</surname><given-names>S.</given-names></name>
<name><surname>Seyedsayamdost</surname><given-names>M.R.</given-names></name>
</person-group><article-title>Targeted discovery of cryptic metabolites with antiproliferative activity</article-title><source>ACS Chem. Biol.</source><year>2022</year><volume>17</volume><fpage>3121</fpage><lpage>3130</lpage><pub-id pub-id-type="doi">10.1021/acschembio.2c00588</pub-id><pub-id pub-id-type="pmid">36228140</pub-id></element-citation></ref><ref id="B144-life-13-01073"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arakawa</surname><given-names>K.</given-names></name>
</person-group><article-title>Manipulation of metabolic pathways controlled by signaling molecules, inducers of antibiotic production, for genome mining in <italic toggle="yes">Streptomyces</italic> spp.</article-title><source>Antonie Leeuwenhoek</source><year>2018</year><volume>111</volume><fpage>743</fpage><lpage>751</lpage><pub-id pub-id-type="doi">10.1007/s10482-018-1052-6</pub-id><pub-id pub-id-type="pmid">29476430</pub-id></element-citation></ref><ref id="B145-life-13-01073"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sekurova</surname><given-names>O.N.</given-names></name>
<name><surname>Schneider</surname><given-names>O.</given-names></name>
<name><surname>Zotchev</surname><given-names>S.B.</given-names></name>
</person-group><article-title>Novel bioactive natural Products from bacteria via bioprospecting, genome mining and metabolic engineering</article-title><source>Microb. Biotechnol.</source><year>2019</year><volume>12</volume><fpage>828</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1111/1751-7915.13398</pub-id><?supplied-pmid 30834674?><pub-id pub-id-type="pmid">30834674</pub-id></element-citation></ref><ref id="B146-life-13-01073"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Baral</surname><given-names>B.</given-names></name>
<name><surname>Akhgari</surname><given-names>A.</given-names></name>
<name><surname>Mets&#x000e4;-Ketel&#x000e4;</surname><given-names>M.</given-names></name>
</person-group><article-title>Activation of microbial secondary metabolic pathways: Avenues and challenges</article-title><source>Synth. Syst. Biotechnol.</source><year>2018</year><volume>3</volume><fpage>163</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1016/j.synbio.2018.09.001</pub-id><?supplied-pmid 30345402?><pub-id pub-id-type="pmid">30345402</pub-id></element-citation></ref><ref id="B147-life-13-01073"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xiao</surname><given-names>S.</given-names></name>
<name><surname>Deng</surname><given-names>Z.</given-names></name>
<name><surname>Gao</surname><given-names>J.</given-names></name>
</person-group><article-title>CRISPR/Cas-based strategy for unearthing hidden chemical space from microbial genomes</article-title><source>Tr. Chem.</source><year>2021</year><volume>3</volume><fpage>997</fpage><lpage>1001</lpage><pub-id pub-id-type="doi">10.1016/j.trechm.2021.09.012</pub-id></element-citation></ref><ref id="B148-life-13-01073"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lim</surname><given-names>Y.H.</given-names></name>
<name><surname>Wong</surname><given-names>F.T.</given-names></name>
<name><surname>Yeo</surname><given-names>W.L.</given-names></name>
<name><surname>Ching</surname><given-names>K.C.</given-names></name>
<name><surname>Lim</surname><given-names>Y.W.</given-names></name>
<name><surname>Heng</surname><given-names>E.</given-names></name>
<name><surname>Chen</surname><given-names>S.</given-names></name>
<name><surname>Tsai</surname><given-names>D.-J.</given-names></name>
<name><surname>Lauderdale</surname><given-names>T.-L.</given-names></name>
<name><surname>Shia</surname><given-names>K.-S.</given-names></name>
<etal/>
</person-group><article-title>Auroramycin: A potent antibiotic from <italic toggle="yes">Streptomyces roseosporus</italic> by CRISPR-Cas9 activation</article-title><source>ChemBioChem</source><year>2018</year><volume>19</volume><fpage>1716</fpage><lpage>1719</lpage><pub-id pub-id-type="doi">10.1002/cbic.201800266</pub-id></element-citation></ref><ref id="B149-life-13-01073"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yeo</surname><given-names>W.L.</given-names></name>
<name><surname>Heng</surname><given-names>E.</given-names></name>
<name><surname>Tan</surname><given-names>L.L.</given-names></name>
<name><surname>Lim</surname><given-names>Y.W.</given-names></name>
<name><surname>Ching</surname><given-names>K.C.</given-names></name>
<name><surname>Tsai</surname><given-names>D.-J.</given-names></name>
<name><surname>Jhang</surname><given-names>Y.W.</given-names></name>
<name><surname>Lauderdale</surname><given-names>T.-L.</given-names></name>
<name><surname>Shia</surname><given-names>K.-S.</given-names></name>
<name><surname>Zhao</surname><given-names>H.</given-names></name>
<etal/>
</person-group><article-title>Biosynthetic engineering of the antifungal, anti-MRSA auroramycin</article-title><source>Microb. Cell Fact.</source><year>2020</year><volume>19</volume><fpage>3</fpage><pub-id pub-id-type="doi">10.1186/s12934-019-1274-y</pub-id><pub-id pub-id-type="pmid">31906943</pub-id></element-citation></ref><ref id="B150-life-13-01073"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>B.</given-names></name>
<name><surname>Guo</surname><given-names>F.</given-names></name>
<name><surname>Dong</surname><given-names>S.-H.</given-names></name>
<name><surname>Zhao</surname><given-names>H.</given-names></name>
</person-group><article-title>Activation of silent biosynthetic gene clusters using transcription factor decoys</article-title><source>Nat. Chem. Biol.</source><year>2019</year><volume>15</volume><fpage>111</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1038/s41589-018-0187-0</pub-id><pub-id pub-id-type="pmid">30598544</pub-id></element-citation></ref><ref id="B151-life-13-01073"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tojo</surname><given-names>S.</given-names></name>
<name><surname>Tanaka</surname><given-names>Y.</given-names></name>
<name><surname>Ochi</surname><given-names>K.</given-names></name>
</person-group><article-title>Activation of antibiotic production in <italic toggle="yes">Bacillus</italic> spp. by cumulative drug resistance mutations</article-title><source>Antimicrob. Agents Chemother.</source><year>2015</year><volume>59</volume><fpage>7799</fpage><lpage>7804</lpage><pub-id pub-id-type="doi">10.1128/AAC.01932-15</pub-id><pub-id pub-id-type="pmid">26369962</pub-id></element-citation></ref><ref id="B152-life-13-01073"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ochi</surname><given-names>K.</given-names></name>
</person-group><article-title>Insights into microbial cryptic gene activation and strain improvement: Principle, application and technical aspects</article-title><source>J. Antibiot.</source><year>2017</year><volume>70</volume><fpage>25</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1038/ja.2016.82</pub-id></element-citation></ref><ref id="B153-life-13-01073"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhu</surname><given-names>S.</given-names></name>
<name><surname>Duan</surname><given-names>Y.</given-names></name>
<name><surname>Huang</surname><given-names>Y.</given-names></name>
</person-group><article-title>The application of ribosome engineering to natural product discovery and yield improvement in <italic toggle="yes">Streptomyces</italic></article-title><source>Antibiotics</source><year>2019</year><volume>8</volume><elocation-id>133</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics8030133</pub-id><pub-id pub-id-type="pmid">31480298</pub-id></element-citation></ref><ref id="B154-life-13-01073"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
<name><surname>Ren</surname><given-names>J.-W.</given-names></name>
<name><surname>Wang</surname><given-names>W.</given-names></name>
<name><surname>Zhai</surname><given-names>J.</given-names></name>
<name><surname>Yang</surname><given-names>J.</given-names></name>
<name><surname>Liu</surname><given-names>N.</given-names></name>
<name><surname>Huang</surname><given-names>Y.</given-names></name>
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Pan</surname><given-names>G.</given-names></name>
<name><surname>Fan</surname><given-names>K.</given-names></name>
</person-group><article-title>A versatile transcription&#x02013;translation in one approach for activation of cryptic biosynthetic gene clusters</article-title><source>ACS Chem. Biol.</source><year>2020</year><volume>15</volume><fpage>2551</fpage><lpage>2557</lpage><pub-id pub-id-type="doi">10.1021/acschembio.0c00581</pub-id><pub-id pub-id-type="pmid">32786260</pub-id></element-citation></ref><ref id="B155-life-13-01073"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Guo</surname><given-names>F.</given-names></name>
<name><surname>Xiang</surname><given-names>S.</given-names></name>
<name><surname>Li</surname><given-names>L.</given-names></name>
<name><surname>Wang</surname><given-names>B.</given-names></name>
<name><surname>Rajas&#x000e4;rkk&#x000e4;</surname><given-names>J.</given-names></name>
<name><surname>Gr&#x000f6;ndahl-Yli-Hannuksela</surname><given-names>K.</given-names></name>
<name><surname>Ai</surname><given-names>G.</given-names></name>
<name><surname>Mets&#x000e4;-Ketel&#x000e4;</surname><given-names>M.</given-names></name>
<name><surname>Yang</surname><given-names>K.</given-names></name>
</person-group><article-title>Targeted activation of silent natural product biosynthesis pathways by reporter-guided mutant selection</article-title><source>Metabol. Eng.</source><year>2015</year><volume>28</volume><fpage>134</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1016/j.ymben.2014.12.006</pub-id></element-citation></ref><ref id="B156-life-13-01073"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mao</surname><given-names>D.</given-names></name>
<name><surname>Yoshimura</surname><given-names>A.</given-names></name>
<name><surname>Wang</surname><given-names>R.</given-names></name>
<name><surname>Seyedsayamdost</surname><given-names>M.R.</given-names></name>
</person-group><article-title>Reporter-guided transposon mutant selection for activation of silent gene clusters in <italic toggle="yes">Burkholderia thailandensis</italic></article-title><source>ChemBioChem</source><year>2020</year><volume>21</volume><fpage>1826</fpage><lpage>1831</lpage><pub-id pub-id-type="doi">10.1002/cbic.201900748</pub-id><pub-id pub-id-type="pmid">31984619</pub-id></element-citation></ref><ref id="B157-life-13-01073"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yoshimura</surname><given-names>A.</given-names></name>
<name><surname>Covington</surname><given-names>B.C.</given-names></name>
<name><surname>Gallant</surname><given-names>&#x000c9;.</given-names></name>
<name><surname>Zhang</surname><given-names>C.</given-names></name>
<name><surname>Li</surname><given-names>A.</given-names></name>
<name><surname>Seyedsayamdost</surname><given-names>M.R.</given-names></name>
</person-group><article-title>Unlocking cryptic metabolites with mass spectrometry-guided transposon mutant selection</article-title><source>ACS Chem. Biol.</source><year>2020</year><volume>15</volume><fpage>2766</fpage><lpage>2774</lpage><pub-id pub-id-type="doi">10.1021/acschembio.0c00558</pub-id><pub-id pub-id-type="pmid">32808751</pub-id></element-citation></ref><ref id="B158-life-13-01073"><label>158.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Covington</surname><given-names>B.C.</given-names></name>
<name><surname>Seyedsayamdost</surname><given-names>M.R.</given-names></name>
</person-group><article-title>Guidelines for metabolomics-guided transposon mutagenesis for microbial natural product discovery</article-title><source>Methods in Enzymology</source><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2022</year><volume>Volume 665</volume><fpage>305</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1016/bs.mie.2021.11.020</pub-id></element-citation></ref><ref id="B159-life-13-01073"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hudson</surname><given-names>M.A.</given-names></name>
<name><surname>Lockless</surname><given-names>S.W.</given-names></name>
</person-group><article-title>Elucidating the mechanisms of action of antimicrobial agents</article-title><source>mBio</source><year>2022</year><volume>13</volume><fpage>e02240-21</fpage><pub-id pub-id-type="doi">10.1128/mbio.02240-21</pub-id><pub-id pub-id-type="pmid">35435702</pub-id></element-citation></ref><ref id="B160-life-13-01073"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>R&#x000fc;tten</surname><given-names>A.</given-names></name>
<name><surname>Kirchner</surname><given-names>T.</given-names></name>
<name><surname>Musiol-Kroll</surname><given-names>E.M.</given-names></name>
</person-group><article-title>Overview on strategies and assays for antibiotic discovery</article-title><source>Pharmaceuticals</source><year>2022</year><volume>15</volume><elocation-id>1302</elocation-id><pub-id pub-id-type="doi">10.3390/ph15101302</pub-id><pub-id pub-id-type="pmid">36297414</pub-id></element-citation></ref><ref id="B161-life-13-01073"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sergiev</surname><given-names>P.V.</given-names></name>
<name><surname>Osterman</surname><given-names>I.A.</given-names></name>
<name><surname>Golovina</surname><given-names>A.Y.</given-names></name>
<name><surname>Andreyanova</surname><given-names>E.S.</given-names></name>
<name><surname>Laptev</surname><given-names>I.G.</given-names></name>
<name><surname>Pletnev</surname><given-names>P.I.</given-names></name>
<name><surname>Evfratov</surname><given-names>S.A.</given-names></name>
<name><surname>Marusich</surname><given-names>E.I.</given-names></name>
<name><surname>Leonov</surname><given-names>S.V.</given-names></name>
<name><surname>Ivanenkov</surname><given-names>Y.A.</given-names></name>
<etal/>
</person-group><article-title>Application of reporter strains for screening of new antibiotics</article-title><source>Biochem. Moscow Suppl. Ser. B</source><year>2016</year><volume>10</volume><fpage>293</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1134/S1990750816040065</pub-id></element-citation></ref><ref id="B162-life-13-01073"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Osterman</surname><given-names>I.A.</given-names></name>
<name><surname>Komarova</surname><given-names>E.S.</given-names></name>
<name><surname>Shiryaev</surname><given-names>D.I.</given-names></name>
<name><surname>Korniltsev</surname><given-names>I.A.</given-names></name>
<name><surname>Khven</surname><given-names>I.M.</given-names></name>
<name><surname>Lukyanov</surname><given-names>D.A.</given-names></name>
<name><surname>Tashlitsky</surname><given-names>V.N.</given-names></name>
<name><surname>Serebryakova</surname><given-names>M.V.</given-names></name>
<name><surname>Efremenkova</surname><given-names>O.V.</given-names></name>
<name><surname>Ivanenkov</surname><given-names>Y.A.</given-names></name>
<etal/>
</person-group><article-title>Sorting out antibiotics&#x02019; mechanisms of action: A double fluorescent protein reporter for high-throughput screening of ribosome and DNA biosynthesis inhibitors</article-title><source>Antimicrob. Agents Chemother.</source><year>2016</year><volume>60</volume><fpage>7481</fpage><lpage>7489</lpage><pub-id pub-id-type="doi">10.1128/AAC.02117-16</pub-id><pub-id pub-id-type="pmid">27736765</pub-id></element-citation></ref><ref id="B163-life-13-01073"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Osterman</surname><given-names>I.A.</given-names></name>
<name><surname>Wieland</surname><given-names>M.</given-names></name>
<name><surname>Maviza</surname><given-names>T.P.</given-names></name>
<name><surname>Lashkevich</surname><given-names>K.A.</given-names></name>
<name><surname>Lukianov</surname><given-names>D.A.</given-names></name>
<name><surname>Komarova</surname><given-names>E.S.</given-names></name>
<name><surname>Zakalyukina</surname><given-names>Y.V.</given-names></name>
<name><surname>Buschauer</surname><given-names>R.</given-names></name>
<name><surname>Shiriaev</surname><given-names>D.I.</given-names></name>
<name><surname>Leyn</surname><given-names>S.A.</given-names></name>
<etal/>
</person-group><article-title>Tetracenomycin X inhibits translation by binding within the ribosomal exit tunnel</article-title><source>Nat. Chem. Biol.</source><year>2020</year><volume>16</volume><fpage>1071</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.1038/s41589-020-0578-x</pub-id><pub-id pub-id-type="pmid">32601485</pub-id></element-citation></ref><ref id="B164-life-13-01073"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Volynkina</surname><given-names>I.A.</given-names></name>
<name><surname>Zakalyukina</surname><given-names>Y.V.</given-names></name>
<name><surname>Alferova</surname><given-names>V.A.</given-names></name>
<name><surname>Belik</surname><given-names>A.R.</given-names></name>
<name><surname>Yagoda</surname><given-names>D.K.</given-names></name>
<name><surname>Nikandrova</surname><given-names>A.A.</given-names></name>
<name><surname>Buyuklyan</surname><given-names>Y.A.</given-names></name>
<name><surname>Udalov</surname><given-names>A.V.</given-names></name>
<name><surname>Golovin</surname><given-names>E.V.</given-names></name>
<name><surname>Kryakvin</surname><given-names>M.A.</given-names></name>
<etal/>
</person-group><article-title>Mechanism-based approach to new antibiotic producers screening among actinomycetes in the course of the citizen science project</article-title><source>Antibiotics</source><year>2022</year><volume>11</volume><elocation-id>1198</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics11091198</pub-id><pub-id pub-id-type="pmid">36139977</pub-id></element-citation></ref><ref id="B165-life-13-01073"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wex</surname><given-names>K.W.</given-names></name>
<name><surname>Saur</surname><given-names>J.S.</given-names></name>
<name><surname>Handel</surname><given-names>F.</given-names></name>
<name><surname>Ortlieb</surname><given-names>N.</given-names></name>
<name><surname>Mokeev</surname><given-names>V.</given-names></name>
<name><surname>Kulik</surname><given-names>A.</given-names></name>
<name><surname>Niedermeyer</surname><given-names>T.H.J.</given-names></name>
<name><surname>Mast</surname><given-names>Y.</given-names></name>
<name><surname>Grond</surname><given-names>S.</given-names></name>
<name><surname>Berscheid</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Bioreporters for direct mode of action-informed screening of antibiotic producer strains</article-title><source>Cell Chem. Biol.</source><year>2021</year><volume>28</volume><fpage>1242</fpage><lpage>1252.e4</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2021.02.022</pub-id><pub-id pub-id-type="pmid">33761329</pub-id></element-citation></ref><ref id="B166-life-13-01073"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Johnson</surname><given-names>E.O.</given-names></name>
<name><surname>LaVerriere</surname><given-names>E.</given-names></name>
<name><surname>Office</surname><given-names>E.</given-names></name>
<name><surname>Stanley</surname><given-names>M.</given-names></name>
<name><surname>Meyer</surname><given-names>E.</given-names></name>
<name><surname>Kawate</surname><given-names>T.</given-names></name>
<name><surname>Gomez</surname><given-names>J.E.</given-names></name>
<name><surname>Audette</surname><given-names>R.E.</given-names></name>
<name><surname>Bandyopadhyay</surname><given-names>N.</given-names></name>
<name><surname>Betancourt</surname><given-names>N.</given-names></name>
<etal/>
</person-group><article-title>Large-scale chemical&#x02013;genetics yields new <italic toggle="yes">M. tuberculosis</italic> inhibitor classes</article-title><source>Nature</source><year>2019</year><volume>571</volume><fpage>72</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1315-z</pub-id><?supplied-pmid 31217586?><pub-id pub-id-type="pmid">31217586</pub-id></element-citation></ref><ref id="B167-life-13-01073"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gehrke</surname><given-names>S.S.</given-names></name>
<name><surname>Kumar</surname><given-names>G.</given-names></name>
<name><surname>Yokubynas</surname><given-names>N.A.</given-names></name>
<name><surname>C&#x000f4;t&#x000e9;</surname><given-names>J.-P.</given-names></name>
<name><surname>Wang</surname><given-names>W.</given-names></name>
<name><surname>French</surname><given-names>S.</given-names></name>
<name><surname>MacNair</surname><given-names>C.R.</given-names></name>
<name><surname>Wright</surname><given-names>G.D.</given-names></name>
<name><surname>Brown</surname><given-names>E.D.</given-names></name>
</person-group><article-title>Exploiting the sensitivity of nutrient transporter deletion strains in discovery of natural product antimetabolites</article-title><source>ACS Infect. Dis.</source><year>2017</year><volume>3</volume><fpage>955</fpage><lpage>965</lpage><pub-id pub-id-type="doi">10.1021/acsinfecdis.7b00149</pub-id><?supplied-pmid 29069544?><pub-id pub-id-type="pmid">29069544</pub-id></element-citation></ref><ref id="B168-life-13-01073"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Farha</surname><given-names>M.A.</given-names></name>
<name><surname>French</surname><given-names>S.</given-names></name>
<name><surname>Brown</surname><given-names>E.D.</given-names></name>
</person-group><article-title>Systems-level chemical biology to accelerate antibiotic drug discovery</article-title><source>Acc. Chem. Res.</source><year>2021</year><volume>54</volume><fpage>1909</fpage><lpage>1920</lpage><pub-id pub-id-type="doi">10.1021/acs.accounts.1c00011</pub-id><?supplied-pmid 33787225?><pub-id pub-id-type="pmid">33787225</pub-id></element-citation></ref><ref id="B169-life-13-01073"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ito</surname><given-names>T.</given-names></name>
<name><surname>Masubuchi</surname><given-names>M.</given-names></name>
</person-group><article-title>Dereplication of microbial extracts and related analytical technologies</article-title><source>J. Antibiot.</source><year>2014</year><volume>67</volume><fpage>353</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1038/ja.2014.12</pub-id><?supplied-pmid 24569671?><pub-id pub-id-type="pmid">24569671</pub-id></element-citation></ref><ref id="B170-life-13-01073"><label>170.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>B&#x000e9;rdy</surname><given-names>J.</given-names></name>
</person-group><source>CRC Handbook of Antibiotic Compounds</source><publisher-name>CRC Press</publisher-name><publisher-loc>Boca Raton, FL, USA</publisher-loc><year>1980</year><isbn>978-0-8493-3450-4</isbn></element-citation></ref><ref id="B171-life-13-01073"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gaud&#x000ea;ncio</surname><given-names>S.P.</given-names></name>
<name><surname>Pereira</surname><given-names>F.</given-names></name>
</person-group><article-title>Dereplication: Racing to speed up the natural products discovery process</article-title><source>Nat. Prod. Rep.</source><year>2015</year><volume>32</volume><fpage>779</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.1039/C4NP00134F</pub-id><pub-id pub-id-type="pmid">25850681</pub-id></element-citation></ref><ref id="B172-life-13-01073"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>M.</given-names></name>
<name><surname>Carver</surname><given-names>J.J.</given-names></name>
<name><surname>Phelan</surname><given-names>V.V.</given-names></name>
<name><surname>Sanchez</surname><given-names>L.M.</given-names></name>
<name><surname>Garg</surname><given-names>N.</given-names></name>
<name><surname>Peng</surname><given-names>Y.</given-names></name>
<name><surname>Nguyen</surname><given-names>D.D.</given-names></name>
<name><surname>Watrous</surname><given-names>J.</given-names></name>
<name><surname>Kapono</surname><given-names>C.A.</given-names></name>
<name><surname>Luzzatto-Knaan</surname><given-names>T.</given-names></name>
<etal/>
</person-group><article-title>Sharing and community curation of mass spectrometry data with global natural products social molecular networking</article-title><source>Nat. Biotechnol.</source><year>2016</year><volume>34</volume><fpage>828</fpage><lpage>837</lpage><pub-id pub-id-type="doi">10.1038/nbt.3597</pub-id><pub-id pub-id-type="pmid">27504778</pub-id></element-citation></ref><ref id="B173-life-13-01073"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>van Santen</surname><given-names>J.A.</given-names></name>
<name><surname>Jacob</surname><given-names>G.</given-names></name>
<name><surname>Singh</surname><given-names>A.L.</given-names></name>
<name><surname>Aniebok</surname><given-names>V.</given-names></name>
<name><surname>Balunas</surname><given-names>M.J.</given-names></name>
<name><surname>Bunsko</surname><given-names>D.</given-names></name>
<name><surname>Neto</surname><given-names>F.C.</given-names></name>
<name><surname>Casta&#x000f1;o-Espriu</surname><given-names>L.</given-names></name>
<name><surname>Chang</surname><given-names>C.</given-names></name>
<name><surname>Clark</surname><given-names>T.N.</given-names></name>
<etal/>
</person-group><article-title>The natural products atlas: An open access knowledge base for microbial natural products discovery</article-title><source>ACS Cent. Sci.</source><year>2019</year><volume>5</volume><fpage>1824</fpage><lpage>1833</lpage><pub-id pub-id-type="doi">10.1021/acscentsci.9b00806</pub-id><pub-id pub-id-type="pmid">31807684</pub-id></element-citation></ref><ref id="B174-life-13-01073"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>van Santen</surname><given-names>J.A.</given-names></name>
<name><surname>Poynton</surname><given-names>E.F.</given-names></name>
<name><surname>Iskakova</surname><given-names>D.</given-names></name>
<name><surname>McMann</surname><given-names>E.</given-names></name>
<name><surname>Alsup</surname><given-names>T.A.</given-names></name>
<name><surname>Clark</surname><given-names>T.N.</given-names></name>
<name><surname>Fergusson</surname><given-names>C.H.</given-names></name>
<name><surname>Fewer</surname><given-names>D.P.</given-names></name>
<name><surname>Hughes</surname><given-names>A.H.</given-names></name>
<name><surname>McCadden</surname><given-names>C.A.</given-names></name>
<etal/>
</person-group><article-title>The natural products atlas 2.0: A database of microbially-derived natural products</article-title><source>Nucl. Acids Res.</source><year>2022</year><volume>50</volume><fpage>D1317</fpage><lpage>D1323</lpage><pub-id pub-id-type="doi">10.1093/nar/gkab941</pub-id><pub-id pub-id-type="pmid">34718710</pub-id></element-citation></ref><ref id="B175-life-13-01073"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>van Santen</surname><given-names>J.A.</given-names></name>
<name><surname>Kautsar</surname><given-names>S.A.</given-names></name>
<name><surname>Medema</surname><given-names>M.H.</given-names></name>
<name><surname>Linington</surname><given-names>R.G.</given-names></name>
</person-group><article-title>Microbial natural product databases: Moving forward in the multi-omics era</article-title><source>Nat. Prod. Rep.</source><year>2021</year><volume>38</volume><fpage>264</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1039/D0NP00053A</pub-id><pub-id pub-id-type="pmid">32856641</pub-id></element-citation></ref><ref id="B176-life-13-01073"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jarmusch</surname><given-names>S.A.</given-names></name>
<name><surname>van der Hooft</surname><given-names>J.J.J.</given-names></name>
<name><surname>Dorrestein</surname><given-names>P.C.</given-names></name>
<name><surname>Jarmusch</surname><given-names>A.K.</given-names></name>
</person-group><article-title>Advancements in capturing and mining mass spectrometry data are transforming natural products research</article-title><source>Nat. Prod. Rep.</source><year>2021</year><volume>38</volume><fpage>2066</fpage><lpage>2082</lpage><pub-id pub-id-type="doi">10.1039/D1NP00040C</pub-id><pub-id pub-id-type="pmid">34612288</pub-id></element-citation></ref><ref id="B177-life-13-01073"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wolfender</surname><given-names>J.-L.</given-names></name>
<name><surname>Litaudon</surname><given-names>M.</given-names></name>
<name><surname>Touboul</surname><given-names>D.</given-names></name>
<name><surname>Queiroz</surname><given-names>E.F.</given-names></name>
</person-group><article-title>Innovative omics-based approaches for prioritisation and targeted isolation of natural products&#x02014;New strategies for drug discovery</article-title><source>Nat. Prod. Rep.</source><year>2019</year><volume>36</volume><fpage>855</fpage><lpage>868</lpage><pub-id pub-id-type="doi">10.1039/C9NP00004F</pub-id><pub-id pub-id-type="pmid">31073562</pub-id></element-citation></ref><ref id="B178-life-13-01073"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fox Ramos</surname><given-names>A.E.</given-names></name>
<name><surname>Evanno</surname><given-names>L.</given-names></name>
<name><surname>Poupon</surname><given-names>E.</given-names></name>
<name><surname>Champy</surname><given-names>P.</given-names></name>
<name><surname>Beniddir</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Natural products targeting strategies involving molecular networking: Different manners, one goal</article-title><source>Nat. Prod. Rep.</source><year>2019</year><volume>36</volume><fpage>960</fpage><lpage>980</lpage><pub-id pub-id-type="doi">10.1039/C9NP00006B</pub-id><pub-id pub-id-type="pmid">31140509</pub-id></element-citation></ref><ref id="B179-life-13-01073"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gurevich</surname><given-names>A.</given-names></name>
<name><surname>Mikheenko</surname><given-names>A.</given-names></name>
<name><surname>Shlemov</surname><given-names>A.</given-names></name>
<name><surname>Korobeynikov</surname><given-names>A.</given-names></name>
<name><surname>Mohimani</surname><given-names>H.</given-names></name>
<name><surname>Pevzner</surname><given-names>P.A.</given-names></name>
</person-group><article-title>Increased diversity of peptidic natural products revealed by modification-tolerant database search of mass spectra</article-title><source>Nat. Microbiol.</source><year>2018</year><volume>3</volume><fpage>319</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1038/s41564-017-0094-2</pub-id><pub-id pub-id-type="pmid">29358742</pub-id></element-citation></ref><ref id="B180-life-13-01073"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Paulo</surname><given-names>B.S.</given-names></name>
<name><surname>Sigrist</surname><given-names>R.</given-names></name>
<name><surname>Angolini</surname><given-names>C.F.F.</given-names></name>
<name><surname>De Oliveira</surname><given-names>L.G.</given-names></name>
</person-group><article-title>New cyclodepsipeptide derivatives revealed by genome mining and molecular networking</article-title><source>ChemistrySelect</source><year>2019</year><volume>4</volume><fpage>7785</fpage><lpage>7790</lpage><pub-id pub-id-type="doi">10.1002/slct.201900922</pub-id></element-citation></ref><ref id="B181-life-13-01073"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>T.</given-names></name>
<name><surname>Lu</surname><given-names>Q.</given-names></name>
<name><surname>Sun</surname><given-names>C.</given-names></name>
<name><surname>Lukianov</surname><given-names>D.</given-names></name>
<name><surname>Osterman</surname><given-names>I.A.</given-names></name>
<name><surname>Sergiev</surname><given-names>P.V.</given-names></name>
<name><surname>Dontsova</surname><given-names>O.A.</given-names></name>
<name><surname>Hu</surname><given-names>X.</given-names></name>
<name><surname>You</surname><given-names>X.</given-names></name>
<name><surname>Liu</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Hetiamacin E and F, new amicoumacin antibiotics from <italic toggle="yes">Bacillus subtilis</italic> PJS using MS/MS-based molecular networking</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>4446</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25194446</pub-id><pub-id pub-id-type="pmid">32992672</pub-id></element-citation></ref><ref id="B182-life-13-01073"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nothias</surname><given-names>L.-F.</given-names></name>
<name><surname>Petras</surname><given-names>D.</given-names></name>
<name><surname>Schmid</surname><given-names>R.</given-names></name>
<name><surname>D&#x000fc;hrkop</surname><given-names>K.</given-names></name>
<name><surname>Rainer</surname><given-names>J.</given-names></name>
<name><surname>Sarvepalli</surname><given-names>A.</given-names></name>
<name><surname>Protsyuk</surname><given-names>I.</given-names></name>
<name><surname>Ernst</surname><given-names>M.</given-names></name>
<name><surname>Tsugawa</surname><given-names>H.</given-names></name>
<name><surname>Fleischauer</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Feature-based molecular networking in the GNPS analysis environment</article-title><source>Nat. Methods</source><year>2020</year><volume>17</volume><fpage>905</fpage><lpage>908</lpage><pub-id pub-id-type="doi">10.1038/s41592-020-0933-6</pub-id><?supplied-pmid 32839597?><pub-id pub-id-type="pmid">32839597</pub-id></element-citation></ref><ref id="B183-life-13-01073"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aron</surname><given-names>A.T.</given-names></name>
<name><surname>Gentry</surname><given-names>E.C.</given-names></name>
<name><surname>McPhail</surname><given-names>K.L.</given-names></name>
<name><surname>Nothias</surname><given-names>L.-F.</given-names></name>
<name><surname>Nothias-Esposito</surname><given-names>M.</given-names></name>
<name><surname>Bouslimani</surname><given-names>A.</given-names></name>
<name><surname>Petras</surname><given-names>D.</given-names></name>
<name><surname>Gauglitz</surname><given-names>J.M.</given-names></name>
<name><surname>Sikora</surname><given-names>N.</given-names></name>
<name><surname>Vargas</surname><given-names>F.</given-names></name>
<etal/>
</person-group><article-title>Reproducible molecular networking of untargeted mass spectrometry data using GNPS</article-title><source>Nat. Protoc.</source><year>2020</year><volume>15</volume><fpage>1954</fpage><lpage>1991</lpage><pub-id pub-id-type="doi">10.1038/s41596-020-0317-5</pub-id><pub-id pub-id-type="pmid">32405051</pub-id></element-citation></ref><ref id="B184-life-13-01073"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schmid</surname><given-names>R.</given-names></name>
<name><surname>Petras</surname><given-names>D.</given-names></name>
<name><surname>Nothias</surname><given-names>L.-F.</given-names></name>
<name><surname>Wang</surname><given-names>M.</given-names></name>
<name><surname>Aron</surname><given-names>A.T.</given-names></name>
<name><surname>Jagels</surname><given-names>A.</given-names></name>
<name><surname>Tsugawa</surname><given-names>H.</given-names></name>
<name><surname>Rainer</surname><given-names>J.</given-names></name>
<name><surname>Garcia-Aloy</surname><given-names>M.</given-names></name>
<name><surname>D&#x000fc;hrkop</surname><given-names>K.</given-names></name>
<etal/>
</person-group><article-title>Ion identity molecular networking for mass spectrometry-based metabolomics in the GNPS environment</article-title><source>Nat. Commun.</source><year>2021</year><volume>12</volume><fpage>3832</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-23953-9</pub-id><pub-id pub-id-type="pmid">34158495</pub-id></element-citation></ref><ref id="B185-life-13-01073"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Morehouse</surname><given-names>N.J.</given-names></name>
<name><surname>Clark</surname><given-names>T.N.</given-names></name>
<name><surname>McMann</surname><given-names>E.J.</given-names></name>
<name><surname>van Santen</surname><given-names>J.A.</given-names></name>
<name><surname>Haeckl</surname><given-names>F.P.J.</given-names></name>
<name><surname>Gray</surname><given-names>C.A.</given-names></name>
<name><surname>Linington</surname><given-names>R.G.</given-names></name>
</person-group><article-title>Annotation of natural product compound families using molecular networking topology and structural similarity fingerprinting</article-title><source>Nat. Commun.</source><year>2023</year><volume>14</volume><fpage>308</fpage><pub-id pub-id-type="doi">10.1038/s41467-022-35734-z</pub-id><pub-id pub-id-type="pmid">36658161</pub-id></element-citation></ref><ref id="B186-life-13-01073"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zani</surname><given-names>C.L.</given-names></name>
<name><surname>Carroll</surname><given-names>A.R.</given-names></name>
</person-group><article-title>Database for rapid dereplication of known natural products using data from MS and fast NMR experiments</article-title><source>J. Nat. Prod.</source><year>2017</year><volume>80</volume><fpage>1758</fpage><lpage>1766</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.6b01093</pub-id><pub-id pub-id-type="pmid">28616931</pub-id></element-citation></ref><ref id="B187-life-13-01073"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kleks</surname><given-names>G.</given-names></name>
<name><surname>Holland</surname><given-names>D.C.</given-names></name>
<name><surname>Porter</surname><given-names>J.</given-names></name>
<name><surname>Carroll</surname><given-names>A.R.</given-names></name>
</person-group><article-title>Natural products dereplication by diffusion ordered NMR spectroscopy (DOSY)</article-title><source>Chem. Sci.</source><year>2021</year><volume>12</volume><fpage>10930</fpage><lpage>10943</lpage><pub-id pub-id-type="doi">10.1039/D1SC02940A</pub-id><?supplied-pmid 34476071?><pub-id pub-id-type="pmid">34476071</pub-id></element-citation></ref><ref id="B188-life-13-01073"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brugui&#x000e8;re</surname><given-names>A.</given-names></name>
<name><surname>Derbr&#x000e9;</surname><given-names>S.</given-names></name>
<name><surname>Dietsch</surname><given-names>J.</given-names></name>
<name><surname>Leguy</surname><given-names>J.</given-names></name>
<name><surname>Rahier</surname><given-names>V.</given-names></name>
<name><surname>Pottier</surname><given-names>Q.</given-names></name>
<name><surname>Br&#x000e9;ard</surname><given-names>D.</given-names></name>
<name><surname>Suor-Cherer</surname><given-names>S.</given-names></name>
<name><surname>Viault</surname><given-names>G.</given-names></name>
<name><surname>Le Ray</surname><given-names>A.-M.</given-names></name>
<etal/>
</person-group><article-title>MixONat, a software for the dereplication of mixtures based on <sup>13</sup>C NMR spectroscopy</article-title><source>Anal. Chem.</source><year>2020</year><volume>92</volume><fpage>8793</fpage><lpage>8801</lpage><pub-id pub-id-type="doi">10.1021/acs.analchem.0c00193</pub-id><?supplied-pmid 32479074?><pub-id pub-id-type="pmid">32479074</pub-id></element-citation></ref><ref id="B189-life-13-01073"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Egan</surname><given-names>J.M.</given-names></name>
<name><surname>van Santen</surname><given-names>J.A.</given-names></name>
<name><surname>Liu</surname><given-names>D.Y.</given-names></name>
<name><surname>Linington</surname><given-names>R.G.</given-names></name>
</person-group><article-title>Development of an NMR-based platform for the direct structural annotation of complex natural products mixtures</article-title><source>J. Nat. Prod.</source><year>2021</year><volume>84</volume><fpage>1044</fpage><lpage>1055</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.0c01076</pub-id><?supplied-pmid 33750122?><pub-id pub-id-type="pmid">33750122</pub-id></element-citation></ref><ref id="B190-life-13-01073"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pauli</surname><given-names>G.F.</given-names></name>
<name><surname>Chen</surname><given-names>S.-N.</given-names></name>
<name><surname>Lankin</surname><given-names>D.C.</given-names></name>
<name><surname>Bisson</surname><given-names>J.</given-names></name>
<name><surname>Case</surname><given-names>R.J.</given-names></name>
<name><surname>Chadwick</surname><given-names>L.R.</given-names></name>
<name><surname>G&#x000f6;decke</surname><given-names>T.</given-names></name>
<name><surname>Inui</surname><given-names>T.</given-names></name>
<name><surname>Krunic</surname><given-names>A.</given-names></name>
<name><surname>Jaki</surname><given-names>B.U.</given-names></name>
<etal/>
</person-group><article-title>Essential parameters for structural analysis and dereplication by <sup>1</sup>H NMR spectroscopy</article-title><source>J. Nat. Prod.</source><year>2014</year><volume>77</volume><fpage>1473</fpage><lpage>1487</lpage><pub-id pub-id-type="doi">10.1021/np5002384</pub-id><?supplied-pmid 24895010?><pub-id pub-id-type="pmid">24895010</pub-id></element-citation></ref><ref id="B191-life-13-01073"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Williams</surname><given-names>R.B.</given-names></name>
<name><surname>O&#x02019;Neil-Johnson</surname><given-names>M.</given-names></name>
<name><surname>Williams</surname><given-names>A.J.</given-names></name>
<name><surname>Wheeler</surname><given-names>P.</given-names></name>
<name><surname>Pol</surname><given-names>R.</given-names></name>
<name><surname>Moser</surname><given-names>A.</given-names></name>
</person-group><article-title>Dereplication of natural products using minimal NMR data inputs</article-title><source>Org. Biomol. Chem.</source><year>2015</year><volume>13</volume><fpage>9957</fpage><lpage>9962</lpage><pub-id pub-id-type="doi">10.1039/C5OB01713K</pub-id><pub-id pub-id-type="pmid">26381222</pub-id></element-citation></ref><ref id="B192-life-13-01073"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wong</surname><given-names>W.R.</given-names></name>
<name><surname>Oliver</surname><given-names>A.G.</given-names></name>
<name><surname>Linington</surname><given-names>R.G.</given-names></name>
</person-group><article-title>Development of antibiotic activity profile screening for the classification and discovery of natural product antibiotics</article-title><source>Chem. Biol.</source><year>2012</year><volume>19</volume><fpage>1483</fpage><lpage>1495</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2012.09.014</pub-id><pub-id pub-id-type="pmid">23177202</pub-id></element-citation></ref><ref id="B193-life-13-01073"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cox</surname><given-names>G.</given-names></name>
<name><surname>Sieron</surname><given-names>A.</given-names></name>
<name><surname>King</surname><given-names>A.M.</given-names></name>
<name><surname>De Pascale</surname><given-names>G.</given-names></name>
<name><surname>Pawlowski</surname><given-names>A.C.</given-names></name>
<name><surname>Koteva</surname><given-names>K.</given-names></name>
<name><surname>Wright</surname><given-names>G.D.</given-names></name>
</person-group><article-title>A common platform for antibiotic dereplication and adjuvant discovery</article-title><source>Cell Chem. Biol.</source><year>2017</year><volume>24</volume><fpage>98</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2016.11.011</pub-id><pub-id pub-id-type="pmid">28017602</pub-id></element-citation></ref><ref id="B194-life-13-01073"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>S.</given-names></name>
<name><surname>van Santen</surname><given-names>J.A.</given-names></name>
<name><surname>Farzaneh</surname><given-names>N.</given-names></name>
<name><surname>Liu</surname><given-names>D.Y.</given-names></name>
<name><surname>Pye</surname><given-names>C.R.</given-names></name>
<name><surname>Baumeister</surname><given-names>T.U.H.</given-names></name>
<name><surname>Wong</surname><given-names>W.R.</given-names></name>
<name><surname>Linington</surname><given-names>R.G.</given-names></name>
</person-group><article-title>NP Analyst: An open online platform for compound activity mapping</article-title><source>ACS Cent. Sci.</source><year>2022</year><volume>8</volume><fpage>223</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1021/acscentsci.1c01108</pub-id><pub-id pub-id-type="pmid">35233454</pub-id></element-citation></ref><ref id="B195-life-13-01073"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hughes</surname><given-names>C.C.</given-names></name>
</person-group><article-title>Chemical labeling strategies for small molecule natural product detection and isolation</article-title><source>Nat. Prod. Rep.</source><year>2021</year><volume>38</volume><fpage>1684</fpage><lpage>1705</lpage><pub-id pub-id-type="doi">10.1039/D0NP00034E</pub-id><pub-id pub-id-type="pmid">33629087</pub-id></element-citation></ref><ref id="B196-life-13-01073"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sch&#x000e4;fer</surname><given-names>R.J.B.</given-names></name>
<name><surname>Wilson</surname><given-names>K.</given-names></name>
<name><surname>Biedermann</surname><given-names>M.</given-names></name>
<name><surname>Moore</surname><given-names>B.S.</given-names></name>
<name><surname>Sieber</surname><given-names>S.</given-names></name>
<name><surname>Wennemers</surname><given-names>H.</given-names></name>
</person-group><article-title>Identification of isonitrile-containing natural products in complex biological matrices through ligation with chlorooximes</article-title><source>Chem. Eur. J.</source><year>2023</year><volume>29</volume><fpage>e202203277</fpage><pub-id pub-id-type="doi">10.1002/chem.202203277</pub-id><pub-id pub-id-type="pmid">36331430</pub-id></element-citation></ref><ref id="B197-life-13-01073"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>M&#x000fc;ller</surname><given-names>M.J.</given-names></name>
<name><surname>Dorst</surname><given-names>A.</given-names></name>
<name><surname>Paulus</surname><given-names>C.</given-names></name>
<name><surname>Khan</surname><given-names>I.</given-names></name>
<name><surname>Sieber</surname><given-names>S.</given-names></name>
</person-group><article-title>Catch-enrich-release approach for amine-containing natural products</article-title><source>Chem. Commun.</source><year>2022</year><volume>58</volume><fpage>12560</fpage><lpage>12563</lpage><pub-id pub-id-type="doi">10.1039/D2CC04905H</pub-id></element-citation></ref><ref id="B198-life-13-01073"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Berlinck</surname><given-names>R.G.S.</given-names></name>
<name><surname>Monteiro</surname><given-names>A.F.</given-names></name>
<name><surname>Bertonha</surname><given-names>A.F.</given-names></name>
<name><surname>Bernardi</surname><given-names>D.I.</given-names></name>
<name><surname>Gubiani</surname><given-names>J.R.</given-names></name>
<name><surname>Slivinski</surname><given-names>J.</given-names></name>
<name><surname>Michaliski</surname><given-names>L.F.</given-names></name>
<name><surname>Tonon</surname><given-names>L.A.C.</given-names></name>
<name><surname>Venancio</surname><given-names>V.A.</given-names></name>
<name><surname>Freire</surname><given-names>V.F.</given-names></name>
</person-group><article-title>Approaches for the isolation and identification of hydrophilic, light-sensitive, volatile and minor natural products</article-title><source>Nat. Prod. Rep.</source><year>2019</year><volume>36</volume><fpage>981</fpage><lpage>1004</lpage><pub-id pub-id-type="doi">10.1039/C9NP00009G</pub-id><pub-id pub-id-type="pmid">31049509</pub-id></element-citation></ref><ref id="B199-life-13-01073"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>H.</given-names></name>
<name><surname>Han</surname><given-names>X.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Dong</surname><given-names>Y.</given-names></name>
<name><surname>Xu</surname><given-names>S.</given-names></name>
<name><surname>Bao</surname><given-names>Y.</given-names></name>
<name><surname>Chen</surname><given-names>C.</given-names></name>
<name><surname>Feng</surname><given-names>Y.</given-names></name>
<name><surname>Cui</surname><given-names>Q.</given-names></name>
<name><surname>Li</surname><given-names>W.</given-names></name>
</person-group><article-title>An effective strategy for identification of highly unstable bacillaenes</article-title><source>J. Nat. Prod.</source><year>2019</year><volume>82</volume><fpage>3340</fpage><lpage>3346</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.9b00609</pub-id><pub-id pub-id-type="pmid">31773959</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="life-13-01073-f001"><label>Figure 1</label><caption><p>Traditional phenotypic screening (the &#x0201c;Waksman platform&#x0201d;).</p></caption><graphic xlink:href="life-13-01073-g001" position="float"/></fig><fig position="float" id="life-13-01073-f002"><label>Figure 2</label><caption><p>Structures of gausemycins, recently discovered lipoglycopeptide antibiotics.</p></caption><graphic xlink:href="life-13-01073-g002" position="float"/></fig><fig position="float" id="life-13-01073-f003"><label>Figure 3</label><caption><p>Main modern approaches in the screening of new antibiotics from natural sources.</p></caption><graphic xlink:href="life-13-01073-g003" position="float"/></fig><fig position="float" id="life-13-01073-f004"><label>Figure 4</label><caption><p>Basic microbiological approaches to the search for new antibiotics.</p></caption><graphic xlink:href="life-13-01073-g004" position="float"/></fig><fig position="float" id="life-13-01073-f005"><label>Figure 5</label><caption><p>Peptide antibiotics darobactin and evybactin, recently found to be produced by the nematode microbiome.</p></caption><graphic xlink:href="life-13-01073-g005" position="float"/></fig><fig position="float" id="life-13-01073-f006"><label>Figure 6</label><caption><p>Instrumentation of the iChip technology: diffusion chambers and their multiplication on iChip.</p></caption><graphic xlink:href="life-13-01073-g006" position="float"/></fig><fig position="float" id="life-13-01073-f007"><label>Figure 7</label><caption><p>Antibiotics teixobactin, amycobactin, and hypeptin, recently discovered using the iChip technology.</p></caption><graphic xlink:href="life-13-01073-g007" position="float"/></fig><fig position="float" id="life-13-01073-f008"><label>Figure 8</label><caption><p>Repurposed antibiotics fidaxomicin and hygromycin A.</p></caption><graphic xlink:href="life-13-01073-g008" position="float"/></fig><fig position="float" id="life-13-01073-f009"><label>Figure 9</label><caption><p>Narrow-spectrum antibiotics threoglucin A and tryglusins A and B.</p></caption><graphic xlink:href="life-13-01073-g009" position="float"/></fig><fig position="float" id="life-13-01073-f010"><label>Figure 10</label><caption><p>Basic molecular biology approaches to the search for new antibiotics.</p></caption><graphic xlink:href="life-13-01073-g010" position="float"/></fig><fig position="float" id="life-13-01073-f011"><label>Figure 11</label><caption><p>Clinically approved antibiotic daptomycin and its congeners taromycins discovered using a metagenomics approach; differences in structure are highlighted in red.</p></caption><graphic xlink:href="life-13-01073-g011" position="float"/></fig><fig position="float" id="life-13-01073-f012"><label>Figure 12</label><caption><p>Lipopeptide antibiotics malacidins and cadasides discovered using metagenomics search for the Ca-binding motif. In the lower diagram: Red&#x02014;conserved Ca-binding motif, gray&#x02014;D-amino acids.</p></caption><graphic xlink:href="life-13-01073-g012" position="float"/></fig><fig position="float" id="life-13-01073-f013"><label>Figure 13</label><caption><p>Glycopeptide antibiotics A50926 and A40926.</p></caption><graphic xlink:href="life-13-01073-g013" position="float"/></fig><fig position="float" id="life-13-01073-f014"><label>Figure 14</label><caption><p>New antimicrobial (lipo)peptide antibiotics macolacin, cilagicin and dynobactin, discovered by genome mining.</p></caption><graphic xlink:href="life-13-01073-g014" position="float"/></fig><fig position="float" id="life-13-01073-f015"><label>Figure 15</label><caption><p>Structures of corbomycin, rimomycins A&#x02013;C, and misaugamycins A,B.</p></caption><graphic xlink:href="life-13-01073-g015" position="float"/></fig><fig position="float" id="life-13-01073-f016"><label>Figure 16</label><caption><p>Structures of marinolactam A and bipentaromycins A&#x02013;F.</p></caption><graphic xlink:href="life-13-01073-g016" position="float"/></fig><fig position="float" id="life-13-01073-f017"><label>Figure 17</label><caption><p>Peptide antibiotic cebulantin and its inductors furosemide and fenofibrate; peptide antibiotic cinnapeptin and its inductor amygdalin.</p></caption><graphic xlink:href="life-13-01073-g017" position="float"/></fig><fig position="float" id="life-13-01073-f018"><label>Figure 18</label><caption><p>Cyclopeptide momomycin and its elicitors.</p></caption><graphic xlink:href="life-13-01073-g018" position="float"/></fig><fig position="float" id="life-13-01073-f019"><label>Figure 19</label><caption><p>Structures of auroramycin, oxazolepoxidomycin A, piloquinone and homopiloquinone.</p></caption><graphic xlink:href="life-13-01073-g019" position="float"/></fig><fig position="float" id="life-13-01073-f020"><label>Figure 20</label><caption><p>Structures of gaudimycins D, E discovered by means of RGMS.</p></caption><graphic xlink:href="life-13-01073-g020" position="float"/></fig><fig position="float" id="life-13-01073-f021"><label>Figure 21</label><caption><p>Reporter strain-assisted screening strategy.</p></caption><graphic xlink:href="life-13-01073-g021" position="float"/></fig><fig position="float" id="life-13-01073-f022"><label>Figure 22</label><caption><p>Basic chemical approaches to the search for new antibiotics.</p></caption><graphic xlink:href="life-13-01073-g022" position="float"/></fig><fig position="float" id="life-13-01073-f023"><label>Figure 23</label><caption><p>Molecular networking used for dereplication.</p></caption><graphic xlink:href="life-13-01073-g023" position="float"/></fig><fig position="float" id="life-13-01073-f024"><label>Figure 24</label><caption><p>Structures of arromycin and echinoserine sulfoxide.</p></caption><graphic xlink:href="life-13-01073-g024" position="float"/></fig><fig position="float" id="life-13-01073-f025"><label>Figure 25</label><caption><p>Structures of amychelin C and dracolactam C.</p></caption><graphic xlink:href="life-13-01073-g025" position="float"/></fig><fig position="float" id="life-13-01073-f026"><label>Figure 26</label><caption><p>Chemical derivatization of labile isonitrile natural products.</p></caption><graphic xlink:href="life-13-01073-g026" position="float"/></fig><fig position="float" id="life-13-01073-f027"><label>Figure 27</label><caption><p>Structures of unstable bacillaenes.</p></caption><graphic xlink:href="life-13-01073-g027" position="float"/></fig><fig position="float" id="life-13-01073-f028"><label>Figure 28</label><caption><p>Schematic representation of modern trends in antibiotic discovery.</p></caption><graphic xlink:href="life-13-01073-g028" position="float"/></fig></floats-group></article>